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Abbreviations 
m-CPBA 3-chloroperbenzoic acid 
3D-QSAR three-dimensional quantitative structure activity relationship 
Ac  acetyl 
acac  acetoacetyl 
ATP  adenosine triphosphate 
Bn  benzyl 
Borsm  based on recovered starting material 
Bu  butyl 
But-Me 2-methylbutanoyl 
Bz  benzoyl 
Cin  cinnamyl 
CSA  camphorsulfonic acid 
Cy  cyclohexyl 
d.r.  diastereomeric ratio 
DBN  1,5-diazabicyclo-(4,3,0)-nonene 
DBU  1,8-diazobicyclo[5.4.0]ndec-7-ene 
DCC  N,N’-dicyclohexylcarbodiimide 
DEAD  diethyl azodicarboxylate 
DEPT   Distortionless Enhancement by Polarization Transfer 
DHP  dihydropyran 
DIAD  diisopropyl azodicarboxylate 
DIBAL-H diisobutyl aluminium hydride 
DIPEA diisopropylethylamine 
DIPT  diisopropyl tartrate 
DMAP  4-dimethylaminopyridine 
DMDO dimethyldioxirane 
DME  dimethoxyethane 
DMF  dimethylformamide 
DMP  2,2-dimethoxypropane 
Abbreviations 
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DMPU  N,N´-Dimethylpropyleneurea 
EVK  ethyl vinyl ketone 
Fu  2-furyl 
h  hour(s) 
HIV  human immunodeficiency virus 
HMDS  hexamethyldisilazane 
HMPA  hexamethylphosphoramide 
IR  infra-red 
LDA  lithium diisopropylamine 
MANT methyantranoyl 
MDR  multi-drug resistance 
Me  methyl 
min  minute(s) 
MOM  methoxymethyl 
Ms  methanesulfonyl 
MS  mass spectrometry 
NBS  N-bromosuccinimide 
NMO  N-methylmorpholine-N-oxide 
NMP  N-methylpyrrolidin-2-one 
nOe  nuclear overhauser effect 
NOESY nuclear overhauser effect spectroscopy 
PG  protecting group 
P-GP  p-glycoprotein 
Ph  phenyl 
PMB  para-methoxybenzyl 
PMP  para-methoxyphenyl 
PPTS  pyridinium para-toluenesulfonate 
Pr  propyl 
PTSA  para-toluenesulfonic acid 
Py  pyridine 
PyBOP benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate 
Abbreviations 
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RCM  ring-closing metathesis 
rt  room temperature 
SAR  structure activity relationship 
SD  standard deviation 
sol  solvent  
TBAF  tetrabutylammonium fluoride 
TBS  tert-butyldimethylsilyl 
TES  triethylsilyl 
Tf  trifluoromethanesulfonyl 
TFA  trifluoroacetic acid 
THF  tetrahydrofuran 
TLC  thin layer chromatography 
TMEDA N,N,N´,N´-trimethylethylenediamine 
TMS  trimethylsilyl 
Ts  para-toluenesulfonyl 
 
α,β-nomenclature: in this thesis faces of molecules are referred to as either α- or β-. In 
keeping with naming conventions in the literature for dihydroagarofurans, the α-face 
designates the top face and the β-face designates the lower face as drawn. 
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Abstract 
(–)-euonyminol is a poly-oxygenated sesquiterpene which was first isolated in 1953 by 
Beroza. It was isolated by the saponification of a mixture of four alkaloids from 
Tripterygium wilfordii Hook, a member of the Celastraceae plant family. Since its 
discovery, (–)-euonyminol has been found to be a common core for a plethora of other 
Celastraceae natural products. Among these are hypogluanine B and triptonine B, two 
potent anti-HIV compounds. 
In this thesis, an overview of the natural products of the Celastraceae is given, 
highlighting euonyminol as a core of high value both in terms of biological activity and 
as an intriguing synthetic target. The biological significance of the natural product class is 
described with particular focus upon anti-HIV and multi-drug resistance reversal 
properties. Prior synthetic work towards euonyminol and other molecules similar in 
structure is also described. 
The remainder of the thesis describes work carried out towards the total asymmetric 
synthesis of (–)-euonyminol, employing a model system to develop chemistry suitable for 
installing the southern hemisphere oxygenation pattern. Two synthetic routes are 
described and both of these feature an Ireland-Claisen rearrangement as the key step. 
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CHAPTER 1 - Introduction 
1.1. Natural products of the Celastraceae family 
The Celastraceae family comprises some 1300 species of plants.1 Extracts from these 
plants have been valued throughout history for the range of biological activities that they 
possess. The medicinal properties attributed to Celastraceae extracts include anti-tumour, 
anti-bacterial, stimulant, appetite suppressant, male contraceptive, anti-leukaemic and 
anti-HIV activity.2 Extracts have also been widely used for their insect anti-feedant and 
insecticidal properties.3 
 
A number of structurally diverse secondary metabolites have been isolated from the 
Celastraceae (Figure 1.1).  
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Figure 1.1 Secondary metabolites of the Celastraceae family 
 
The isolation of the macrolide maytansine from Maytenus ovatus and the discovery of its 
anti-leukaemic properties4 heralded the beginning of a period of intense interest in the 
biological activity of Celastraceae natural products. Swiftly following the isolation of 
maytansine came the isolation of the diterpene triepoxide triptolide from Tripterygium 
wilfordii Hook.5 This also displayed anti-tumour and anti-leukaemic activity. A vast 
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number of natural products have since been isolated from the Celastraceae family and 
another example is the sesquiterpene-based alkaloid hypogluanine B which has more 
recently been shown to possess potent anti-HIV properties.6 
 
1.2. Sesquiterpenoids of the Celastraceae family 
 
The class of compounds from the Celastraceae that has received the most attention is the 
group of highly oxygenated sesquiterpenoids of which hypogluanine B is a member. 
Generally these sesquiterpenoids are composed of a tricyclic C15 scaffold known as 
dihydroagarofuran (Figure 1.2).  
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Figure 1.2 The structure of the dihydroagarofuran skeleton 
 
Compounds of this type are pervasive in nature with well over 200 having been isolated 
to date. The tricyclic dihydroagarofuran skeleton features a trans-decalin structure, which 
is axially alkylated at positions C4, C7 and C10. An ether linkage between C5 and C11 
gives rise to the tetrahydrofuran ring on the bottom face of the decalin as drawn. The 
structure shown is often referred to as β-dihydroagarofuran. The β-designation comes 
from the fact that this compound is the major isomer obtained from the catalytic 
hydrogenation of (–)-β-agarofuran which has a double bond between C4 and C15.  
 
Natural products of the Celastraceae contain cores in which almost any carbon may be 
oxygenated, with variable stereochemistry.  These various oxygenation patterns, 
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combined with the range of esterifying groups that each oxygen may bear, contribute to 
the expansive range of structures seen in Nature.  
 
1.3. Euonyminol 
 
Euonyminol is one of the most highly oxygenated of the dihydroagarofuran skeletons and 
was first isolated by Beroza from extracts of the root bark of Tripterygium wilfordii 
Hook.7 Four discrete ester alkaloids were separated from the extraction: wilforine, 
wilfordine, wilforgine and wilfortrine (Figure 1.3).  
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Figure 1.3 Beroza’s extracts from Trypterygium wilfordii 
 
Upon saponification these esters were all found to be based on the same 
polyhydroxylated core with the molecular formula C15H25O10. The white crystalline solid 
itself was seen to have no distinct melting point and no ultraviolet chromophore (Figure 
1.4). 
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Figure 1.4 – (–)-euonyminol 
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The compound was given the name euonyminol by the group of Hirata8 when their 
sample, obtained from the LiAlH4 reduction of the alkaloid evonine, was found to be 
identical to the polyol derived  from euonymine, a minor alkaloid from Euonymus 
sieboldiana. A structure for euonyminol was proposed independently by the groups of 
both Hirata9 and Streicher10 based upon nOe studies of the major diastereoisomer 
obtained from the LiAlH4 reduction of evonine and neoevonine (Figure 1.5).  
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Figure 1.5 – Structures of evonine and neoevonine 
 
In 1972, an anomalous dispersion single crystal X-ray structure determination of an 
evonine derivative by Hirata determined the absolute stereochemistry of the natural 
material.11 The relative stereochemistry observed was found to be in accordance with that 
assigned previously by nOe studies for (–)-euonyminol, with the exception of the C7 
centre which is at the ketone oxidation level in evonine. By correlation, the absolute 
stereochemistry of (–)-euonyminol could then be assigned, with Hirata and Streicher’s 
nOe studies guiding the choice of epimer at C7. In 1977, the first single crystal X-ray 
structure determination of (–)-euonyminol isolated from Tripterygium wilfordii 
confirmed the relative stereochemistry of all stereogenic centres, importantly including 
C7, and this was found to agree with that originally proposed by Hirata and Streicher.12 
 
Euonyminol has been found to be the core substituent of a number of Celastraceae natural 
products and some of these possess interesting biological properties, particularly with 
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regard to anti-HIV activity and inhibition of multi-drug resistance (vide infra). It stands 
as an intriguing target for total synthesis from this biological viewpoint and, with its 
symmetrical array of functionalisation across the top half of the molecule; it provides an 
attractive challenge for the synthetic chemist.  
 
1.4. Biological activity of the sesquiterpenoids 
 
The biological activity of the Celastraceae sesquiterpenoids was reviewed in 2002.13 This 
report will therefore focus upon developments since 2002 with particular emphasis placed 
upon the potential for these compounds as agents for multi-drug resistance reversal and 
also for the treatment of HIV. A more recent review has also appeared which gives a 
summary of the biological activities of a number of extracts from across the Celastraceae 
family.14 
 
1.4.1. Applications in inhibiting multi-drug resistance 
 
Multi-drug resistance (MDR) is a common problem encountered in the chemotherapy of 
cancer and of diseases produced by protozoan parasites such as malaria. In cancer for 
instance, it is often seen that cancer cells become less responsive to drug treatment as the 
duration of treatment increases. There has recently been a great deal of attention placed 
on the understanding of MDR in the field of oncology.15,16  
 
There are a number of mechanisms postulated for the resistance17 and one of the most 
prominent involves the transporter protein P-glycoprotein (P-GP).16 P-GP is an ATP-
dependant plasma membrane protein which has been shown to pump substrates out of 
tumour cells. Among important transport substrates of P-GP are the chemotherapeutic 
agents vinblastine and daunomycin (Figure 1.6).  
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Figure 1.6 Chemotherapeutic agents which are substrates for P-GP. 
 
It has been shown that tumour cells over-express P-GP18,19 and so drugs which are 
targeted at inhibiting its function have been a major goal over the last 15 years.20 One of 
the major obstacles to the development of an effective drug treatment for MDR has been 
the high toxicity associated with many of the agents. While many modulators of P-GP 
have been found, they are often themselves transported by P-GP and so are effluxed by 
the pump along with the cytotoxic compounds. This requires there to be a high, often 
toxic concentration of the P-GP modulator in the blood for appreciable MDR reversal to 
occur. 
 
The Celastraceae sesquiterpenes have recently been highlighted as having the potential to 
be the next generation of MDR reversal agents. In experiments testing 28 β-
dihydroagarofuran sesquiterpenes for their effects on the cytotoxicity of both vinblastine 
and daunomycin, the group of Castanys has shown that sesquiterpenes bind exclusively to 
PG-P and not to any other pumps thought to be implicated in MDR.21 Furthermore, the 
same group synthesised the fluorescent methyantranoyl (MANT) sesquiterpene derivative 
1 which retained most of the modulator activity (Figure 1.7).  
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Figure 1.7 Synthesis of a fluorescent-labelled sesquiterpene22 
 
The MANT derivative was then shown to be transported insignificantly by P-GP.22 This 
work serves to highlight the attractiveness of these privileged structures for future use as 
MDR reversal agents. In principle, a drug substrate which is not itself transported by P-
GP could be effective at much lower concentrations than existing drugs. Further 
structure-activity relationship (SAR) studies could improve the P-GP modulator efficacy 
while maintaining the low levels of toxicity. 
 
A number of SAR studies have been carried out on dihydroagarofuran sesquiterpenes in 
relation to their MDR reversal activity.23,24 The most recent and most extensive study 
tested a panel of 76 naturally occurring and semi-synthetic dihydroagarofurans on NIH-
3T3 cells overexpressing human P-GP25 (Figure 1.8).  
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Figure 1.8 Selected examples of sesquiterpene polyesters tested for MDR reversal25 
 
The relative potencies calculated from these tests were then used to construct a three 
dimensional quantitative structure-activity relationship (3D-QSAR) which helped identify 
key structural features of sesquiterpenes which promote P-GP inhibition (Table 1.1). 
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Compound Ki† ± SD (µM) pKi (M) logP Imax 
2 2.19 ± 0.46 5.66 6.5 80.5 
3 2.91 ± 0.43 5.54 5.1 95.7 
4 4.16 ± 0.21 5.38 4.3 51.8 
5 0.70 ± 0.05 6.15 7.1 93.1 
6 1.13 ± 0.17 5.95 6.2 100.0 
7 0.57 ± 0.06 6.24 6.6 95.5 
8 100.00 ± 1.00 4.00 4.3 100.0 
9 6.61 ± 0.85 5.18 5.3 96.3 
10 5.53 ± 0.79 5.26 4.7 41.2 
11 17.48 ± 8.27 4.76 3.4 100.0 
12 0.70 ± 0.05 6.15 6.1 85.9 
13 4.39 ± 0.12 5.36 5.0 85.0 
14 2.36 ± 0.50 5.63 5.7 80.8 
15 1.74 ± 0.24 5.76 7.6 97.0 
16 1.71 ± 0.18 5.77 8.3 86.2 
17 8.46 ± 1.49 5.07 6.3 82.9 
18 4.25 ± 1.07 5.37 6.2 63.7 
19 6.94 ± 3.64 5.16 6.0 76.6 
20 2.72 ± 0.30 5.57 7.4 75.8 
†Sesquiterpene concentration which yields half maximal inhibition of P-GP (Imax) 
Table 1.1 Biological data on a subset of compounds tested 
 
There are a number of general trends which may be drawn from the data obtained and 
with the restricted data set presented here it is possible to highlight a few of the most 
fundamental. Generally speaking, the presence of free hydroxyl groups in a molecule 
does not confer high activity. The reason for this is partly due to the influence that a free 
hydroxyl group has on the logP of a molecule. An inhibitor of P-GP must be sufficiently 
lipophilic to be absorbed into the cell membrane and two of the most polar compounds 
presented, 8 (logP = 4.3) and 11 (logP = 3.4), are also the least potent. Derivatives 
containing hydroxyl groups at C1, C3 and C6 were also shown to be less potent than their 
congeners having esterifying residues at these positions. Compounds 2, 3, 12 and 20 are 
all more potent than the analogous compounds 10, 8, 11, and 17 where one esterifying 
group is absent. An esterifying group at C2 also appears to be important for activity. This 
can be seen by comparing the potency of the C2 esters 2, 3 and 5-7 with the C2 alcohol 4 
and the unsubstituted methylene-containing derivative 9. It was proposed that the 
carbonyl oxygen of the ester functionality is able to act as a hydrogen bond acceptor 
within the P-GP binding site. Another point to note is that the presence of a bulky, 
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lipophilic benzoate ester substituent at C8 seems to improve potency. This can be seen by 
directly comparing compounds 13 and 14 with compounds 15 and 16 respectively. 
 
A 3D-QSAR study was carried out to better understand the structural basis for inhibitory 
action of P-GP using the comparative molecular similarity indices analysis (CoMSIA). 
This computational method highlights structural elements which are key to activity and is 
also informative when trying to synthesise more active analogues.  
 
The results of Castanys’ 3D-QSAR can be concisely represented in a schematic diagram 
(Figure 1.9).25 
 
 
Figure 1.9 - 3D-QSAR using the comparative molecular similarity indices analysis 
(CoMSIA)25 
 
The pink spheres around the scaffold indicate areas where pendant groups act as 
hydrogen bond acceptors with the PG-P receptor. This is consistent with the observation 
that carbonyl groups attached to the C2α, C3 and C8 positions are beneficial for activity. 
The green and blue spheres show the importance of a hydrophobic substituent at the C2β 
and C6 positions respectively. 
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1.4.2. Anti-HIV activity 
 
Another aspect which has generated a great deal of interest in the sesquiterpenes of the 
Celastraceae has been their anti-HIV activity. The group of Takaishi have recently 
evaluated the anti-HIV activity of a number of macrocyclic sesquiterpene pyridine 
alkaloids.6,26 Upon the isolation of three new compounds, triptonides A-C, sufficient data 
(22 compounds) was available to perform the first SAR studies for anti-HIV activity.27 
All compounds tested were based upon the euonyminol skeleton with a nicotinic acid-
derived ligand forming a macrocyclic dilactone. Compounds were screened on HIV-1-
infected H9 lymphocytes and four compounds, triptonine B, hyponine B (Figure 1.10), 
hypogluanine B (Figure 1.1) and wilfortrine (Figure 1.3), were found to have a 
therapeutic index (TI) >1000. Typically, a TI greater than 5 is considered significant.   
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Figure 1.10 – Natural products tested in the HIV assay 
 
A number of conclusions were drawn from the data and one of the most notable was that 
all active compounds bore an OAc group at the C6 position. Other groups at this position 
reduced activity, with the 3-furyl ester being the least favourable. This derivative was less 
active than even the free hydroxyl group. The substitution pattern on the pyridine ring 
does not seem to have a profound effect on activity. Compounds containing either a 2-
substituted nicotinic acid (e.g. hyponine B) or a 4-substituted nicotinic acid moiety (e.g. 
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triptonine B) were assigned and both motifs were found in active compounds. The 
presence of a hydroxyl group in the diacid ligand also seems to be favourable although 
hyponine B is clearly an exception to this trend. All of the compounds tested were 
naturally occurring and were isolated from plant material. This fact highlights further the 
need for a synthetic approach towards molecules of this type. In general, the abundances 
of these natural products are low and a synthetic approach which allows access to 
structural analogues of active natural products could well lead to exciting developments 
in the field of HIV treatment. Euonyminol itself can be singled out on these grounds as a 
valuable synthetic target; with all active compounds containing it as their core scaffold. 
 
1.5. Previous synthetic work towards the dihydroagarofuran 
skeleton 
 
The interesting biological activities displayed by the dihydroagarofuran structural class 
have encouraged a number of groups to develop syntheses of poly-functionalised 
members of this group of compounds. As indicated above, synthetic approaches to 
Celastraceae sesquiterpenoids were reviewed in 2002 and so the following sections focus 
mainly on more recent developments. 
 
1.5.1. Ducrot’s dihydoagarofuran synthesis 
 
A major contributor to the synthetic effort has been the group of Ducrot. In early work,28 
1,4-dione 27 was made racemically and highlighted as being an important intermediate en 
route to forming dihydroagarofuran structures. This intermediate was later made 
enantioselectively29 (Scheme 1.1).  
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oC; (ii) (S,S)-hydrobenzoin, PTSA, benzene, reflux [56% two 
steps]; (iii) Dess Martin Periodinane, CH2Cl2, pyridine, 0 
oC [88%]; (iv) NaH, (MeO)2CO, THF, reflux [78%]; 
(v) PhSeCl, pyridine, CH2Cl2, 0 
oC to rt; (vi) H2O2, 0 
oC to rt [99% two steps]; (vii) Furan, BF3.Et2O, CH2Cl2, 
-78 oC to -60 oC [84%]; (viii) DMDO, acetone, -10 oC to rt then MgSO4 [54%] (ix) TBSOTf, 2,6-lutidine, 
CH2Cl2, 0 
oC to rt [65%]; (x) H2, Pd/C 10%, MeOH, rt [85%]; (xi) Li(t-BuO)3AlH, THF, -70 
oC to rt [66%]; (xii) 
H2, Pd(OH)2/C 10%, EtOAc, rt, 18 h [68%]
Scheme 1.1 - Ducrot’s enantioselective synthesis of key 1,4-dione intermediate 2728  
 
The chiral 1,2-diol employed to form the mono-ketal-protected dione 21 was responsible 
for inducing the enantioselectivity in the final target. Conjugate addition of furan to the 
α,β-unsaturated keto ester 23  was selective for attack on the top face under the 
conditions shown. The resulting product was then well set up to undergo an oxidative 
cyclisation to form cis-decain 25 via ring opening of the furan and subsequent 
intramolecular aldol condensation. The protecting group was removed by hydrogenolysis 
as other methods attempted yielded degraded products or unreacted starting material.  
 
With a route to enantiomerically enriched dione 27 established, Ducrot looked into the 
installation of the THF ring via oxidation at C7 (Scheme 1.2).30  
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Scheme 1.2 - Ducrot’s development of a procedure for allylic oxidation at C730 
 
Following elimination of secondary alcohol 27, selective 1,2-attack of MeLi onto the 
resulting α,β-unsaturated carbonyl installed the allylic alcohol functionality. It was then 
found that a large excess of DMDO at room temperature was optimal for the formation of 
ketone 30 in preference to the possible rearrangement products.  
 
At the same time as work on the allylic oxidation, work towards the fully furnished 
tricyclic dihydroagarofuran structure was being performed on a model system 31 
(Scheme 1.3).31  
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Reagents and yields: (i) DIBAL-H, CH2Cl2, -70 
oC [97%]; (ii) NO2)2C6H3CO2H, DEAD, PPh3, THF, -10 
oC to 
rt; (iii) K2CO3, MeOH, 0
 oC; (iv) 3-CPBA, CH2Cl2, -10 
oC to rt; (v) TsCl, pyridine, -10 oC to 0 oC [42% four 
steps]; (vi) NaCN, HMPA, rt [70%]; (vi) MeLi, Et2O, -60
 oC to 0 oC; (viii) PPTS, Et2O/H2O, rt [75% two steps]; 
(ix) MeLi, Et2O, -70 
oC to 0 oC [80%]; (x) 3-CPBA, CH2Cl2, rt [91%]; (xi) H2SO4, acetone/H2O, rt [39%]  
Scheme 1.3 – Ducrot’s installation of the tricyclic ring system from a model compound 
missing a carbon substituent at the C4 position31 
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The model system was a surrogate for the α,β-unsaturated ketone 30 and was further 
functionalised starting with a reduction of the C7 ketone and then a Mitsunobu inversion 
of the resulting alcohol 32. Epoxidation and tosylation gave the intermediate 27 which 
was converted to the α,β-unsaturated nitrile 35 by treatment with NaCN in HMPA. The 
final ring-closing step of the synthesis involves acid-catalysed displacement of the 
hydroxyl group at the decalin bridgehead with simultaneous hydrolytic opening of the 
epoxide. 
 
In principle, the elaboration of the α,β-unsaturated ketone 31 to the tricyclic compound 
38, combined with the allylic oxidation procedure, paves the way for a synthesis of a 
number of polyhydroxylated agarofurans from the enantiomerically pure dione 27. 
 
1.5.2. Li’s dihydroagarofuran synthesis 
 
Another contributor to the field has been the group of Li, who have recently described an 
enantioselective synthesis of the dihydroagarofuran skeleton. The Li synthesis, like 
several previous syntheses of dihydroagarofurans, starts from naturally occurring (–)-
carvone (Scheme 1.4).32  
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oC, 2.5 h; (ii) 1N NaOH, H2O, reflux, 1 h [25% 
two steps]; (iii) EVK, KOH, MeOH, reflux, 6 h [85%]; (iv) D-(+)-phenylalanine, D-(+)-CSA, 30-70 oC 6 days 
[51%]; (v) NaBH4, MeOH, 0 
oC, 3 h [75%]; (vi) TsNHNH2, BF3.Et2O, rt, 2 h [95%]; (vii) n-BuLi, THF, -78 
oC 
to 0 oC, 10 h [90%]; (viii) O3-P(OPh)3, CH2Cl2, -78
 oC to 0 oC, 2.5 h [81%]; (ix) K2CO3, THF, 40 
oC, 24 h 
[78%]; (x) Mn(OAc)3, PhH, reflux, 10 h [53%]; (xi) TfOH, THF, rt, 5 min [95%]
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Scheme 1.4 - Li’s synthesis of the dihydroagarofuran skeleton32 
 
The key step in setting up the decalin framework is an asymmetric Robinson annulation 
of the triketone 40. This was catalysed by D-(+)-phenylalanine and proceeded in 
moderate yield (51%). Selective borohydride reduction of the C9 ketone followed by 
tosyl hydrazone formation at C3 allowed formation of the conjugated diene 42 by 
treatment with excess n-BuLi. The endoperoxide 43 was then formed and upon treatment 
with K2CO3, underwent a Kornblum-DeLaMare rearrangement to give hydroxy-enone 
44. This compound was later used by the same group as an advanced intermediate in the 
synthesis of the natural product (–)-isocelorbicol.33 Before cyclisation to form the THF 
ring, a regioselective acetoxylation was performed on the ketone with Mn(OAc)3. The 
cyclisation itself was induced by treatment with TfOH.  
 
1.5.3. Mehta’s dihydoragarofuran synthesis 
 
The group of Mehta have also published an approach to the dihydroagarofuran skeleton 
starting from (–)-carvone.34 They have employed a ring–closing metathesis (RCM) 
reaction to form the decalin core (Scheme 1.5).  
Chapter 1 - Introduction 
23 
 
46 47 48
49 5051
O O
O
O
OH
O
OH
OH
OH
OH
OH
OH
OH
i ii
iii
iv
Ratio 47:48 = 55:45
Ratio 49:50 = 45:55
Reagents and yields: (i) 30% H2O2, 6N NaOH, MeOH, 0 
oC [92%]; (ii) Li, NH3, CH2=CHCH2Br, 
Et2O, -78 
oC [60%]; (iii) CH2=CHCH(CH3)MgCl, CeCl3, THF, -78 
oC [95%]; (iv) Grubbs' I catalyst, 
PhH, 85 oC [95%]  
Scheme 1.5 - Mehta’s ring-closing metathesis approach to installing the decalin 
framework34 
 
The route starts with facially selective epoxidation, then α-allylation of the ketone under 
dissolving metal conditions. Two epimers arise from this allylation and the major isomer 
47 was taken forward in the synthesis. A second allylation by treatment with an allyl 
Grignard reagent gave rise to the terminal dienes 49 and 50. Both were shown to undergo 
RCM, with diene 49 doing so in very good yield (95%) to form decalin 51. Further 
functional group interconversions from this intermediate were able to provide tertiary 
alcohol 52 (Scheme 1.6). 
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Reagents and yields: (i) 3-CPBA, NaHCO3, CH2Cl2 [90%]; (ii) TMSOTf, CH2Cl2, 0 
oC [55%]  
Scheme 1.6 – Mehta’s ring-closure to form the THF ring34 
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Alcohol 52 could be cyclised under Lewis acidic conditions after epoxidation on the top 
face of the molecule as drawn using m-CPBA. 
 
1.5.4. Floreancig’s dihydroagarofuran synthesis  
 
Another RCM-based approach to a dihydroagarofuran target starting from (–)-carvone 
has been recently published by Floreancig (Scheme 1.7).35  
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Reagents and yields: (i) LDA, THF, TMSCl, -78 oC then 3-CPBA, NaHCO3, CH2Cl2 then HF, MeOH 
[63%, anti:syn - 5.5:1]; (ii) MOMCl, DMAP, i-Pr2NEt, CH2Cl2, 40
 oc [99%]; (iii) Me2AlCl, PhSH, 
CH2Cl2, -50 
oC, then 55, then 4-phenylselenobutanal [51% borsm]; (iv) MOMCl, DMAP, i-Pr2NEt, 
CH2Cl2, 40 
oC [95%]; (v) 3-CPBA, CH2Cl2, -78 
oC then pyridine, DHP, reflux [97%]; (vi) Isopropyl 
magnesium bromide, THF, rt [80% borsm]; (vii) Grubbs' II catalyst, CH2Cl2, reflux [94%]; (viii) TfOH, 
THF [30%]; (ix) Ac2O, pyridine, DMAP, CH2Cl2 [56%]
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Scheme 1.7 - Floreancig’s RCM-based approach to the dihydroagarofuran skeleton35 
 
Here the key metathesis step was used to install the C3-C4 double bond. This allowed 
access to dihydroagarofurans with different substitution patterns to those made by Mehta. 
A key step towards the metathesis diene precursor is the conjugate addition of thiophenol 
to α,β-unsaturated ketone 55 with in situ trapping of the resulting enolate with a selenide-
containing aldehyde. The diene 58 is eventually furnished by the diastereoselective attack 
of an isoprenyl Grignard reagent on ketone 57. The RCM occurs in excellent yield (94%) 
and then the THF ring formation is performed in a fashion analogous to the Li synthesis 
although, in this case, the reaction seems less facile (30% compared to 95% yield). With 
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the dihydroagarofuran skeleton in place, Floreancig then demonstrated that the C1 and C6 
alcohols were vastly different in their reactivity. This allows for differential acylation at 
either position and offers a flexible approach to make analogues for investigation into 
MDR-reversal activity. It has since been shown that esterification at C1 and C6 is 
beneficial for activity.25 
 
1.5.5. Barrett’s synthesis of the dihydroagarofuran skeleton 
 
The most recent work in the area has been published by Barrett (Scheme 1.8).36  
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 oC [84%]; (ii) 3-CPBA, CH2Cl2, 0 
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Scheme 1.8 - Barrett’s rapid construction of the dihydoragarofuran skeleton36 
 
The synthetic route developed to the dihydoragarofuran skeleton was short and multi-
gram quantities of diol 67 were prepared. The scaffold was elaborated to give a variety of 
polyhydroxylated derivatives. The diverse array of compounds synthesised was tested for 
insecticidal activity.  
 
The synthetic route to the key diol 67 begins with a Mukaiyama aldol reaction of the 
tetrahydronaphthalene enol silane 62 with acetone to give the silylated tertiary alcohol 63. 
Upon treatment with m-CPBA, epoxidation occurs to give a 1:4 mixture of the syn and 
anti  bridgehead epoxides. Following reduction of 64 with NaBH4 to give a single isomer 
of silyl ether 65, desilylation via treatment with tetrabutylammonium fluoride gives the 
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diol 66 which undergoes facile acid-catalyzed cyclisation to the THF containing tricycle 
67. The scaffold was elaborated further with the intention of maximizing insecticidal 
activity. To this end, a carbonyl functionality was introduced at C8 following the 
observations of Gonzàlez et al. that a keto-functionality at C8 favours insecticidal 
properties.3 With the ketone installed, a number of substitution patterns around the 
decalin ring could then be accessed (Scheme 1.9). 
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Reagents and yields: (i) Dess-Martin periodinane, pyridine, CH2Cl2, rt [84%]; (ii) OsO4, NMO, 
Me2CO, H2O, rt [72%]; (iii) 3-CPBA, CH2Cl2, rt [84%]; (iv) 1 M H2SO4, THF, rt [67%]
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Scheme 1.9 – Barrett’s introduction of varied functionality on the scaffold by oxidative 
methods36 
 
Oxidation of the secondary alcohol 67 using the Dess-Martin periodinane gave the C8 
ketone 68 in good yield. This was then converted into a 1:1 mixture of syn-1,2-diols by 
dihydroxylation with catalytic OsO4. A divergent two step route to the anti-1,2-diol was 
also developed from the alkene 67. This route comprised initial oxidation with m-CPBA 
and then a hydrolytic opening of the resulting epoxide 70 under acidic conditions to give 
the desired diequatorial diol 71. Further elaboration of the scaffold by means of 
elimination of the tertiary alcohol 69 and then conjugate addition of cyanide (using 
Et2AlCN) to the resulting enone allowed access a C14 derivative 74 corresponding to a 
C4-desmethyl Celastraceae sesquiterpenoid core (Scheme 1.10). 
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Scheme 1.10 – Barrett’s Introduction of a carbon substituent at the decalin bridgehead36 
 
The newly introduced nitrile functionality was eventually reduced to both the aldehyde 
and to the hydroxymethyl substituent with the aldehyde proving a particularly versatile 
synthetic handle. 
 
In addition to the recent contributions to the area of synthesis of Celastraceae 
sesquiterpenoids described above, it should be noted that one total synthesis of (±) 
euonyminol was achieved in 1997. This synthesis is overviewed in the following section. 
 
1.5.6. White’s synthesis of (±)-euonyminol 
 
The synthesis of racemic euonyminol itself was achieved by White et al. and remains the 
only total synthesis of this molecule published to date (Scheme 1.11).37  
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oC to rt [88%]; (ii) NBS, Bz2O2, CCl4, reflux then Et3N reflux 
[95%]; (iii) NaBH4, CeCl3.7H2O, MeOH, 0 
oC [90%]; (iv) 3-CPBA, NaH2PO4, CH2Cl2, 0
 oC [88%]; 
(v) LDA, THF, 15-crown-5, -78 oC to rt [63%]; (vi) t-BuOOH, 2,6-lutidine, VO(acac)2, PhMe, rt 
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Scheme 1.11 – White’s synthesis of (±) euonyminol part 1.37 
 
The White approach to euonyminol begins with a Diels-Alder reaction between 
siloxydiene 75 and the benzoquinone 76, derived from quinol. This installs the key 
decalin framework. Subsequent one-pot bromination and elimination gives the 
homoannular diene 78 in good yield and then selective Luche reduction at the C6 ketone 
followed by the epoxidation of the resulting allylic alcohol gives allylic epoxide 80. The 
installation of an isoprenyl unit on the α-face was achieved via conjugate addition of an 
isoprenyl Grignard reagent directed by the C6 hydroxyl group. This hydroxyl group is 
also used to direct the subsequent vanadium-mediated epoxidation to give the terminal 
epoxide 82. Treatment of 82 with TFA opens the allylic epoxide by SN2ʹ attack of the 
trifluoroacetate anion and subsequent ring closure onto the terminal epoxide elegantly 
installs the THF ring.  
 
With the core dihydroagarofuran skeleton now established, the remaining steps involved 
extensive functional group manipulations (Scheme 1.12).  
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Scheme 1.12 - White’s synthesis of (±) euonyminol part 2.37 
 
The trifluoroacetate 83 could be hydrolysed in a pyridine, water and THF mixture. Upon 
treatment with imidazole, the resulting alcohol readily lactonised to give tetracyclic 
lactone 84. Further elaboration to (±)-euonyminol required twelve synthetic steps. 
Notable steps include a TBAF-induced retroaldol fission of silyl ether 85 followed by 
recondensation which allows the C1 hydroxyl group to equilibrate to its more stable β-
epimer. Later, the α-hydroxy ketone 87 was seen to undergo 1,2 transposition of 
functionality when treated with trimethylaluminium. The use of a Lewis acid here 
encourages the formation of the isomer with the C9 hydroxyl group on the β-face. It was 
suggested that an aluminium-complexed enediol species was a key intermediate in the 
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rearrangement. Euonyminol was finally furnished by base-catalysed hydrolysis of the 
polyester 90. The overall yield was 5.2% over 20 steps. 
 
1.5.7. Yamada’s semi-synthesis of evonine 
 
In addition to the plethora of sesquiteprenoid cores observed in Celastraceae natural 
products, there is also significant variation in both the extent and type of esterification of 
the hydroxyl groups present. A common but intriguing esterification motif is for the C3 
and C13 hydroxyls to be tethered together by a pyridine containing diacid ligand, giving 
rise to a 14-membered dilactone ring. Evonine is an example of such a natural product 
and it has been the subject of the only synthetic work to date regarding macrolactone 
formation in these systems. In work by Yamada and co-workers,38,39 evonine isolated 
from Euonymus Sieboldiana Blume was transformed to the ketal 91 and this was 
subsequently elaborated to re-form synthetic evonine. 
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Scheme 1.13 – Evonine and the ketal derivative 91 used for semi-synthetic studies by 
Yamada39 
 
The pyridine diacid moiety present in evonine is (–)-evoninic acid. This ligand has more 
recently been a synthetic target within the Spivey group.40 The sesquiterpene core is 
referred to as evoninol and is identical to euonyminol except for the ketone present at C8. 
The synthetic work towards evonine starts from dimethyl evoninate, which was isolated 
from the same natural product source (Scheme 1.14).  
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Scheme 1.14 – Yamada’s elaboration of dimethyl evoninate and attachment to the 
sesquiterpene core39 
 
The two methyl ester groups were differentiated by reduction of the non-benzylic one to 
give the primary alcohol 92. This was then protected as the trityl ether and the benzylic 
ester was converted to the mixed anhydride 95 in two steps. Esterification with the 
aforementioned alcohol 91 gave the desired ester 96.  
 
With the C13 alcohol esterified, the C3 alcohol was unmasked prior to 
macrolactonisation to yield synthetic evonine (Scheme 1.15). 
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Scheme 1.15 – Yamada’s closure of the 14-membered lactone ring leading to evonine39 
 
After removal of the trityl ether and ketal protecting groups and oxidation, the 
macrolactonisation was achieved in just 12% yield by intramolecular reaction of the C3 
sodium alkoxide with the methyl ester. Following this, cleavage of all methyl ethers and 
subsequent acetylation yielded evonine. To date, this work remains the only synthetic 
endeavour towards incorporation of this important class of diacids into their 
macrodilactone parent natural products. Further investigation will undoubtedly lay crucial 
foundations for future synthetic efforts towards the most complex Celastraceae natural 
products. 
 
1.6. The Spivey approach to (–)-euonyminol 
 
One of the striking features of euonyminol is the symmetric array of oxygenation across 
the northern periphery of the molecule. Euonyminol is one of several Celastraceae cores 
which exhibit such a hydroxylation pattern and a key feature of Spivey’s synthetic plan 
was to exploit this latent symmetry. The intention was to carry out a two-directional 
synthesis leading to a meso-compound as an advanced intermediate. This meso-
intermediate could undergo a late stage desymmetrisation before being elaborated to (–)-
euonyminol (Scheme 1.16).   
 
Chapter 1 - Introduction 
33 
OP
OP
OP
PO
OP
OH
OP
OP
OP
PO
OP
OH O
OP
OP
OP
PO
OP
OP
O
O
H
H
HO
OH OH
OH
O
OH
OH
OH
OH
Diastereoselective Ireland-
Claisen rearrangement
(–)-euonyminol
Desymmetrisation via 
adapted 
Sharpless AE
7
6
OH
 
Scheme 1.16 - Outline of Spivey’s synthetic plan starting from naphthalene 
 
The synthetic strategy starts from naphthalene and arrives at a meso-diallylic alcohol after 
having installed the hydroxylation pattern across the northern periphery. An asymmetric 
desymmetrisation by means of a Sharpless-type asymmetric epoxidation would give 
access to an allylic epoxide which could be further elaborated to the target. One 
foreseeable route to (–)-euonyminol from the allylic epoxide features a diastereoselective 
Ireland-Claisen rearrangement which sets up the required stereochemistry at C6 and C7. 
 
What follows is a summary of the progress made prior to my involvement in the project 
towards the synthetic goal. Five previous group members have contributed: Steven 
Woodhead (Spivey group 1995-1998),41 Matthew Weston (Spivey group 1998-2002),42 
Ben Andrews (Spivey group 1996-2000),43 Damian Grainger (Spivey group 2001-2004)44 
and Stacy Lloyd (Spivey group 2003-2006).45 
 
1.6.1. Early progress on the naphthalene route 
 
The synthetic route developed for the installation of the top rim functionality begins with 
cheap, commercially available naphthalene (Scheme 1.17).  
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Scheme 1.17 - Spivey’s synthesis part 1: the first steps from naphthalene41,42 
 
Birch reduction gives isotetralin 99 which is epoxidised with peracetic acid to afford the 
mono-epoxide 100 where only the most electron rich double bond has been oxidised. 
Efficient opening of this epoxide with Et2AlCN sets up the trans-decalin ring junction 
and the resulting cyanohydrin 101 is epoxidised via a Sharpless procedure where 
VO(acac)2 is used to direct epoxidation to the same face of the molecule as the tertiary 
alcohol. Following protection of the tertiary alcohol as the benzyl ether, the bis-epoxide is 
opened with PPh3Br2 to give the dibromohydrin which, prior to DBU-induced 
elimination, is protected as the TBS-ether.        
 
With diene 103 in hand, attention was then focused upon delivering the protected tetraol 
107 (Scheme 1.18).  
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oC, 30 min [91%]; (vi) MsCl, 
CH2Cl2, rt, 1 h [99%]; (vii) DBU, toluene, 110 
oC, 20 h [67%]
103
 
Scheme 1.18 – Spivey’s synthesis part 2: stepwise double-dihydroxylation followed by 
elimination to give a key meso intermediate41,42 
 
Despite extensive endeavours towards performing a double dihydroxylation in a single 
step, it was found that two separate dihydroxylations followed by protection steps had to 
be performed in order to gain access to protected tetraol 104. It was found that under 
conditions intended to carry out both dihydroxylations together that an imido-lactone was 
formed by attack of a newly-installed hydroxyl group onto the nitrile functionality.    
 
The remaining steps towards the diallylic alcohol 107 began with the deprotection of the 
benzyl and silyl ethers. The resulting triol was then mesylated with an excess of mesyl 
chloride; only the secondary alcohols react. The resulting bis-mesylate 106 was then 
heated with DBU to induce elimination to form 107. 
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1.6.2. Introduction of the model system and development of a desymmetrisation 
procedure 
 
At this point attention was turned towards the development of an asymmetric 
desymmetrisation procedure and a more readily accessible model system was sought on 
which to carry out early investigations towards the southern periphery functionalisation. 
The synthesis of this model shares a common intermediate with the synthesis of the fully 
oxygenated system, the cyanohydrin 102 (Scheme 1.19). 
 
108 109
110
OH
OO
CN
OH
CN
OHHO
OH
CN
OMsMsO
OH
CN
i ii
iii
Reagents and yields: (i) AlMe3, CH2Cl2, reflux, 24 h [88%]; (ii) MsCl, Et3N, CH2Cl2, rt, 6 h [81%]; 
(iii) DBU, toluene, 110 oC, 16 h [70%]
2
37
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102
 
Scheme 1.19 – Spivey’s synthesis part 3: synthesis of a model meso-diallylic alcohol41-43 
 
The first three steps of the synthesis from naphthalene are identical to those developed for 
the real system. In the case of the model, bis-epoxide 102 is opened with AlMe3 to give 
triol 108. Mesylation and then elimination gave meso-diallylic alcohol 110 (cf. Scheme 
1.15, above). The reason that bis-epoxide 102 was opened with AlMe3 was to block 
elimination of the bis-mesylate 109 across the either the C2-C3 or the C7-C8 bonds.  
 
The development of the desymmetrisation was then performed on the model meso-
diallylic alcohol 110 (Scheme 1.20).46  
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111
CN
OH
CN
OH O
i
Reagents and yields: (i) Zr(Oi-Pr)4, t-BuOOH, L-(+)-DIPT, CH2Cl2, CH2Cl2, -20 
oC, 3 d [76% yield; 92% ee]
110
 
Scheme 1.20 - Spivey’s Zr-based Sharpless-type asymmetric epoxidative 
desymmetrisation42,43 
 
Initially both catalytic and stoichiometric Sharpless asymmetric epoxidation (AE) 
procedures were attemped with a range of tartrate and tartramide ligands. Although yields 
of up to 70% were obtained, the ee values were consistently disappointing. Tertiary 
alcohols are known to be poor substrates for the Sharpless AE because they bind poorly 
to Ti tartrate complexes. It was found that by using commercially available Zr(Oi-Pr)4, 
the desymmetrised epoxide 111 could be obtained in good yield and high ee. It was 
initially thought that the change to Zr from Ti accommodated a longer metal-oxygen 
bond and consequently better substrate binding. However, the process displays a reversed 
sense of stereochemical induction relative to that predicted by the Sharpless mnemonic 
and so it is likely that an alternative transition state is operative. Brückner has further 
investigated this system more recently.47 The Zr-mediated epoxidation is stoichiometric 
in Zr(Oi-Pr)4 and all attempts at rendering it catalytic were unsuccessful. With the 
procedure optimised it was then shown that the desymmetrisation could be performed on 
the fully oxygenated diene 107 with comparable results (Scheme 1.21). 
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Reagents and yields: (i) Zr(Oi-Pr)4, t-BuOOH, L-(+)-DIPT, CH2Cl2, -20 
oC, 3 d [44% yield; 95% ee]
107
 
Scheme 1.21 - Spivey’s desymmetrisation on the fully oxygenated system42 
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Investigations into further functionalisation towards the installation of the C ring were 
performed on the model system (Scheme 1.22).  
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Reagents and yields: (i) n-BuLi, (CH3CH2CO)2O, THF, 70 
oC [88%]; (ii) LHMDS, TMSCl, 
THF, -78 oC then 60 oC [70%]
~3:1 mixture of epimers
7
11
111
 
Scheme 1.22 – Spivey’s Ireland-Claisen rearrangement and ring closure of an 
intermediate silyl ester44 
 
Ireland-Claisen rearrangement of propionate ester 113 allowed the formation of the key 
C7-C11 bond on the bottom face of the decalin. The product initially expected from the 
rearrangement was silyl ester 114 or the corresponding hydrolysed carboxylic acid. In 
fact, under the reaction conditions, silyl ester 114 undergoes conjugate addition to the 
epoxide and it is lactone 115, which is isolated from the reaction. The lactone product is 
obtained as an inseparable 3:1 mixture of diastereoisomers which can be readily 
epimerised to give exclusively the major epimer upon treatment with base in a protic 
solvent.  
 
With the Ireland-Claisen rearrangement procedure now developed for the model system, 
it was applied by Lloyd to the fully-oxygenated system (Scheme 1.23). 
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Scheme 1.23 – Propionate Ireland-Claisen rearrangement applied to the fully-oxygenated 
system45 
 
The fully oxygenated propionate ester 117 underwent rearrangement and subsequent 
lactonisation in analogous fashion to the model system albeit in a relatively low, 
unoptimised yield of 32%. Notably, high selectivity for the formation of a single C11 
epimer was observed for the rearrangement (13:1). This selectivity was greater than that 
observed in the model system (3:1) and can possibly be attributed to greater rigidity in the 
fully-functionalised system.  
 
1.6.3. Variants of the Ireland-Claisen rearrangement 
 
Variants of the Ireland-Claisen rearrangement were then studied using functionally more 
complex allylic esters. A smooth rearrangement of one of these substrates would make 
further elaboration to the model target more straightforward. The first substrate to be 
looked at was the α-brominated ester 119 (Scheme 1.24).  
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O
O
O
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O
O
Br OH
H
H
Reagents and yields: (i) n-BuLi, 2-bromopropionyl chloride, THF, 70 oC [39%]; 
(ii) TBSOTf, NEt3, Et2O
Br
i ii
111
 
Scheme 1.24 – Spivey’s attempted rearrangement of an α-bromoester using Nakai’s 
conditions44 
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The substrate was made in a fashion analogous to the propionic ester 113 but in lower 
yield (39% cf. 88%). This low yield was likely caused by the steric effect of a large 
bromine atom adjacent to the reacting centre. 
 
The conditions attempted for the Ireland-Claisen rearrangement were developed by 
Nakai48 who had shown that by avoiding the use of strong base to generate a silyl ketene 
acetal, base sensitive halogen substituents could be tolerated in the starting allylic ester. 
Under the Nakai conditions, only starting material was observed in the 1H NMR spectrum 
of the crude reaction mixture and despite further investigations, no brominated rearranged 
product was ever observed. The second substrate studied was the α,β-unsaturated ester 
121 (Scheme 1.25).  
 
121
122
CN
OH O
CN
O
O
O
CN
O
O
OH
H
H
Reagents and yields: (i) n-BuLi, acryloyl chloride, THF [43%]; (ii) TBSCl, PCy3, DBN, MeCN, 70 
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Scheme 1.25 - Spivey’s use of Inanga’s conditions in the attempted synthesis of an exo-
methylene lactone44 
 
It was thought that this substrate would serve as a precursor to the exo-methylene lactone 
122 under phosphine catalysed Ireland-Claisen rearrangement conditions developed by 
Inanga.49 Conjugate addition of the phosphine to the ester followed by the trapping of the 
resulting enolate with a silicon electrophile gives a silyl ketene acetal which is set up to 
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rearrange. Unfortunately, no rearranged product was observed and instead tertiary alcohol 
111 was obtained as the major product as a result of deacylation of the starting material.  
 
The third substrate assessed in the Ireland-Claisen rearrangement was the α-oxygenated 
ester 124 (Scheme 1.26).  
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Reagents and yields: (i) n-BuLi, 123, DMAP, THF, rt, 12 h [20%]; (ii) TMSCl, LHMDS, 
THF, -78 oC to 70 oC, 1 h [125, 9%][126, 6%]
i ii
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Scheme 1.26 – Spivey’s Ireland-Claisen rearrangement of a PMB-protected lactate 
ester45 
 
Two products were isolated from the reaction, alcohol 125 and the silyl ether 126, albeit 
in very low yields. It is interesting to note that only a single epimer at C11 was observed 
for both products. Even with the low yields obtained, it seems that the rearrangement 
shows a marked preference for one epimer of the product although the relative 
stereochemistry of the epimer was not established unequivocally. 
 
Inducing rearrangement of the lactate ester 124 is desirable as it furnishes a product with 
a heteroatom at C11. This leaves C11 at the correct oxidation level for further elaboration 
to euonyminol. An alternative route to such compounds would be to introduce the 
heteroatom post-rearrangement and this approach has also been explored. 
 
1.6.4. C11 functionalisation post-rearrangement 
 
After the Ireland-Claisen rearrangement of simple propionate ester 113 (Scheme 1.19, 
above), the mixture of epimers readily equilibrates to the major isomer under basic 
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conditions and after protection of the free hydroxyl functionality as a benzoate ester, the 
lactone may be brominated via formation of the silyl ketene acetal (Scheme 1.27). 
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i iiiii
Reagents and yields: (i) KOt-Bu, t-BuOH, 90 oC, 2 h [62%]; (ii) Bz2O, DMAP, Et3N, CH2Cl2 [99%]; 
(iii) LDA, TMSCl, NBS, THF -78 oC to rt [76%]
116115
 
Scheme 1.27 - Spivey’s synthetic route to α-brominated lactone 12844 
 
The bromination step is selective for a single isomer and the absolute stereochemistry of 
the α-bromolactone 128 was determined by anomalous dispersion X-ray crystallography. 
A striking aspect of the reaction is that the bromine is seen to add on the more hindered 
concave face of the molecule (Figure 1.10).  
 
 
Figure 1.10 - X-ray crystal structure of α-bromolactone 128 showing two distinct decalin 
conformations present in the unit cell44 
 
Obtaining this crystal structure was a significant milestone in the project because the 
presence of the large bromine atom allowed the absolute stereochemistry to be confirmed 
for the first time in the synthesis. It pertains that the correct absolute stereochemistry for 
elaboration to the levorotatory [i.e. (–)-] natural product is obtained by the use of L-(+)-
DIPT in the oxidative desymmetrisation step.  
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1.7 The lactate variant of the Ireland-Claisen rearrangement 
 
The Claisen rearrangement, the [3,3]-sigmatropic rearrangement of an allyl vinyl ether, 
has been the subject of a tremendous amount of research since its discovery early in the 
20th century.50 This work has been extensively reviewed with the most recent reviews 
being those of Martín Castro in 200451 and Hiersemann and Nubbemeyer in 2007.52 
Among a number of variants of the rearrangement that have been developed, the Ireland 
variant53 stands out as the one of the most applicable to complex molecule synthesis. The 
rearrangement of allyl ester enolates or silyl ketene acetals generally occurs at low 
temperatures relative to the parent Claisen rearrangement and the allyl ester substrates for 
the reaction are readily synthesised (Scheme 1.28).  
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Scheme 1.28 – General scheme for the Ireland-Claisen rearrangement 
 
The Ireland-Claisen rearrangement has been most recently reviewed in 2002.54 
Particularly relevant to this project are expansions in the scope of the rearrangement 
which allow the presence of an α-heteroatom on the allyl ester. With a possible synthetic 
route to euonyminol featuring rearrangement of a lactate ester as attempted by Lloyd 
(Scheme 1.22, above), prior examples of similar reactions in the literature were envisaged 
to be informative for the work described in this thesis. Of the huge number of 
applications of the Ireland-Claisen rearrangement in total synthesis, only a small fraction 
feature substrates with an α-heteroatom. Among this subset, only two examples exist to 
our knowledge of the use of lactate esters. The first of these forms part of Takano’s 
calcitriol lactone synthesis (Scheme 1.29).55 
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Scheme 1.29 – Takano’s use of a lactate Ireland-Claisen rearrangement for the synthesis 
of calcitriol lactone55  
 
The reaction was reported to proceed in near quantitative yield via silylation of a Z-
enolate, where both oxygens chelate to the lithium cation. The equivalent benzyl ether 
also underwent rearrangement in similar yield but with a slightly lower d.r. (85:15). This 
was thought to be due to the increased Lewis basicity of the PMB-protected oxygen in 
relation to the benzyl-protected analogue. Increased Lewis basicity would encourage 
stronger chelation to a lithium cation and in turn improve the stereoselectivity of enolate 
formation. A more recent example of a lactate Ireland-Claisen rearrangement in total 
synthesis comes from McIntosh’s approach to cladiell-11-ene-3,6,7-triol (Scheme 1.30).56 
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Reagents and yields: (i) i. KHMDS, TIPSOTf, Et2O, -78 
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Cladiell-11-ene-3,6,7-triol
 
Scheme 1.30 – McIntosh’s use of a lactate Ireland-Claisen rearrangement in an approach 
to cladiell-11-ene-3,6,7-triol56 
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In this case, rearrangement of a triisopropylsilyl ketene acetal of benzyl-protected lactate 
ester 131 followed by fluoride-induced desilylation gave acid 132 as a single 
stereoisomer. Although not discussed, this selectivity is likely to result from highly 
selective enolate formation. With the propensity for [3,3]-sigmatropic rearrangements to 
proceed via ordered six-membered transition states, this selectivity is reflected in the 
newly formed stereogenic centre in the product.  
 
1.8. Aims and objectives 
 
Following directly from the work of Damian Grainger44 and Stacy Lloyd45, there were 
two aspects of their work in particular that merited further attention at the start of this 
thesis project: 
 
• Firstly, Grainger’s lactone α-bromination step which gave the unexpected 
C11 epimer resulting from introduction of bromine on the hindered, 
concave face of the molecule needed to be investigated. There was no clear 
explanation for the unusual selectivity and little synthetic work had been 
carried out starting from this intermediate. 
• Secondly, Lloyd’s preliminary result showing an Ireland-Claisen 
rearrangement of lactate ester 124 potentially paves the way for a more 
convergent route to the target, provided the yield could be substantially 
increased and the sense of stereoselectivity established. 
 
Beyond these two objectives, it was planned to develop chemistry that would allow the 
complete functionality found on the southern periphery of euonyminol to be installed on 
the model system. Once this had been achieved, the chemistry would be transferred to the 
fully-functionalised scaffold to allow completion of (–)-euonyminol. Additionally, the 
model system was envisaged to be suitable for use as a tool to probe the formation and 
chemistry of the 14-membered macrodilactones commonly observed in the natural 
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product class. 
 
1.7.1. Examination of the unusual stereoselective lactone bromination step  
 
In the bromination of lactone 127 (Scheme 1.27, above), the bromine electrophile is seen 
to add to the more hindered, concave face of the decalin whereas in all other examples 
found in the literature for the α-bromination of similar cis-fused γ-lactones, bromine is 
seen to add to the face opposite to the sterically demanding decalin fragment.57-63  
 
It seemed likely at the outset of this project that a non-steric factor was responsible for 
inducing the selectivity and efforts were planned to investigate this. It was envisaged that 
the choice of the benzoate ester protecting group would have a bearing on the selectivity 
and this could be tested by subjecting differently protected alcohols to the bromination 
conditions.  
 
It was also considered possible that this effect might be unique for bromination reactions. 
It  was therefore planned to investigate other electrophiles which it was hoped would give 
rise to other useful products such as α-hydroxy lactones. Synthetic routes towards the 
target through such intermediates were to be investigated (Scheme 1.31). 
 
133
CN
O
O
OR
CN
O
O
ORX
Bromination/
Oxygenation
X = OH or Br  
Scheme 1.31 – Planned investigation into bromination and oxygenation of differentially 
substituted γ-lactones 
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1.7.2. Investigation into a lactate variant of the Ireland-Claisen rearrangement 
 
In light of the preliminary result for the Ireland-Claisen rearrangement of lactate ester 124 
(Scheme 1.22, above), an attractive avenue for further investigation was the optimisation 
of the initial esterification to form lactate ester 124 and then the study of factors affecting 
selectivity of the subsequent rearrangement. Once the yield of this esterification had been 
improved (currently 20%), it was hoped that investigation of the subsequent Ireland-
Claisen rearrangement would be enabled. The selectivity of such rearrangements is pivotal 
to the eventual synthesis because a quaternary centre is created at C11 which cannot be 
epimerised. Completion of the southern periphery functionality of euonyminol would 
require either retention or inversion of the stereochemistry at this quaternary centre 
depending on the selectivity of this step (Scheme 1.32).  
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Scheme 1.32 – Optimisation of hindered esterification and subsequent Ireland-Claisen 
rearrangement 
 
1.7.3. Completion of the southern periphery functionality on the model system 
 
Following these initial investigations, it was thought likely at the outset that structures of 
type 133 and 134 would be accessible from lactone derivatisation (Scheme 1.28, above) 
or the lactate Ireland-Claisen rearrangement (Scheme 1.32, above) respectively. With 
compounds of this type in hand, a few important challenges would remain in order for the 
full southern periphery substitution pattern to be realised (Scheme 1.33). 
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Scheme 1.33 – Highlighting the key challenges remaining for completion of the southern 
periphery functionalisation on the model system 
 
To complete the tricyclic scaffold of the dihydroagarofuran, the lactone ring would 
require opening with synthetic work targeting an alkene of type 135. A suitable oxidation 
of the C4-C5 alkene could enable the crucial THF C-ring formation and following 
oxidation at C4 to the ketone oxidation level, a stereoselective methylation would be 
required to install the C15 methyl group on the top face of the decalin. 
 
1.7.4. Completion of the synthesis of (–)-euonyminol and model studies into 
macrodilactonisation between C3 and C11 
 
In order to complete the synthesis of (–)-euonyminol the chemistry developed for the 
model system will be applied to the fully oxygenated system. The established synthetic 
route currently followed for the fully oxygenated system will be assessed and, where 
possible, improvements will be sought to improve the overall step efficiency. 
 
With the fully-functionalised model serving as a surrogate for (–)-euonyminol, it may be 
possible to attach an array of commonly observed pyridine-containing diacids, some of 
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which feature as yet unassigned stereogenic centres. By comparison of natural material 
with a series of synthetic isomers based on our model system, it should be possible to 
assign the absolute stereochemistry of important natural products such as hypogluanine 
B6 (Scheme 1.34). 
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Scheme 1.34 – Proposed approach to defining the stereochemical assignment of 
hypogluanine B via comparison with a fully-functionalised model system 
 
Chapter 2 describes progress towards these objectives. 
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CHAPTER 2 - Results and Discussion 
 
2.1. Propionate Ireland-Claisen Rearrangement Route 
 
The work reported in this section is categorised as belonging to the propionate Ireland-
Claisen rearrangement route because all the molecules stem from a single intermediate in 
the synthesis, the α-methyl γ-lactone 116 which is the rearrangement product of 
propionate ester 113. 
 
2.1.1. Development of Existing Procedures 
 
In order to investigate the chemistry of the southern periphery of euonyminol, the 
synthetic route to the desymmetrised model alcohol 111, developed by previous members 
of the group,41-44 needed to be carried out on a large scale starting from naphthalene 
(Scheme 2.1). 
 
CN
O
OH
i ii iii
Reagents and yields: (i) Na, NH3, EtOH, Et2O, -78 
oC, 3 h [76%]; (ii) CH3CO3H, NaOAc, 
CH2Cl2, 0 
oC to rt, 1.5 h [74%]; (iii) Et2AlCN, CH2Cl2, rt, 2 h [85%]
99 100 101
 
Scheme 2.1 – Synthesis of cyanohydrin 101 
 
The Birch reduction was carried out on naphthalene at scales up to 100 g and proceeded 
in good yield following recrystallisation of triene 99. Peracid-mediated epoxidation gave 
the mono-epxide 100 in 74% yield with careful monitoring of the reaction to ensure no 
over-oxidation. The epoxide was then opened to the trans-cyanohydrin 101 with 
Et2AlCN. With this material in hand, the synthesis continued starting with a directed 
double epoxidation of the diene (Scheme 2.2). 
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CN
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i ii iii
Reagents and yields: (i) VO(acac)2, t-BuOOH, CH2Cl2, 40 
oC, 24 h [74%]; (ii) AlMe3, CH2Cl2, 
40 oC, 16 h [69%]; (iii) MsCl, Et3N, CH2Cl2, rt [92%]
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Scheme 2.2 – Conversion of diene 101 to bis-mesylate 109 
 
The vanadium-mediated bis-epoxidation of diene 101 allowed stereoselective formation 
of bis-epoxide 102. This compound was then converted to triol 108 by treatment with 
AlMe3. The two secondary hydroxyl groups were sulfonylated with MsCl to prepare for a 
double elimination to give the important meso-diene 110 (Scheme 2.3). 
 
i ii iii
Reagents and yields: (i) DBU, 100 oC, 3 h [92%]; (ii) Zr(Oi-Pr)4, L-(+)-DIPT, t-BuOOH, 
CH2Cl2, -20 
oC, 24 h [89%, 39% ee] ; (iii) n-BuLi, propionic anhydride, THF, rt, 24 h [98%]
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Scheme 2.3 – Synthesis of propionate ester 113 
 
The bis-sulfonate 109 was efficiently eliminated to the diene 110 in high yield by heating 
in DBU as a solvent. The reaction was found to work equally well using DBN as a base 
and also, when performing reactions on a large scale, it was possible to heat the mesylate 
in toluene with an excess of base and achieve comparable yields. The desymmetrisation 
was carried out in a freezer at -20 °C and the resulting epoxy-alcohol 111 (isolated in 
89% yield and an unusually low ee of 39%) was esterified with propionic anhydride to 
furnish propionate ester 113 in excellent yield. Propionyl chloride was found to be an 
equally effective electrophile for this process. At this point, ester 113 was treated to the 
Ireland-Claisen rearrangement conditions developed by Grainger44 and Weston42 
(Scheme 2.4). 
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Reagents and yields: (i) TMSCl, LHMDS, THF, -78 oC to 40 oC, 3 h, [68%; 3:1 mixture of epimers]
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Scheme 2.4 – Propionate Ireland-Claisen rearrangement of ester 113 
 
The rearrangement was carried out in comparable yield and selectivity to that which had 
previously been achieved and the same lactone ring-closing cascade previously described 
was observed. With the completion of the synthesis of γ-lactone 116, the foundations 
were laid for further synthetic work on the southern periphery of the molecule. 
 
2.1.2. Bromination of a  γ-lactone  
 
Following from the work of Grainger,44 elaboration of the southern periphery 
functionality of euonyminol via bromination of the simple propionate-derived lactone 
116 was investigated as anticipated in the aims and objectives. 
 
Before derivatising the α-position of lactone 116, it was necessary to protect the C3 
alcohol. This was done by treatment with benzoic anhydride under nucleophilic catalysis. 
The benzoate ester 127 was obtained in quantitative yield (Scheme 2.5).   
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Reagents and yields: (i) Bz2O, DMAP, Et3N, CH2Cl2, rt [100%]; (ii) i. LDA, TMSCl, -78
 oC ii. NBS, rt, THF [25%]
127 128
 
Scheme 2.5 - Protection of secondary alcohol 116 and subsequent NBS bromination 
 
The first attempt at bromination of the γ-lactone 127 used the conditions developed by 
Grainger.44 Thus, the silyl ketene acetal of the lactone was prepared in situ by treatment 
with LDA and TMSCl and then addition of NBS and warming to room temperature 
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yielded the α-bromolactone in 25% yield (cf. 75% by Grainger44). Nevertheless, the 
bromination was selective with the bromine adding to the concave face of the molecule. 
This yield proved to be very difficult to reproduce and, particularly on a small scale, the 
reaction was consistently unsuccessful. For an investigation into the curious selectivity of 
this bromination to be carried out, a more reliable bromination procedure needed to be 
established. It was decided to use a model system to optimise conditions. The model 
system chosen was the decalin-fused γ-lactone 108 which could be easily accessed from 
the commercially available natural product α-(–)-santonin64 (Scheme 2.6).        
 
138 139
O
O
O
O
O
O
H
O
O
H O
O
i, ii iii
Reagents and yields: (i) 10% Pd/CaCO3, H2, 1 atm, EtOAc, 50 
oC; (ii) HCl, EtOH, 80 oC 
[46% over two steps]; (iii) HO(CH2CH2)OH, CSA, PhH, reflux [65%]
H H H
!-(–)-santonin
 
Scheme 2.6 - Synthesis of the santonin-derived model γ-lactone 139 
 
Santonin was hydrogenated over Pd on CaCO3; conditions which had been reported to 
favour the trans-decalin product.65 The complex mixture of isomers formed was then 
treated with acid to epimerise the C4 stereogenic centre. The yield of 46%  for the 
diastereoisomer drawn after recrystallisation is indicative that some of the cis-decalin 
product was formed in the initial hydrogenation. The ketone was then protected as its 
ketal 139 in 65% yield. With this model lactone in hand, investigations into its α-
bromination were initiated (Table 2.8). 
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139 140
O
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H O
OH
See Table
O
O
H O
OH
Br
 
Entry Conditions Amount of 139 
(mg) 
Yield (%) 
1 LiCPh3, (CH2Br2), THF, -78 °C 100 37 
2 i. LDA, TMSCl, -78 °C 
ii. NBS to RT 92 80 
3 i. LDA, TMSCl, -78 °C 
ii. Recrystallised NBS to rt 92 78 
4 i. LDA, TMSCl, -78 °C 
ii. Recrystallised NBS to rt 20 
Starting lactone 
fully recovered 
5 i. LDA, TMSCl, -78 °C 
ii. Recrystallised NBS to rt 
(Very slow addition of 139 – 1 h) 
20 
30% conversion of 
139 to brominated 
product 
6 i. LDA, TMSCl, -78 °C 
ii. Recrystallised NBS to rt 
(Slow addition of 139, in situ quench 
of enolate with TMSCl) 
20 
45% conversion of 
139 to brominated 
product 
7 i. LDA, TMSCl, -78 °C 
ii. Recrystallised NBS to rt 
(Slow addition of 139, in situ quench 
of enolate with TMSCl)  
Under atmosphere of argon 
20 85 
Table 2.1 - Optimisation of the bromination conditions for the model lactone 
 
Ando and co-workers have brominated lactone 139 using LiCPh3 followed by 1,2-
dibromoethane (77% yield),57,66 and established that bromine adds to the enolate on the 
face carrying the decalin ring system. In our hands, this result was reproduced despite a 
lower yield (entry 1) and the stereochemistry was unambiguously confirmed by 
performing a single crystal X-ray structural determination which confirmed Ando’s 
assignment which had been made based on analysis of the 1H NMR spectrum (Figure 
2.1).  
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Figure 2.1 - Molecular structure of the brominated product 140 by single crystal X-ray 
structure determination 
 
Next, the α-bromination conditions previously employed with limited success on the 
lactone 127 (Scheme 2.5, above) were applied to the santonin-derived model. 
Surprisingly, both using recrystallised NBS and NBS directly from the bottle, a good 
yield of the brominated product was obtained (entries 2 and 3). It was thought that the 
quality of the brominating reagent would be key to the reaction as it is known that NBS 
decomposes on exposure to light to give bromine which can be detrimental to this type of 
reaction. Under the same reaction conditions but on a smaller scale of 20 mg, none of the 
desired product could be obtained (entry 4). Clearly, using this method, the scale of the 
reaction has a profound effect upon the outcome. It was thought that the practicalities of 
working at this smaller scale might have prevented the deprotonation. For this reason, a 
further attempt was made at the reaction where the addition of the lactone to the LDA 
solution was very much slowed down such that it was added over the course of 1 h by use 
of a syringe pump (entry 5). In this case, a 30% yield of 90 was obtained. The method 
was further improved by altering the order of addition of reagents so that the enolate was 
silylated in situ (45% conversion of lactone 139, entry 6) but a more notable 
improvement was achieved upon switching to an Ar atmosphere for the reaction. This 
enabled the desired product to be isolated in an 85% yield (cf. 45% yield using N2 
previously) (entry 7). 
 
When the optimised conditions established for the model system were first applied to the 
lactone 127, no conversion was seen. In light of this surprising result, a reactivity 
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comparison between the santonin-based system 139 and the desired lactone 127 was 
carried out. An equimolar quantity of both compounds was placed in the same reaction 
vessel under the conditions optimised for the santonin-based system. The composition of 
the reaction mixture was monitored as a function of time by 1H NMR (Table 2.2).  
 
CN
O
O
OBz
CN
O
O
OBz
Br
O
O
H O
OH
See Table
O
O
H O
OH
Br
11
Reagents and conditions: TMSCl, LDA -78 oC, 1 h then NBS -78 oC to rt
127 128
139 140
 
Entry Time/h Ratio 139:140 Ratio 127:128 
1 1 1:3.7 1.7:1 
2 2 1:4.6 1.6:1 
3 3 1:4.3 1.6:1 
4 19 1:4.2 1.6:1 
5 21 (2 h reflux) 1:4.2 1.6:1 
Table 2.2 - Reactivity comparison between lactones 127 and 139. 
 
The reaction was stirred for 19 h at room temperature before it was heated at reflux for a 
further 2 h. It is clear from the data obtained that the reaction ceases to progress after 2 h. 
The transformation of the santonin-based lactone 139 proceeds to give a final ratio of 
1:4.2 in favour of the product 140 and this equates to a conversion of 81% (cf. Table 2.8, 
entry 7). Concomitantly, the brominated lactone 128 is formed in a ratio relative to 
starting material of 1:1.6. This equates to a conversion of 38% and demonstrated that the 
lactone 127 is significantly less reactive than the santonin-based lactone 139. The same 
C11 epimer was seen to be favoured in the reaction i.e. the bromolactone where bromine 
had been incorporated onto the concave face of the molecule. Upon analysis of the 1H 
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NMR spectrum of the crude reaction mixture, a ratio of epimers of 87:13 could be 
observed.  
 
The conversion value obtained with the desired lactone 127 (38%) correlates with the 
yield obtained previously without the santonin-based lactone 139 present (25%). 
‘Doping’ of the reaction with lactone 139 has the effect of increasing the scale of the 
reaction. In doing so, some of the problems associated with carrying these reactions out 
on a small scale (see Table 2.1) are alleviated and a greater yield results. This observation 
raised the possibility of using the readily available santonin-derived lactone as a ‘dopant’ 
in future brominations when the scale of the reaction is a problem. 
 
Having confirmed the bromination selectivity for benzoate ester 127, further investigation 
was designed to probe the origin of this surprising selectivity. It was thought that the 
benzoate ester protecting group on the C3 hydroxyl may have a role to play in directing 
the facial selectivity of bromination. For this reason a selection of analogues were 
prepared with different protecting groups at this position. The benzyl ether 141 was 
synthesised in quantitative yield by treatment of alcohol 116 with 
benzyltrichloroacetimidate and catalytic acid67 (Scheme 2.7).   
 
141
CN
O
O
OBn
CN
O
O
OH
i
Reagents and yields: (i) Benzyltrichloroacetimidate, TfOH, CH2Cl2:cyclohexane, rt (1:1), rt, 15 h, [100%]
116
 
Scheme 2.7 – Preparation of benzyl ether 141 
 
The triethylsilyl ether 142 was also synthesised in good yield by treatment of alcohol 116 
with Et3SiCl and imidazole (Scheme 2.8).  
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CN
O
O
OH
CN
O
O
OSiEt3
i
Reagents and yields: (i) Et3SiCl, imidazole, DMF, rt, 2 h [85%]
116
 
Scheme 2.8 – Preparation of the triethylsilyl ether 142 
 
The use of different silyl ether protecting groups would allow for an element of tuning for 
the steric environment around the lactone itself. To this end, the more bulky tert-
butyldimethylsilyl ether 143 was also a synthetic target. It was proposed that this bulky 
group might be able to prevent bromination from occurring on the concave face of the 
lactone. Synthetic work towards 143 is detailed in Table 2.3. 
 
143
CN
O
O
OTBS
CN
O
O
OH
See table
116
 
Entry Conditions Observation 
1 TBSOTf, 2,6-lutidine, CH2Cl2, rt, 6 h Starting material recovered 
73% 
2 TBSCl, N-methylimidazole, I2, CH2Cl2, rt, 18 h 76% yield of 143 
Table 2.3 – TBS protection of secondary alcohol 116 
 
An initial attempt at silylation using TBSOTf (entry 1) failed to afford any of the desired 
product with the starting material being re-isolated in 73% yield. Silylation with TBSCl 
was then achieved in 76% yield (entry 2) using conditions developed by the group of 
Stawinski.68 The conditions are unique for their inclusion of iodine. It is proposed that 
chloride ions in the reaction medium combine with iodine to form the less nucleophilic 
trihalide anion I2Cl-. This lowers the concentration of nucleophilic chloride and promotes 
silylation of the alcohol by a pentavalent silicon species. 
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With a selection of differentially protected bromination substrates now available, the silyl 
ethers were subjected to the optimised bromination conditions and the results compared 
to those obtained for the benzoate ester 127 (Table 2.4). 
 
 
 
 
Reagents and conditions: TMSCl, LDA -78 oC, 1 h then NBS -78 oC to rt, 3 h
CN
O
O
OR
CN
O
O
OR
Br
CN
O
O
OR
Br
See Table
11 11
Concave face
bromination
Convex face
bromination
 
Entry Compound R Conversion (%) Ratio 
Concave:Convex 
1† 127 Bz 38 87:13 
2 142 TES 100 18:82 
3 143 TBS 100 <5:95 
 Table 2.4 – Bromination of a small array of γ-lactones 
† Data taken from experiment described in Table 2.2 
 
It was found that both silyl ethers 142 and 143 were brominated efficiently under the 
conditions. Both were also seen to preferentially react on what appeared to be the convex 
face of the tricyclic scaffold, thus demonstrating a switch in the stereochemical outcome 
with regard to the benzoate ester as evidenced by analysis of the 1H NMR spectrum 
(entry 1). The TES ether was obtained as an inseparable mixture of epimers at C11 
(18:82, entry 2). In an attempt to confirm the stereochemistry at C11 of the major isomer, 
it was decided to convert the TES ether protecting group to the benzoate ester and 
compare the spectroscopic data of the resulting mixture with that of the known benzoate 
ester 128 for which a crystal structure had been obtained (Scheme 2.9).  
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Scheme 2.9 – Proposed switching of protecting group to confirm C11 stereochemistry 
 
Upon treatment with TBAF and subsequent subjection to acylating conditions with 
benzoic anhydride, the mixture of silyl ethers yielded alkene 147 as the major product 
(Scheme 2.10). 
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O
OSiEt3
Br
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O
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O
OBz
CN
O
O
OBz
Br
i, ii
Reagents and yields: (i) TBAF, THF, rt, 2 h; (ii) Bz2O, Et3N, DMAP, CH2Cl2, rt, 4 h 
[147 - 55%, 146 - 5% over two steps]
146
 
Scheme 2.10 - Attempted switch of protecting group to confirm C11 stereochemistry 
 
The alkene 147 results from elimination during the deprotection step. TBAF is 
sufficiently basic to eliminate the tertiary bromide to give the exo-methylene compound. 
The only brominated material isolated from the reaction sequence was benzoate ester 146 
in 5% yield from the silyl ether. This was found to be the opposite C11 epimer to the 
previously obtained benzoate ester 128. Owing to the poor yield of this two-step process, 
it cannot definitively be said that 146 is derived from the major epimer of bromolactone 
144.  
 
The stereochemistry at C11 of the product derived from the bromination of TBS ether 
143 was assigned initially by 1H NMR comparison with both epimers of the benzoate 
ester. Specifically, the proton at C7 was seen at a chemical shift of 3.2 ppm, which was 
indicative of its syn-relationship with the bromine atom. This assignment was 
corroborated by X-ray diffraction analysis, giving a molecular structure clearly showing 
the newly installed bromine atom on the convex face of the molecule (Figure 2.2).  
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Figure 2.2 - Molecular structure of the TBS ether 148 by single crystal X-ray structure 
determination 
 
The crystal structure clearly shows the cyclohexane ring in a boat-like conformation. It 
presumably crystallises into this conformation in preference to a chair to reduce strain 
across the five-membered lactone ring. Notably, the conformation of the decalin unit in 
this crystal structure closely resembles the conformations present in the crystal structure 
of the brominated benzoate ester analogue 128 (Figure 1.10). These crystal structures of 
opposing C11 epimers, combined with NMR data, subsequently provided a useful 
reference when assigning the stereochemistry in a number of other C11 functionalised 
lactones later in this study (vide infra). 
 
The remaining bromination substrate, benzyl ether 141, had only been obtained in small 
quantities. In order to assess the selectivity of a bromination reaction upon it, the reaction 
was ‘doped’ with the santonin-based lactone 139 (Scheme 2.11). 
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149
Reagents and conditions: TMSCl, LDA -78 oC, 1 h then NBS -78 oC to rt, 3 h 
[68% conversion; 50:50 mix of epimers]
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Scheme 2.11 – Bromination of benzyl ether 141 in the presence of santonin based 
‘dopant’ 
 
The two C11 epimers of the α-bromolactone product were formed in a 50:50 ratio as 
determined by 1H NMR. Despite the similarity in structure of benzyl ether 141 to that of 
benzoate ester 127, no selectivity for concave face bromination is observed. Given that an 
appreciable amount of concave bromination does occur for the benzyl ether, this seems to 
suggest that in the case of the benzoate ester 127, the carbonyl group does not have a 
decisive role to play in delivering the bromine electrophile as we had considered possible 
at the outset. Instead, the lack of facial selectivity in the benzyl ether probably reflects the 
delicate nature of the selectivity where subtle structural changes can give rise to large 
switches in selectivity. 
 
The reactions described above allow for selective access to brominated lactones with 
opposing stereochemistry at C11. Access to two opposing epimers would potentially 
allow greater flexibility in future chemistry.  
 
2.1.3. Oxygenation of a γ-lactone 
 
Having established that the stereoselectivity of bromination could be effectively tuned by 
changing the C3 protecting group, it was decided to investigate the selectivity when using 
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different electrophiles. An α-hydroxylation process was expected to be particularly 
advantageous as the basis for an alternative synthetic route to the target molecule and so 
investigations were focused on electrophiles that would deliver this functionality. The 
readily available santonin-based lactone 139 was used to screen three commonly used 
oxidants under similar conditions.  
  
One of the oxidants used was the peroxomolybdenum complex MoO5•py•DMPU 
(MoOPD). This is an alternative to the commonly used MoOPH reagent introduced by 
Vedejs69 where DMPU is used in the place of HMPA for reasons of safety. It was 
prepared according to the method of Anderson70 (Scheme 2.12). 
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i ii
Reagents and yields: (i) i. 35% H2O2 (aq), 40 
oC, ii. DMPU, 10 oC; (ii) Pyridine, THF [23 % over two steps]
Mo
O
O
O
O
O
OH2O
N N
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Scheme 2.12 – Preparation of Anderson’s MoOPD reagent 
 
The other oxidants used were m-CPBA, as used in the Rubottom oxidation71 and Davis’ 
oxaziridine,72 an oxidant commonly used for enolate and silyl enol ether oxidations. The 
results of the screen are given in Table 2.5. 
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150 151
O
O
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OH See Table
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OH
HO
O
O
H O
OH
Me3SiO
139  
Entry Conditions Observation 
1 i. LDA, TMSCl, -78 °C, ii. m-CPBA to rt, THF 
Incomplete conversion of 
139, mixture of products 
observed 
2 i. LDA, TMSCl, -78 °C, ii. Davis’ oxaziridine to rt, THF 
Full conversion of 139, 
mixture of products 
observed, major product 151 
(45%) 
3 i. LDA, TMSCl, -78 °C, ii. MoOPD to rt, THF No conversion of starting material 
4 i. LDA, -78 °C, ii. MoOPD to rt, THF 
150 isolated in 62% yield; 
28% recovered starting 
material 
Table 2.5 – Oxidant screen for α-hydroxylation of the santonin-based model system 139 
 
The reactions were carried out under conditions for enolate formation analogous to those 
optimised in the bromination study. With the m-CPBA oxidant (entry 1) a complex 
mixture of products was obtained despite incomplete conversion of the starting material.  
The use of Davis’ oxaziridine as the oxidant (entry 2) led to a less complex mixture of 
products with the major product being the TMS ether 151, isolated in 45% yield. Despite 
the MoOPD reagent being completely unreactive to the preformed silyl ketene acetal of 
the lactone (entry 3), the most successful conditions were found to be those using the 
MoOPD reagent directly on the enolate (entry 4). The reaction was seen to be very clean 
with few by-products and the desired α-hydroxylated lactone 150 was obtained in 62% 
yield. The stereochemistry of the product was assigned by 1H NMR comparison with the 
α-bromolactone 140 for which a crystal structure had been obtained.  
 
The MoOPD reagent would be the reagent of choice for future work on the euonyminol-
based system. The first substrate to be subjected to the oxygenation conditions was the 
TBS ether 143 which, in the bromination study, had given a single isomer with 
electrophilic attack on the convex face of the molecule (Scheme 2.13). 
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Reagents and yields: (i) LDA, -78 oC, then MoOPD, -78 oC to rt, 4 h [63%; 12% recovered 143]
143
 
Scheme 2.13 – Hydroxylation of TBS ether 143 
 
The lactone was found to oxygenate cleanly under the conditions to give α-hydroxy 
lactone as a single isomer in comparable yield to that observed for the santonin-based 
system. Notably, the isomer formed was analogous to the isomer formed under 
bromination conditions (i.e. resulting from the electrophile reacting on the convex face of 
the molecule). The stereochemical assignment was made by analysis of the NMR spectra, 
where a chemical shift of 2.61 for the proton at C7 was indictive of its syn-relationship 
with the newly-installed oxygen atom. Also, spectral data was compared with a related 
compound 177 (see page 82) for which a crystal structure had been obtained. 
 
Given that the benzoate ester 127 allowed for a switch in diastereoselectivity in the 
bromination reaction, it was hoped that this same phenomenon might be mirrored by the 
MoOPD system. If it was, this would be both informative and synthetically useful as 
access to each of the C11 epimers for both the α-bromo- and α-hydroxylactones would 
provide a wealth of options for further synthetic work. For this reason the benzoate ester 
127 was assessed under the α-oxygenation protocol (Scheme 2.14). 
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Reagents and yields: (i) LDA, -78 oC, then MoOPD, -78 oC to rt, 4 h [59%; 22% recovered 127]
127
 
Scheme 2.14 – Hydroxylation of benzoate ester 127 
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Once again the α-hydroxylated product was isolated in comparable yield to previous 
oxygenations (59%) and notably a single epimer was observed. However oxygenation 
had occurred on the convex face of the molecule; the switch in selectivity that had been 
observed with bromination did not operate when using the MoOPD electrophile. It is not 
immediately clear why this should be the case but if the stereoselectivity is determined on 
steric grounds, the MoOPD electrophile, with its molybdenum centre and relatively large 
ligands could be considered less likely to approach the hindered concave face of the 
decalin than the smaller NBS electrophile. 
 
2.1.4. – Mitsunobu inversion of C11 alcohol 
 
It was decided that the α-hydroxylactone 153 would be more suitable than either the α-
bromolactones 128 or 148 for carrying through further synthetic steps towards the target. 
The α-hydroxylation procedure offers access to a single epimer with an (S)-configuration 
at C11. In order to elaborate the final target this centre must be inverted to the (R)-
configured centre as observed in the final target (Scheme 2.15).  
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Scheme 2.15 – Strategies for further synthesis from hydroxylactone 154 
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Two possible strategies for managing this switch were considered. The first, Route A, 
involves an immediate inversion of stereochemistry followed by the newly installed 
oxygen (shown in blue) acting as a nucleophile to form the THF ring. The second, Route 
B, requires the conversion of the C11 hydroxyl to a leaving group (shown in red) and 
subsequent inversion of the centre upon closure of the THF ring. Of the two approaches, 
Route A was deemed the most desirable. This route requires functionalisation on the α-
face of the decalin system to give an electrophilic component at the bridgehead position. 
On account of the sterically congested β-face of the molecule, it was expected that this 
mode of functionalisation would be more straightforward than the β-face 
functionalisation required at the bridgehead in Route B. 
 
With the intention to investigate Route A, a means to invert the C11 alcohol was sought. 
It has recently been shown that it is possible to invert chiral tertiary alcohols via SN2 
nucleophilic displacement73-75 and it was thought that this Mitsunobu protocol could be 
suitable for our purposes. Typically, sterically hindered alcohols such as this tertiary 
alcohol are challenging substrates for the Mitsunobu reaction76,77 but it was thought that 
based on precedent by Shi and co-workers,73 the use of a phenol nucleophile would allow 
for the clean SN2 displacement of the tertiary alcohol. They had shown several examples 
of chiral tertiary alcohols undergoing full inversion upon reaction with a range of phenols 
and to the best of our knowledge, these examples constitute the only ones to date in 
which the Mitsunobu inversion of chiral tertiary alcohols with an oxygen nucleophile is 
achieved. It was thought that in our case, the use of 4-methoxyphenol as the nucleophile 
would serve to effectively protect the tertiary alcohol as the PMP ether as well as 
inverting it. The Shi conditions were first applied to a model alcohol 150 derived from   
(–)-santonin (Scheme 2.16).  
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Scheme 2.16 – Proposed Mitsunobu reaction on the santonin-based model system 150 
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The work by Shi did not feature any lactone examples and although the procedure was 
highly tolerant of a range of phenols, the reaction was shown to be sensitive to the steric 
environment around the alcohol. In the case of the model alcohol 150, an undesired 
eliminated product was formed (Scheme 2.17). 
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Scheme 2.17 – Attempted phenol Mitsunobu reaction of α–hydroxy lactone 150 
 
The Mitsunobu conditions were sufficiently basic to bring about dehydration to give the 
endocyclic alkene 156. The structure of this undesired product was confirmed by a single 
crystal X-ray structure determination (Figure 2.3). 
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Figure 2.3 - Molecular structure of dehydrated lactone 156 by single crystal X-ray 
structure determination 
 
In spite of this discouraging result, it was hoped that such an elimination would not occur 
on the euonyminol-based system. In the model lactone 150, the proton at C7 is 
approximately anti-periplanar to the C11 hydroxyl and this predisposes the molecule to 
undergo E2 elimination. In the case of the euonyminol-based lactone 153, the C7 proton 
is syn- to the C11 hydroxyl and the σC-H orbital is not able to align with the σ*C-OH orbital 
as required for E2 elimination. 
 
The benzoate ester 153 was subjected to the phenol Mitsunobu conditions as previously 
described. A change was made to the reaction solvent because it was found that ester 153 
was insoluble in hot toluene and no reaction was observed under the literature conditions. 
It was found that using THF as a co-solvent in the reaction improved solubility of the 
lactone and allowed for the reaction to proceed (Scheme 2.18). 
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Reagents and yields: 4-methoxyphenol, DIAD, PPh3, toluene:THF (1:1), 100 
oC, 4 h [35%]
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Scheme 2.18 – Mitsunobu reaction of α-hydroxylactone 153 
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Upon subjection to the Mitsunobu conditions, the major product isolated from the 
reaction, as characterised by 1H NMR and mass spectrometry, was PMP ether 157. The 
stereochemistry at C11 was tentatively assigned with inversion having taken place. 
Interestingly, in addition to inversion of the C11 alcohol the 4-methoxyphenol 
nucleophile was seen to attack the lactone carbonyl group to furnish the PMP ester 
moiety. The low yield of 35% reflects the fact that this lactone opening was unexpected, 
with only a single equivalent of 4-methoxyphenol having been deployed in the reaction. 
It was proposed that inversion of stereochemistry at C11 had occurred thanks largely to 
the use of a phenol nucleophile. The mechanism most usually invoked for retention of 
stereochemistry in the Mitsunobu reaction involves the attack of the alcohol on an 
acyloxyphosphonium species 159 generated in the reaction78,79 (Scheme 2.19).  
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Scheme 2.19 – Mechanism for a Mitsunobu reaction with retention of stereochemistry 
 
When using hindered alcohols, the carboxylate anion can attack the phosphonium species 
158 and give rise to an electrophilic acylating agent 159 which can react directly with the 
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alcohol to give the ester with retention of stereochemistry. In the case of a phenol 
Mitsunobu reaction, the equivalent aryloxyphosphonium species 160 is only electrophilic 
at the phosphorus atom and so such a retention pathway is not possible. 
 
Another viable mechanism for the retention of stereochemistry in a Mitsunobu reaction 
would be the formation of an intermediate carbocation, which is then attacked by the 
nucleophile in question (Scheme 2.20). In many cases, this mechanism could be expected 
to give rise to a mixture of epimeric products which is not the case in the reaction of 153. 
Also, the formation of a carbocation intermediate would be favoured under acidic 
conditions. In the case of a phenol Mitsunobu reaction, the reaction medium is likely to 
be less acidic than for a carboxylic acid nucleophile owing to the differences in their 
respective pKa values (10.2 for 4-methoxyphenol vs. ~5.0 for a typical carboxylic acid). 
Most crucially, a carbocation intermediate will be disfavoured in the lactone substrate 
153 given its position α- to the electron withdrawing carbonyl. 
 
CN
O
O
OBz
OMe
HO
CN
O
O
OBz
H2O
CN
O
O
OBz
PMPO
 
Scheme 2.20 – Alternative possible mechanism for retention of stereochemistry 
proceeding through a carbocation intermediate 
 
With access to the PMP ether 157, the proposed synthetic route to the target would 
comprise 6 further synthetic steps (Scheme 2.21). 
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Scheme 2.21 – Proposed synthetic route from PMP ether 157 to the fully-functionalised 
model system 
 
The diester 157 would be reduced and the resulting triol suitably protected. Epoxidation 
of the C4-C5 alkene would follow with the expectation that the dense functionality on the 
β-face of the molecule would encourage oxidation on the α-face. The PMP ether would 
then be deprotected by oxidative means80 to unmask the C11 hydroxyl. It was hoped that 
under the reaction conditions, this tertiary alcohol would spontaneously attack the 
epoxide to give tricyclic THF 163. The remaining steps to furnish the fully functionalised 
model would involve oxidation of the C4 secondary alcohol and subsequent formal 
addition of methane to the resulting ketone 164. Once again the dense functionality on the 
β-face should encourage attack of e.g. a Grignard reagent on the α-face. All that would 
remain at this stage would be universal deprotection to give tetraol 166. 
 
It was at this stage that work on this approach was paused. Work was being carried out in 
parallel on another approach based upon a lactate variant of the previously optimised 
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propionate Ireland-Claisen rearrangement. It is this approach which is described in the 
following section. 
 
2.2. Lactate Ireland-Claisen Rearrangement Route 
 
An Ireland-Claisen rearrangement on a lactate ester of the type investigated by Lloyd45 
was expected to allow a more convergent route to the target than a propionate Ireland-
Claisen rearrangement-based route as described above. The travails associated with the 
installation of a quaternary stereogenic centre at the α-position of a lactone, as described 
in the previous section, could potentially be avoided by incorporating more functionality 
prior to rearrangement. The following section describes efforts towards this goal. 
 
2.2.1. Hindered ester formation  
 
In order to efficiently investigate the Ireland-Claisen rearrangement of an α-oxygenated 
allylic ester such as 124, a robust esterification procedure for its formation had to be 
developed (Scheme 2.22).  
 
CN
OH O
CN
OO O
OPMB
?
111 124
 
Scheme 2.22 - Esterification to form the desired lactate ester 124 
 
Initial work was focused on a model system that was much more readily available than 
the desymmetrised alcohol 111. The bridgehead trans-decalin alcohol 167 was chosen as a 
model and conditions for its acylation were studied beginning with a selection of 
procedures from the literature (Table 2.1). Despite the ester being a ubiquitous functional 
group in organic chemistry, there remain very few examples of esterifications where both 
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a hindered nucleophile, i.e. a tertiary alcohol, and a hindered electrophile, i.e. an α–
substituted acylation reagent, are used. 
 
167 171
SPh
OH
O
X
SPh
OO
168: X = OH
169: X = Cl
170: X = OCOi-Pr
See Tables
2.1 and 2.2
 
 
Entry Electrophile Conditions Outcome 
1 170 MgBr2, Et3N, CH2Cl2, rt, 48 h No reaction progress by TLC. 
2 170 TMSOTf (2mol.%), CH2Cl2, rt 
Immediate consumption of 
167. No desired product 
formation. 
3 169 AgCN (2eq.), PhH, 80 oC, 48 h Trace of product by TLC. 
4 168 PyBOP, DIPEA, CH2Cl2, rt  24 h; Reflux 24 h 
Formation of activated 
intermediate observed. No 
further reaction.  
5 169 i. n-BuLi, THF, rt, 0.5 h ii. Electrophile added, rt, 24 h Product isolated in 10% yield. 
Table 2.6 - Initial attempts at the acylation of the model tertiary alcohol 
 
Like the tertiary alcohol 111, the model alcohol proved to be a challenging acylation 
substrate. Lewis acid-catalysed methods introduced by Vedejs81 and Procopiou82 were 
first tried without success. Only starting material was observed to remain when a dual-
activation procedure was used, employing triethylamine as well as the Lewis acid MgBr2 
(entry 1). In contrast, the starting material was consumed very quickly upon exposure to 
TMSOTf and this was attributed to decomposition via desulfurisation of the starting 
material by analysis of the 1H NMR spectrum of the crude reaction mixture (entry 2). 
The in situ generation of a highly reactive acyl cyanide83 did induce some conversion of 
the starting alcohol but the reaction stopped at low conversion (entry 3). A standard ester 
coupling protocol involving treatment of isobutyric acid with the coupling reagent 
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PyBOP84 and Hunig’s base led to the formation of an activated ester intermediate as 
observed by TLC but this was never seen to react with the alcohol (entry 4). Procedures 
where the alcohol is first deprotonated and then reacted with an electrophile are analogous 
to those used by Lloyd45 to originally form the lactate ester 124 and gave some product 
when the acid chloride was used as the electrophile (entry 5). The desired ester was 
formed in a low yield of 10% but this positive result initiated an investigation into other, 
similar deprotonation-based strategies (Table 2.7). 
 
Entry Electrophile Conditions Outcome 
1 169 i. n-BuLi, THF, rt, 2 h ii. Electrophile added, rt 1 h, reflux, 1 h 
No conversion of 
starting material 
2 169 n-BuLi, THF, 2 h (immediate addition of electrophile) 
No conversion of 
starting material 
3 170 n-BuLi, THF, 2 h (immediate addition of electrophile) 
Partial conversion to 
desired product. 
Reaction stops within 5 
min. 
4 169 n-BuLi, Toluene, rt, 3 h No observable reaction 
5 170 n-BuLi, Toluene, rt, 1 h Reaction stops at 171:167 ratio 62:38 
6 170 n-BuLi, DMAP, Toluene, rt 1 h 
Reaction stops at 
171:167 ratio 80:20 
(64% isolated yield) 
Table 2.7 - Optimisation of the acylation method involving alkoxide generation 
 
Firstly, the influence of the timing of the electrophile addition was investigated. It seems 
that delaying the addition of the electrophile to ensure complete deprotonation of the 
starting alcohol is detrimental to the reaction. When alcohol 167 was left 2 h with base to 
equilibrate, no formation of the desired product was observed (entry 1). In the contrasting 
situation where the electrophile was added immediately after the base, again no 
esterification was observed (entry 2). It was noted that with this experimental procedure, 
partial conversion could be observed when using isobutyric anhydride as an electrophile.  
 
All reactions using n-BuLi as a base had to this point been conducted in THF as a solvent. 
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It was thought that by changing to a less polar solvent such as toluene, the alkoxide anion 
would be less solvated and therefore more reactive. This was not found to be the case 
with the acid chloride (entry 4) but was successful with the acid anhydride electrophile, 
with the reaction running to moderate conversion (entry 5), and to good conversion in the 
presence of stoichiometric DMAP giving a 64% isolated yield of the desired hindered 
ester 171 (entry 6).  
 
2.2.2. Synthesis of the desired electrophile 
 
With a promising set of conditions established on the model system, their application to 
the desired substrate required the synthesis of the acid anhydride 174. The synthesis of 
the prerequisite carboxylic acid 173 had previously been performed by Lloyd from the 
commercially available methyl ester of L-lactic acid (Table 2.8).  
 
172 173
174
O
OMe
OH
O
OMe
OPMB
O
OH
OPMB
O
Cl
OPMB
O
O
OPMB
O
OPMB
Reagents and yields: (i) 4(methoxy)benzyltrichloroacetimidate, TfOH, 
CH2Cl2:cyclohexane (1:1), rt [89%]; (ii) LiOH.H2O, THF:H2O (3:1), rt [84%]; (iii) 
(COCl)2, DMF (cat.), CH2Cl2, rt
i ii
iii
See Table
123
 
Entry Conditions Outcome 
1 123, Poly(4-vinylpyridine), Benzene, reflux 24 h 
2 123, Amberlyst 241 resin, Benzene, reflux 24 h 
Only starting 
acid observed 
3 DCC, CH2Cl2, rt, 30 min 
94% yield of 
174  
Table 2.8 - Synthesis of PMB-protected lactic acid anhydride 175 
L-Lactic acid was first protected as the PMB ether by treatment with 4-
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(methoxy)benzyltrichloroacetimidate and a catalytic amount of TfOH. Saponification of 
the ester afforded the carboxylic acid 173 which in turn could be converted to the acid 
chloride 123 by treatment with oxalyl chloride and catalytic DMF. With the acid 
anhydride 174 being the preferred electrophile for esterification, it would need to be made 
either by reaction of acid 173 with acyl chloride 123, or by the direct dehydration of the 
acid 173. The first attempts at the synthesis of the anhydride sought to react the 
carboxylic acid 173 with its corresponding acid chloride 123 over a resin-bound tertiary 
amine base. These attempts failed to convert any of the acid presumably due to ion pairs 
being formed between the substrate and the resin (entries 1 and 2). Pleasingly, upon 
treatment of the acid with the coupling reagent DCC in CH2Cl2, the by-product 
dicyclohexylurea was seen to precipitate from the reaction mixture immediately and the 
acid anhydride was formed in good yield within 30 minutes (entry 3).   
 
2.2.3. Acylation of the key desymmetrised alcohol 111 
 
With access to the desired electrophile, the conditions optimised for the model system 
167 were applied to the key tertiary alcohol 111. Unlike in the model system, the 
alkoxide formed in the reaction was insoluble in toluene and aggregated in the reaction 
mixture. Consequently, the target allylic ester was formed in only 13% yield with 
appreciable recovery of unreacted starting material (Table 2.9).  
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Reagents: (i) n-BuLi, DMAP, Toluene, reflux
OPMB
i
111 174 124
 
Entry Scale / mg 111 Modification Outcome 
1 100 No modification 
Alkoxide insoluble in 
toluene. 13% isolated 
yield of 124. 70% 
recovery of 111. 
2 100 
Reaction quenched with solid 
NH4Cl to discourage hydrolysis of 
ester in workup. 
Alkoxide insoluble in 
toluene. 20% isolated 
yield of 124. 53% 
recovery of 111. 
3 40 
Anhydride present in reaction 
prior to addition of n-BuLi. 
Reaction sonicated throughout. 
Solubility problems 
reduced. TLC shows 
minimal conversion of 
starting material.  
Table 2.9 - Application of the optimised conditions to the real system 
 
A succession of modifications to the method were made in an effort to improve this 
disappointing yield. Having seen a more promising level of conversion of alcohol 111 by 
analysis of the 1H NMR spectrum of the reaction mixture, it was thought that the low 
yield could also be due to partial hydrolysis of the product during work-up. For this 
reason a NH4Cl quench was incorporated into the work-up to prevent saponification of 
the product by adventitious LiOH derived from the aqueous quenching of the 
organolithium base (entry 2). This modification did improve the yield of ester obtained 
and highlights the lability of the target ester to hydrolysis in work-up. 
 
To circumvent the apparent lack of solubility of the alkoxide anion in toluene, the 
anhydride electrophile was introduced to the reaction mixture prior to the addition of the 
base (entry 3). This was intended to increase the rate of esterification and, with constant 
sonication of the reaction mixture, aggregation of any insoluble alkoxide would be kept to 
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a minimum. In fact, under these conditions, only a trace of product could be observed by 
TLC. It is possible that in this case, the n-BuLi was able to react faster as a nucleophile 
with the anhydride 174 than as a base with the alcohol.  
 
It was clear that the physical properties and reactivity profile of the model system were 
rather different to those of the target system so other methods were sought to carry out 
the transformation (Table 2.10). 
 
O
X
OPMB
CN
OH O
CN
O OO
OPMB
173: X = OH
174: X =
123: X = Cl
O
O
OPMB
N
N
PPY
See Table
111 124
 
Entry Scale / mg 111 Conditions Outcome 
1 40 174, Sc(OTf)3 (20mol.%), MeCN 
No conversion 
observed 
2 40 123, ZnCl2, CH2Cl2 Decomposition of 111 
3 40 174, KHMDS, DMAP (10mol.%), Toluene 
15% yield of 124, 40% 
recovery of 111 
4 40 174, PPY, Mesitylene No conversion observed 
5 83 173, 2,4,6-trichlorobenzoyl chloride, DMAP, Et3N, Toluene, 60 oC 
24% yield of 124 
Table 2.10 - Attempted acylation of the tertiary alcohol 111 
 
Lewis acid-catalysed esterification methods failed to effect acylation (entries 1 and 2). 
The use of Sc(OTf)385 elicited no reaction and use of ZnCl2 resulted in the decomposition 
of substrate 111; possibly by rearrangement of the sensitive allylic alcohol moiety. It was 
hoped that treatment of the starting alcohol with KHMDS would provide a more reactive 
alkoxide and a more toluene soluble anion than treatment with n-BuLi. It was found 
however that replacing the base under otherwise identical conditions to the best result 
previously obtained, only a 15% yield of the ester 124 was achieved (entry 3). It was also 
Chapter 2 – Lactate Ireland-Claisen Rearrangement Route 
80 
found that the nucleophilic catalyst 4-pyrrolidinopyridine (PPY) was ineffective at 
catalysing the reaction (entry 4). The Yamaguchi esterification protocol has been widely 
employed, particularly for the formation of large-ring lactones.86 It was hoped that the 
procedure could be applied to this challenging esterification. Generation of the mixed 
anhydride of acid 173 by treatment with 2,4,6-trichlorobenzoyl chloride and subsequent 
alcoholysis with 111 gave the desired ester in 24% yield (entry 5). Although this yield is 
not yet synthetically useful, it represents the best yield achieved to date for making 124. 
 
Clearly, ester 124 is a challenging target. Acylation of the tertiary alcohol 111 is markedly 
more difficult when there is an α-substituent on the acylating partner (cf. facile acylation 
with propionic anhydride). It is possible that the relatively large protecting group on the 
oxygen in this position is hindering the reaction on steric grounds. With this in mind, a 
less sterically encumbered acylating partner was sought. The commercially available 
methyl-protected L-lactic acid 175 was therefore assessed under the Yamaguchi 
conditions (Table 2.11). 
 
176175
O
OH
OMe
CN
OH O
CN
O OO
Reagents: (i) 2,4,6-trichlorobenzoyl chloride, DMAP, Et3N, toluene, 60 
oC
OMe
i
111
 
Entry Equivalents of 111  Equivalents of 175  Yield 
1 1 2 60% 
2 2 1 87% 
Table 2.11 – Yamaguchi’s protocol for esterification as applied to the methyl-protected 
lactate ester 176 
 
Pleasingly, when the acid 175 was mixed with 2,4,6-trichlorobenzoyl chloride, Et3N and 
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DMAP followed by 2 equivalents of the alcohol 111 a 60% yield of the desired allylic 
ester 102 was obtained (cf. 24% for the PMB-protected substrate 173). The method was 
improved by switching the stoichiometry of the reaction such that the acid 175 was in a 
two-fold excess (87%, entry 2). This procedure was also preferable because it was using 
the commercially available acid 175 in excess. Chromatographic purification was also 
made easier due to there being very little of the starting alcohol 111 in the crude reaction 
product.  
 
2.2.4. Lactate variant of the Ireland-Claisen rearrangement 
 
With an efficient route now established towards the lactate ester 176, it was possible to 
assess its behaviour in Ireland-Claisen rearrangements. Under the conditions optimised for 
the rearrangement of the propionate ester (vide infra), ester 176 rearranged to give 
lactones 177 and 178 in 51% yield. Analysis of the 1H NMR spectrum of the crude 
reaction mixture revealed a diastereomeric ratio of 53:47. As expected, the same lactone 
formation step had occurred immediately after rearrangement in an analogous manner to 
that previously found for the propionate ester (Scheme 2.23). 
 
177
OH
CN
O
O
CN
O
O
O
OMe
i
Reagents and yields: (i) LHMDS (2.2 eq.), TMSCl (2.2 eq.) -78 oC then reflux, 
THF, 4 h [51%] 53:47 mixture of epimers
176
MeO
OH
CN
O
O
MeO
178
 
Scheme 2.23 - Ireland-Claisen rearrangement of methyl-protected lactate ester 176 
 
The major diastereoisomer 177 was crystalline and X-ray analysis confirmed its 
configuration at C11 (Figure 2.4).  
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Figure 2.4 – Molecular structure of 177 by single crystal X-ray structure determination, 
confirming the C11 configuration of one of the lactone epimers 
 
In this crystalline epimer, the methoxy substituent resides on the concave face of the 
tricyclic lactone and this provides proof of concept that the lactate Ireland-Claisen 
rearrangement approach may offer a stereochemically complimentary approach to the 
previously studied enolate oxygenation strategy where only convex face oxygenation 
could be achieved. 
 
However, the rearrangement under these conditions was not appreciably selective for 
either one of the two possible diastereoisomers (53:47, 177:178). It was hoped that by 
tuning the conditions of the reaction, a synthetically useful level of selectivity could be 
achieved.  
 
The key to stereoselectivity in the Ireland-Claisen rearrangement is the selective 
formation of a single enolate stereoisomer.87 Recent work from the group of Zakarian88 
had shown that enolate formation for a series of α-branched allylic esters featuring a 
stereogenic centre could be controlled using chiral bases. The selectivity in enolate 
formation was reflected in subsequent Claisen rearrangements of their trimethylsilyl 
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ketene acetals. The empirical model proposed to account for selectivity invokes a six-
membered transition state for the deprotonation event (Scheme 2.24). 
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Scheme 2.24 – Zakarian’s empirical model for enolate geometry control by chiral bases 
 
In cases where there is no overwhelming steric difference between the substituents R1 and 
R2, it is proposed that the dominant contributor to the relative energies of transition 
states A and B will be stereochemical elements in the chiral base (R* as drawn).  
 
Zakarian’s study extended only to cases where R1 and R2 were simple alkyl groups but it 
was hoped that this chiral base protocol could be applied to our system. In our case, R1 
and R2 are methyl and methoxy groups and although these are undoubtedly different 
electronically, they are both small in size and resemble one another sterically. Our system 
also has the added complication that the allylic alcohol portion of the Ireland-Claisen 
rearrangement substrate (OR3) is chiral.  
 
The selectivity of our rearrangement was assessed first using the chiral lithium amide 
(S,S)-179, originally introduced and subsequently popularised by Simpkins and co-
workers (Table 2.12).89,90  
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O
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O
O
O
OMe MeO OH
CN
O
O
MeO
See Table
Ph N
Li
Ph
(S,S)-179
177 178
176
 
Entry Conditions Outcome 
1 i. (S,S)-179, 1h, -78 °C, ii. TMSCl, 1h, -78 °C, .iii. rt, THF 
Recovery of 
starting material 
2 i. TMSCl, ii. (S,S)-179, 1h, -78 °C, iii. rt, THF Recovery of starting material 
ß3 i. TMSCl, ii. (S,S)-179, 1h, -78 °C, iii. rt, THF Addition of base to ester 
82% conversion 
177:178 ratio: 72:28 
4 i. TMSCl, ii. (R,R)-179, 1h, -78 °C, iii. rt, THF Addition of base to ester 
39% conversion 
177:178 ratio: 58:42 
Table 2.12 - Application of a chiral base (S,S)-179 in the Ireland-Claisen rearrangement 
 
Using the conditions optimised by Zakarian, no rearrangement was observed and starting 
material was recovered (entry 1). Introducing the silylating agent into the reaction prior to 
deprotonation also failed to yield any product (entry 2). Switching the order of addition 
so that the base 179 was added to a solution of the ester 176 led to an overall conversion 
of 82% to lactones 177 and 178 (72:28 mixture) (entry 3). Encouragingly, the use of chiral 
base (S,S)-179 had perturbed the ~1:1 mixture originally obtained by the use of LHMDS 
(Scheme 2.2, above). Using the opposite enantiomer of the chiral base, (R,R)-179, the 
conversion to the desired lactone was lower and interestingly, the same epimer 177 was 
favoured, this time in the ratio 58:42 (entry 4). It would appear that this chiral base is 
able to influence the selectivity of the enolate formation but cannot effect a complete 
switch in selectivity. It is of course possible that other chiral bases might allow a 
complete switch in the selectivity as achieved following a screen of bases in the work of 
Zakarian. 
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In addition to enolate geometry, another factor contributing to the stereochemical outcome 
of the rearrangement is the conformation of the transition state for the [3,3]-sigmatropic 
shift. Generally for [3,3]-sigmatropic rearrangements such as the Cope and Claisen 
rearrangements, there is a well established preference for a chair-like transition state.91 
This is also commonly the case for acyclic Ireland-Claisen rearrangement substrates 
although the magnitude of this preference is smaller.92 Ireland-Claisen rearrangements 
involving cyclic systems, particularly cyclohexenyl systems such as ours, have been 
shown to proceed via both chair and boat-like transition states thus giving rise to poor 
predictability (Scheme 2.25). 
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Scheme 2.25 – The contrasting stereochemical outcomes of boat and chair transition 
states in the Ireland-Claisen rearrangement (E-silyl ketene acetal) 
 
In a theoretical study of cyclohexenyl ester rearrangements, Houk has shown that in the 
absence of substituents at C-6, a boat-like transition state is favoured for rearrangement.93 
This preference derives from the unfavourable interaction of the silyloxy group with an 
axial C-H in the chair-like transition state (as indicated in Scheme 2.25, above).  
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Should the same preference for the boat transition state be operating for ester 176, it can 
be concluded that the chiral base (S,S)-179 is promoting the formation of the (E)-enolate 
as drawn in Scheme 2.25. Further screening of reaction conditions was then conducted to 
assess the effect of changing both the reaction solvent and the silylating reagent (Table 
2.13). 
 
OH
CN
O
O
CN
O
O
O
OMe MeO OH
CN
O
O
MeO
i
i. R3SiCl, Base, Solvent, -78 
oC then warm to rt
176 177 178
 
Entry Solvent R Base Conversion 
(%) 
Ratio 
177:178 
1 THF Me LHMDS 71 53:47† 
2 THF Me KHMDS 57 57:43 
3 t-BuOMe Me LHMDS 0 - 
4 DME Me LHMDS 0 - 
5 THF Et LHMDS 0 - 
Table 2.13 – Further screening of the Ireland-Claisen rearrangement conditions 
†See Scheme 2.23, above 
 
The initial conditions (entry 1) were adapted to employ a different enolate counterion. 
The use of KHMDS as a base had little effect on either the conversion or the selectivity 
of the reaction (entry 2). The reaction showed poor tolerance to the use of alternative 
ethereal solvents, giving no conversion in either t-BuOMe or DME (entries 3 and 4). No 
conversion was observed when the silylating reagent was changed to the more bulky 
chlorotriethylsilane (entry 5).  
 
At this point, with a moderate diastereoselectivity of 72:28 having been achieved (Table 
2.12, entry 3), it was decided to further investigate the route towards the final target. The 
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eventual goal was to apply the diastereoselective procedure to the fully oxygenated 
system leading to (–)-euonyminol. It was known from the work of Lloyd45 that the 
propionate Ireland-Claisen rearrangement could be applied to the fully oxygenated 
system and it was hoped that the same would be true for the lactate analogue (Scheme 
2.26). 
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Scheme 2.26 – Proposed lactate Ireland-Claisen rearrangement and previous propionate 
Ireland-Claisen rearrangement on the fully-oxygenated system 
 
It had been noted by Lloyd that for the propionate analogue, the rearrangement was more 
diastereoselective on the fully oxygenated system than on the model system giving a d.r. 
of 13:1 compared to a d.r. of 3:1 for the model (vide infra). This result suggests that for 
the lactate analogue, the fully-oxygenated system is likely to behave differently upon 
rearrangement to the model studied here. Fine-tuning of the reaction conditions to 
optimise the diastereoselectivity was therefore postponed until working with the real 
system. 
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2.2.5. Lewis acid catalysed THF ring-closure strategy 
 
One of the substantial synthetic milestones on the way to completing the synthesis of the 
fully-functionalised model would be the installation of the C-ring tetrahydrofuran. A 
number of strategies had previously been investigated without success44 and in planning 
future attempts, prior work on similar systems was consulted in order to identify common 
features of successful ring-closures and features that would also be amenable to a 
synthetic route from the Ireland-Claisen rearrangement product 177.   
 
One strategy that pervades in the literature for achieving such transformations is the use 
of a C11 tertiary alcohol reacting with an electrophilic component at C5 under acidic 
conditions. For instance, the previously described syntheses of Mehta (Scheme 1.6) and 
Barrett (Scheme 1.8) both feature acid-catalysed ring closure of C11 tertiary alcohols 
with bridgehead epoxides. Another example of a similar reaction motif is the conversion 
of alkene 180 directly to the tricyclic alcohol 182 by treatment with m-CPBA reported by 
both Marshall94 and Li95 (Scheme 2.27). 
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Scheme 2.27 – Marshall’s spontaneous THF formation upon epoxidation 
 
Under the acidic reaction conditions, a C11 tertiary alcohol is seen to spontaneously 
attack a bridgehead epoxide to furnish the THF ring. The frequency of similar facile ring 
closures in the literature seems to suggest that a C11 alcohol is predisposed to attack a C5 
electrophile in this ring system.  
 
In addition, a successful attempt at ring closure by Grainger on this project had exploited 
a similar reaction mode. The osmate ester 184, formed as a mixture of epimers at C11, 
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was seen to ring-close under acidic conditions via conjugate displacement of the C3 
alcohol (Scheme 2.28). To date this was the only successful C-ring formation strategy in 
relation to this project. 
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oC; (ii) HCl, MeOH [76% - 1:1 mixture of epimers]  
Scheme 2.28 – Grainger’s osmium-mediated C ring-closure 
 
The clear drawback of the osmium-mediated approach is its poor selectivity. Moreover, it 
was found that with the benzyl ether unmasked as the free alcohol, the reaction was 
diastereoselective in favour of the undesired epimer.  
 
In this work, the lactate Ireland-Claisen rearrangement approach offers a chance to 
control the formation of the quaternary C11 stereogenic centre. Subsequent conversion of 
the Ireland-Claisen rearrangement product 177 to an intermediate having a C4-C5 α-
epoxide would set the scene for ring-closure in a similar fashion to that described above 
(Scheme 2.29). 
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Scheme 2.29 – Proposed THF ring-closure strategy 
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Initial synthetic work from the lactone 177 involved opening of the lactone ring. This was 
achieved under alkylating conditions using an excess of LiOH and MeI to give the fully 
protected triol 188. Subsequent treatment with m-CPBA gave the C4-C5 epoxide 189 in a 
70% yield as a single diastereoisomer where the sterically congested bottom face of the 
decalin had directed epoxidation to the α-face of the molecule (Scheme 2.30). This 
stereochemistry was later confirmed by a crystal structure obtained for a derivative of 189 
(see page 93). 
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Scheme 2.30 – Alkylative ring opening followed by diastereoselective epoxidation 
 
With epoxide 189 in hand it was expected that deprotection of the tertiary methyl ether at 
C11 would provide an alcohol predisposed to undergo ring-closure to form the desired 
THF ring. However, given that the methyl ether is a far from labile protecting group 
which often requires harsh Lewis acidic conditions to deprotect,96 it was likely that this 
step would pose a greater synthetic challenge than the ring-closure itself.  
 
In addressing the issue of chemoselective deprotection of the tertiary methyl ether, it was 
hoped that the ether in question could be activated towards deprotection by nucleophilic 
attack on the C4-C5 epoxide. Support for this proposition came from the observation of 
an unexpected and undesired product in a mesylation reaction performed by Grainger 
(Scheme 2.31).44 
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Scheme 2.31 – Grainger’s THF ring formation through nucleophilic methyl ether44 
 
Grainger had treated primary alcohol 190 with MsCl and NEt3 with the intention that the 
resulting sulfonate would be eliminated to give the terminal olefin. Instead of isolating 
the mesylate, the only product observed in the reaction was the tricyclic tetrahydrofuran 
193. This presumably arises from the attack of the C6 methyl ether on the mesylate 
followed by a nucleophilic demethylation of the resulting oxonium ion 192 by the 
chloride counterion.  
 
A similar reaction could be envisaged in the current system where the methyl ether at 
C11 would attack the epoxide functionality and a latent nucleophile in the reaction 
medium would be able to demethylate the resulting oxonium species. It was expected that 
the use of a Lewis acid catalyst would improve the rate of any reaction by activating the 
epoxide to nucleophilic attack and as a result provide a form of ‘relay’ activation for the 
deprotection step (Scheme 2.32). 
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Scheme 2.32 – Proposed Lewis acid-catalysed THF formation from a tertiary methyl 
ether 
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The unusual reactivity displayed in the work of Grainger, in which the methyl ether acts 
as a nucleophile, is possible because of the intramolecular nature of the reaction. The 
atoms due to form the new bond are in very close proximity. In an initial attempt at the 
reaction to form the cyclic ether 195, the Lewis-acid catalyst was omitted in the hope that 
with the proximity of the reacting components, the reaction could be induced thermally 
(Table 2.14). 
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Entry Conditions Observation 
1 NaI, C6D6, reflux No conversion of starting 
material 
2 BBr3, LiI, CH2Cl2, -78 °C, 3 h Full conversion of starting 
material 
74% yield (195:196 = 59:41) 
Table 2.14 – Initial attempts at THF ring formation  
 
Upon heating epoxide 189 in benzene in the presence of NaI which was added with the 
intention to promote demethylation, no conversion to the desired product was observed 
with the epoxide proving to be robust under the reaction conditions (entry 1). Moving to 
conditions using the Lewis acid BBr3 combined with LiI, which are conditions commonly 
employed for the deprotection of methyl ethers, rapid and complete conversion of the 
starting material was observed (entry 2). Two products were isolated from the reaction in 
a combined yield of 74%. The two products arise due to the competition between the 
methyl ether oxygen and the oxygen of the ester carbonyl as nucleophiles on the epoxide. 
The desired tetrahydrofuran product 195, where the ether acts as a nucleophile, is 
favoured in the ratio 59:41 with respect to the undesired lactone 196.  
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The two products can be distinguished by their IR spectra with the carbonyl stretches for 
methyl ester 195 and lactone 196 absorbing at 1748 cm-1 and 1726 cm-1 respectively. 
These values are consistent with the values expected for a methyl ester and for a δ-
lactone respectively97 and the carbonyl stretching frequency for the desired product 195 is 
identical to that of the starting material, thus suggesting retention of the methyl ester in 
this case. Crucially, a crystal structure of 195 was subsequently obtained which displayed 
the correct atom connectivity (Figure 2.5). 
 
 
Figure 2.5 - Molecular structure of the of the tricyclic ether 195 by single crystal X-ray 
structure determination 
 
This result provided proof of principle for the current approach and showed that despite 
the presence of a competing carbonyl nucleophile in the molecule, the THF ring could be 
formed directly from the methyl ether. Furthermore, the cyclic ether product was 
marginally favoured; this is probably a reflection of 5-membered ring formation being 
kinetically favoured over 6-membered ring formation. Also, in both ring-closed products 
195 and 196, all functionalities which have not participated in the ring-closure step have 
remained intact. In the case of the desired product 195, the two secondary methyl ethers 
at C3 and C6 remain and this provides support for the suggestion that the C11 ether is 
activated by the Lewis acid specifically in a ‘relay’ sense through epoxide activation. 
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In order to circumvent the problem of competing lactone formation, it was decided to 
remove the reactive ester functionality altogether. This would be done by means of 
reduction. In the final target molecule the carbon in question, C12, is at the alcohol 
oxidation level (Scheme 2.33).  
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Scheme 2.33 – Planned reduction and protection of the ester at C12 to provide a 2nd 
generation substrate 
 
After reduction of the ester the resulting primary alcohol would be protected to avoid 
having a competing alcohol nucleophile. The protecting group chosen for this was the 
acetate ester. Alternative protecting groups such as silyl ethers were deemed too labile 
under Lewis acidic conditions. On the other hand, the acetate ester has been known to be 
resilient to treatment with BBr3 in deprotections of methyl ethers.98,99 Although an ester 
functionality is effectively re-introduced by the use of this protecting group, the 
nucleophilic carbonyl oxygen is now 8 bonds away from the electrophilic centre thus 
rendering this side reaction highly unlikely on kinetic grounds.  
 
The first attempt to synthesize a second generation ring-closure substrate from the 
epoxide 189 involved treatment with LiAlH4 and in situ trapping of the resulting lithium 
alkoxide with Ac2O (Scheme 2.34). 
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Scheme 2.34 - Attempted reduction of methyl ester 189 
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Unfortunately under the reaction conditions a complex mixture of products was obtained. 
Analysis by 1H NMR suggested reduction to varying degrees of the ester, nitrile and 
epoxide functional groups. The highly reactive reducing agent was clearly not suitable in 
this case for chemoselective reduction. To surmount this problem, it was decided to carry 
out the reduction prior to installing the epoxide (Table 2.15).  
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See Table
188  
Entry Conditions Observation 
1 LiBH4, THF, rt No conversion of starting material 
2 NaBH4, LiCl, EtOH, 60 ˚C No conversion of starting material 
3 LiAlH4, THF, -10 ˚C 65% conversion to desired product 
Table 2.15 – Reduction of methyl ester 188 
 
Upon treatment of ester 188 with LiBH4 at room temperature in THF, no conversion to 
the desired alcohol 198 was observed (entry 1). It is known that metal borohydrides are 
more reactive in alcoholic solvents100 and for this reason, a second reaction was 
attempted in EtOH, heating at 60 ˚C. Even the less reactive NaBH4 is known to reduce 
esters under these conditions101 and stoichiometric LiCl was added to generate LiBH4 in 
situ† (entry 2). Despite this, no reaction was observed under these conditions. The non-
reactivity of the ester substrate 188 to borohydride reducing agents is most likely a 
consequence of the quaternary C11 centre α-to the ester. Consequently the reduction was 
re-investigated using LiAlH4 at -10 ˚C; under these conditions, no side reactions relating 
to the nitrile were observed and the product was obtained in 65% yield (entry 3). The 
reduction was equally selective at -5 °C (Scheme 2.35).  
 
 
†This metathesis process is known and it is the commercial process by which LiBH4 is produced.
102 
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Scheme 2.35 – Sequential reduction and protection to give the C-12 acetate 199 
 
The primary alcohol derived from the reduction of methyl ester 188 was acetylated 
without purification to give the acetate ester 199 in 67% yield over the two steps. It was 
expected that the subsequent epoxidation step would show the same selectivity for 
oxygenation on the α-face as had previously been observed for methyl ester 188 (Scheme 
2.30, above). With the epoxide installed, the stage would be set for the BBr3 catalysed 
ring closure (Scheme 2.36). 
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Scheme 2.36 – Diasteroselective epoxidation followed by Lewis acid-catalysed ring 
closure 
 
Pleasingly, the epoxidation of alkene 199 was found to be diastereoselective for the α-
epoxide and upon treatment with BBr3 and LiI, the tertiary methyl ether attacked the 
epoxide to give the desired product 201 in good yield. As expected, the acetate ester 
protecting group did not participate (<5%). A minor unidentified side product did form to 
a small extent in the reaction and it was noted that the same by-product formed to a 
greater extent when using an older batch of BBr3. This is probably due to the tendency of 
BBr3 to hydrolyse over time to release HBr which presumably mediates formation of this 
by-product. 
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2.2.6. Final elaboration of the model system 
 
With the desired dihydroagarofuran-like ring system now in place, two synthetic steps 
remained for the completion of the southern periphery functionality. The first of these 
was an oxidation of the C4 secondary alcohol to the corresponding ketone. The Dess-
Martin periodinane103 was chosen as a mild and practical oxidant (Scheme 2.37). 
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Scheme 2.37 – Dess-Martin oxidation of the C4 secondary alcohol 201 
 
The ketone 202 was formed in 88% yield using this oxidant. Conversion of this ketone to 
the desired tertiary alcohol would require the formal addition of methane. It was hoped 
that this could be achieved by the use of a methyl Grignard reagent. The use of an excess 
of this reagent would also serve to deprotect the primary alcohol in the molecule, as the 
acetate ester would also be susceptible to nucleophilic attack. Grignard reagent attack on 
the ketone can potentially yield two products, each deriving from attack of the 
nucleophile on a different face of the ketone. It was expected at the outset that the 
presence of the THF ring on the β–face would favour attack on the α-face on steric 
grounds to give the desired product (Scheme 2.38). 
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Scheme 2.38 – Grignard reagent addition to the C4 ketone 202 
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Upon treatment with MeMgCl, attack at both the acetate ester and the ketone was indeed 
observed, giving the desired tertiary alcohol 203 as a single product in 75% yield. The 
relative stereochemistry of the product was assigned by the use of NOESY experiments 
(Figure 2.3).  
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Figure 2.3 – NOESY NMR experiment on final product 203 
 
NOESY experiments supported the proposed structure for the tertiary alcohol with the 
methyl group having been introduced on the less hindered α–face. The protons of the 
newly installed methyl group displayed nOe interactions with both the protons of the C14 
methyl group and the proton at C6. Both of these proton environments are related to the 
newly installed methyl group by means of a 1,3-diaxial interaction and the nOe 
enhancements can be accounted for by their proximity. No evidence for the opposing 
undesired epimer could be observed from NOESY experiments. For this potential product 
one might expect to observe an interaction between the newly installed methyl protons 
and the protons of one or both of the methoxy groups. Both of these interactions are 
absent. 
 
2.3. Alternative approaches 
 
Whilst working on the model system to develop chemistry for the installation on the 
southern periphery functionality, efforts were made to streamline the synthetic route for 
the fully oxygenated system, directly applicable to the natural product. If the synthetic 
steps described above for the model system were transferred to the fully-oxygenated 
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system with its current synthesis, our total synthesis of (–)-euonyminol would be 27 
steps. This does not compare favourably with the 20 step synthesis of the racemic 
material previously developed by White.37 An assessment of the established route 
highlights two inefficient reaction sequences where steps could potentially be saved 
(Scheme 2.39). 
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Scheme 2.39 – Summary of the synthetic route for the fully-oxygenated system 
 
The synthetic route is summarised to the point of the desymmetrisation step. The epoxide 
112 resulting from this will serve as the starting point for implementing the chemistry 
described in the previous section. The overall step count to this intermediate is an 
undesirably high 17 steps and the route has been divided here into shorter reaction sub-
sequences. Those highlighted in red could be considered inefficient, thereby offering 
room for improvement to the synthetic route. The most obvious of these is the sequence 
leading to protected heptaol 105 where two sequential dihydroxylations and protections 
are performed along with two different deprotection steps.  
 
The other inefficient sequence shown starts from diene 101 and involves an epoxidation, 
opening of this epoxide with bromide, then elimination along with two separate 
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protection steps. It is possible that this sequence of steps could be shortened by 
employing an epoxide rearrangement and preliminary investigations into such an 
approach are described in the following section. 
 
2.3.1. Epoxide rearrangement 
 
In order to shorten the existing two-directional synthesis by one step it was thought that a 
diene of type 206 could be accessed in a single step from bis-epoxide 205 by treatment 
with base.104 Deprotonation α- to each epoxide followed by epoxide opening would give 
rise to the allylic alcohol moiety on each ring (Scheme 2.40). Examples of similar 
reactions, albeit not in a two-directional sense as required here, abound in the literature 
and asymmetric variants usually employing chiral lithium amide bases have been 
extensively investigated.105  
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Scheme 2.40 – Proposed base-induced epoxide rearrangement to give diene 206 
 
There are two potential sites for deprotonation on each ring. To address the issue of 
regioselectivity it is instructive to consult the work of Rickborn who describes how a syn-
elimination passing through a cyclic transition state operates for such systems (Scheme 
2.41).106  
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Scheme 2.41 - Rickborn’s proposed cyclic transition state as applied to our system 
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The β-elimination is proposed to pass through a six-membered transition state 208 where 
the lithium cation of a base (in this case LiNR2) co-ordinates to the oxygen of the oxirane. 
In our system the epoxide resides on the β-face of the molecule and so the proton should 
be abstracted from the β-face. Of the two available protons on this face, Ha and Hb, Ha is 
in the more accessible pseudo-axial orientation and so should be abstracted preferentially. 
Moreover, the tertiary hydroxyl group in the bis-epoxide substrate 205 was planned to be 
protected as a trimethylsilyl ether. Aside from reducing the quantity of base required to 
perform the desired rearrangement, it was hoped that the steric bulk of such a protecting 
group would discourage deprotonation of the adjacent Hb. 
 
Epoxide 102 was duly protected as the trimethylsilyl ether by heating in excess 1-
trimethylsilylimidazole (Scheme 2.42), conditions which elsewhere on the project had 
been shown to be particularly effective for hindered substrates (vide infra). 
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Scheme 2.42 – Silylation of alcohol 102 
 
With the rearrangement substrate 207 in hand, it was subjected to conditions originally 
described by Andersson for an asymmetric epoxide rearrangement.107 The conditions 
were modified such that the chiral diamine was omitted and TMEDA used in its place 
(Scheme 2.43). 
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Scheme 2.43 – Attempted double rearrangement of bis-epoxide 207 
 
Disappointingly, a very poor mass balance resulted from the reaction after passing 
through a silica plug. The only product isolated from the reaction was the allylic alcohol 
210. Promisingly, the desired epoxide rearrangement had occurred but it had only taken 
place in one ring. One explanation for the poor mass balance of the reaction could be that 
the polar target diol was indeed formed and the method of isolation prevented a true yield 
being realised. It was hoped that trapping the lithium alkoxides formed in the reaction 
with a suitable electrophile would assist the isolation of the desired product (Table 2.16). 
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Table 2.16 – Attempted in situ trapping of epoxide rearrangement products 
 
The electrophile chosen was TsCl. It was chosen because later in the synthetic route, 
elimination of both alcohol derivatives is required to give the diene 107 which sets the 
stage for oxidative desymmetrisation (Scheme 1.18, above). With the electrophile present 
in the reaction from the beginning, no evidence of rearrangement was observed for either 
Entry Substrate Conditions Outcome 
1 207 
2 102 
TsCl, n-BuLi, DBU, TMEDA, THF, 
rt, 3 h 
No evidence of rearrangement 
3 207 
i. n-BuLi, DBU, TMEDA, rt, 4.5 h;  
ii. TsCl, THF, rt, 15 h 
210 obtained in 13% yield 
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the silyl ether 207 or the unprotected alcohol 102 (entries 1 and 2). Changing the order of 
addition so that the rearrangement was allowed to take place as previously observed 
(Scheme 2.43, above) before attempting to trap the alkoxides with TsCl proved more 
successful (entry 3). In this case a 13% yield of the mono-epoxide 210 was obtained 
which was in keeping with the previous yield achieved. No successful trapping of the 
lithium alkoxides formed in the reaction was observed and once again a poor mass 
balance resulted from the reaction.  
 
It would appear that although the first rearrangement occurs in low yield, the second 
rearrangement in this case is more difficult to induce. One possible reason for this could 
be that once the first rearrangement has occurred, the resulting lithium alkoxide is 
sufficiently different to the starting material in terms of either solubility or pKa for the 
second rearrangement to be significantly slower. Also, the first rearrangement is likely to 
induce a conformational change in the molecule and it is possible that a new orientation 
for the bulky TMS group serves to hinder the second approach of the bulky lithium amide 
base. At this time, further investigations along these lines were taken up by another 
student in the  group. Eventually, conditions were found to successfully achieve the 
desired bis-rearrangement on the C5 benzyl ether in 67% yield.108  
 
Attention then switched to a new line of investigation, exploring a route characterised by 
a greater departure from the established synthetic route on the fully-oxygenated system. It 
was designed to avoid the troublesome double dihydroxylation and protection sequence 
altogether.     
 
2.3.2. A ring-closing metathesis approach 
 
With the aim to reduce the step count in the synthesis of the fully oxygenated system, the 
inefficient double dihydroxylation sequence was targeted for improvement. It was 
thought that the protected heptaol 105, a key intermediate in the established synthesis, 
could be derived from the bis-epoxyalcohol 212 by means of a Payne-like rearrangement 
involving a molecule of acetone (Scheme 2.44). This reaction sequence provides a 
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potential alternative to the double dihydroxylation sequence currently used to install the 
top face oxygenation pattern. 
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Scheme 2.44 – Proposed bis-rearrangement of the 2,3-epoxyalcohol motif  
 
The proposed bis-rearrangement would provide a transformation from the 2,3-
epoxyalcohol to a doubly protected triol motif in a single step. This type of 
transformation is known109,110 and an example described by the group of Díez employs 
AlCl3 as a catalyst (Scheme 2.45). 
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Scheme 2.45  - Díez’s epoxide rearrangement catalysed by AlCl3110 
 
The reaction proceeds with inversion of stereochemistry at C4 which is also required in 
the proposed reaction on our system. With the intention to employ this reaction in a 
revised synthesis of euonyminol, the bis-epoxyalcohol 212 became a synthetic target. It 
was thought that it might be synthesised in a few synthetic steps from the cyanohydrin 
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101, already an intermediate in the first generation synthesis and available in three steps 
from naphthalene (Scheme 2.46).   
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Scheme 2.46 – Proposed synthesis of 212 featuring an allylic oxidation step 
 
The key step in the synthetic sequence would be an allylic oxidation of diene 213 to give 
the bis-allylic alcohol derivative 214. There are two allylic positions on each ring and 
also two potential faces upon which oxidation can occur. The deriviatisation of the 
tertiary bridgehead alcohol as a bulky silyl ether was considered likely to favour 
oxidation at the position and face shown. Subsequent epoxidation of the diene on the β-
face, potentially directable by a free C5 alcohol, would give the target 212.  
 
An alternative potential route would require the diene to be selectively epoxidised on the 
sterically more accessible α-face to give bis-epoxyalcohol 212. In this case, it was hoped 
that the epoxides could be opened with an oxygen nucleophile under Lewis acid 
catalysis111,112 to give pentaol 216 and the synthesis could continue with suitable 
protecting group chemistry (Scheme 2.47).  
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Scheme 2.47 – Proposed double epoxide opening with ammonium acetate 
 
With the two approaches hinging on a double allylic oxidation, the synthesis of a silyl 
ether substrate was investigated (Table 2.17) 
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Entry Conditions Outcome 
1 TBSCl, N-methylimidazole, I2, CH2Cl2, rt, 6 
h 
No conversion of starting 
material 
2 TMSCN, CH2Cl2, reflux 18 h No conversion of starting 
material 
3 1-Trimethylsilylimidazole, 100 °C, 16 h 95% yield of 218 
Table 2.17 – Silylation of tertiary alcohol 101  
 
The initial target was the bulky TBS ether 219. Subjection of the hindered alcohol 101 to 
conditions known to be effective for hindered substrates,68 resulted in no conversion of 
the starting material to product (entry 1). The target was then switched to the less 
sterically demanding TMS ether 218. Although heating with TMSCN113 induced no 
silylation (entry 2), it was found that, as observed for the corresponding bis-epoxide 102 
(Scheme 2.42, above), heating with the silylating agent 1-trimethylsilylimidazole114, neat, 
enabled formation of the TMS ether 218 in excellent yield (entry 3). 
 
Investigations then followed into the allylic oxidation step. There exist a number of 
procedures for allylic oxidation; two commonly employed systems feature use of salts of 
Cu(I)115 and Pd(II) to effect this type of transformation.116 An assessment of catalysis by 
both types of salt was carried out (Table 2.18). 
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CN
OSiMe3
CN
OSiMe3
OR OR
See Table
220: R = Ph
221: R = Ac
218
 
Entry Conditions Product Outcome 
1 PhCO3t-Bu, CuBr (0.1 eq.), PhMe, 80 °C 220 No conversion 
2 PhCO3t-Bu, CuCl (0.1 eq.), PhMe, 80 °C 220 No conversion 
3 PhCO3t-Bu, Cu2O (0.1 eq.), PhMe, 80 °C 220 No conversion 
4 PhCO3t-Bu, Cu(OTf)2.PhH (0.1 eq.), PhMe, 80 °C 220 80% Hydrolysis of  
silyl ether 
5 Pd(OAc)2, benzoquinone, Bu4NOAc, CHCl3, rt 221 No conversion 
Table 2.18 – Attempted bis-allylic oxidation of diene 218 
 
With Cu(I) catalysis (entries 1-4), a reaction commonly referred to as the Kharasch-
Sosnovsky reaction,117 no conversion the desired product was observed even following 
prolonged heating. In the case using Cu(OTf)2 as a catalyst (entry 4), partial hydrolysis of 
the silyl ether was observed and this is likely to be due to the presence of adventitious 
TfOH arising from the catalyst. Disappointingly, the diene 218 also showed no reactivity 
under Pd(II) catalysed oxidative conditions (entry 5).  
 
Discouraged by these initial findings which suggested that our substrate exhibits poor 
reactivity and harbouring additional concerns about the challenges of rendering the allylic 
oxidation sufficiently regioselective, it was hoped that a de novo synthesis of the bis-
epoxide 212 could be developed. An approach that we were attracted to was one featuring 
decalin formation by ring closing metathesis (RCM) (Scheme 2.48).  
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Scheme 2.48 – Retrosynthetic analysis for a de novo approach to bis-epoxide 212 
 
The route would begin with an aldol condensation of ethylcyanoacetate with acrolein to 
give the bis-allylic alcohol 224. Subsequent allylation of the ethyl ester would give diallyl 
carbinol 223 which would serve as the substrate for RCM to simultaneously form both 
cyclohexene rings. To our knowledge, there is only a single example to date of double 
cyclohexene formation by RCM and this features bond formation at a different position in 
the ring to that proposed here.118  
 
The proposed aldol partner, acrolein, is however an excellent Michael acceptor and given 
the soft nature of the nucleophile it is likely that 1,4-addition would be favoured over the 
desired 1,2-addition. To avoid the α,β-unsaturated carbonyl functionality, an α-
haloaldehyde would be used. This would serve as a surrogate for the unsaturated 
aldehyde and would not allow the Michael reactivity to be displayed. The commercially 
available α-chloro acetal 225 was therefore used as a starting material in initial 
investigations with the intention that the acetal would be hydrolysed under acidic 
conditions to liberate the desired aldehyde in situ. In a screen of reaction conditions, 
attempts were made to protect the target 1,3-diol as the ketal 226 in some cases (Table 
2.18). 
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225 226
NC CO2Et H Cl
EtO OEt
CN
OH OH
EtO2C
See Table
CN
O O
EtO2C
See Table
224  
Entry Conditions Target 
Product 
Outcome 
1 i. TsOH, Toluene:H2O (9:1), 100 °C, 3 h ii. DMP, Toluene rt, 2.5 h 226 
Aldehyde volatile 
in hydrolysis step 
2 i. TsOH, THF, rt, 16 h ii. DMP, THF, rt, 1.5 h 226 
3 i. TsOH, CH2Cl2, rt, 16 h ii. DMP, CH2Cl2, rt, 1.5 h 
226 
No conversion of 
ethyl cyanoacetate; 
Partial acetal 
hydrolysis 
4 i. AcOH, H2O:THF (2:1), rt, 1 h ii. NaOMe, ethyl cyanoacetate 224 
Recovery of 
starting materials 
5 
i. TsOH, THF, H2O, 45 °C 3 h 
ii. NaOEt ethyl cyanoacetate, reflux 3.5 
h 
224 Mixture of polymeric products 
6 
i. TsOH, THF, H2O, 45 °C 3 h 
ii. KOt-Bu ethyl cyanoacetate, reflux 
3.5 h 
224 Recovery of ethyl cyanoacetate 
7 i. TsOH, THF, H2O, 45 °C 3 h ii. NEt3 ethyl cyanoacetate, reflux 3.5 h 
224 Recovery of ethyl cyanoacetate 
Table 2.18 – Acetal hydrolysis then attempted aldol condensation between ethyl 
cyanoacetate and 225 
 
In the first attempt at the reaction (entry 1), a mixture of ethyl cyanoacetate and acetal 
225 were heated with catalytic acid to hydrolyse the acetal and then 2,2-
dimethoxypropane (DMP) was added in an attempt to isolate any diol formed as the ketal 
226. In this case none of the desired products were observed and this was attributed to the 
volatility of the aldehyde formed in the hydrolysis. The reaction was heated sufficiently 
for it to have probably escaped the reaction vessel. To avoid this happening, two similar 
reactions were performed in different solvents (THF and CH2Cl2; entries 2 and 3) at room 
temperature. In these cases, no conversion of ethyl cyanoacetate was observed despite 
evidence of partial acetal hydrolysis having occurred.  
 
Switching focus from the acid-catalysed enol reactivity of ethyl cyanoacetate and looking 
to exploit its base-induced enolate reactivity, acetal 225 was stirred for 1 h in aqueous 
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AcOH and then treated with an excess of the sodium enolate of ethyl cyanoacetate (entry 
4). In this case, both ethyl cyanoacetate and acetal 225 were recovered fully from the 
reaction, indicating that acetal hydrolysis had not occurred. Consequently, acetal 225 was 
heated in the presence of catalytic TsOH for 3 h, before the mixture was treated with 
excess quantities of the sodium (entry 5), potassium (entry 6) and ammonium (entry 7) 
enolates of ethyl cyanoacetate. Interestingly, treatment with the enolate generated by 
NaOEt gave rise to a complex mixture of polymeric products whereas the other two 
reactions led to recovery of ethyl cyanoacetate. The polymeric products could potentially 
arise from Knoevenagel condensation process and/or from polymerisation of acrolein 
formed in the hydrolysis step.   
 
None of the desired product had been formed under any of the conditions so far attempted 
and this seemed to stem from the poor reactivity of the cyanoacetate enolate with 3-
chloropropionaldehyde. In some cases, incomplete acetal hydrolysis also contributed to 
the poor reaction. In a final attempt to induce the aldol process, the acetal hydrolysis step 
was monitored by 1H NMR spectroscopy as a function of time and the enolate 
nucleophile was added once a known concentration of the desired aldehyde had been 
obtained (Figure 2.4). 
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H Cl
EtO OEt
H Cl
O
i
Reagents and conditions: (i) Oxalic acid (0.05 eq.), THF (1 eq.), H2O (1 eq.); 
(ii) ethyl cyanoacetate, NaOEt, THF
ii
CN
OH OH
EtO2C
227
 
 
Figure 2.4 – Hydrolysis of diethyl acetal 225 monitored by 1H NMR spectroscopy as a 
function of time 
 
With one equivalent of water present in the reaction, acetal hydrolysis proceeded to 38% 
in 90 min. With the addition of three further equivalents the equilibrium could be shifted 
to 64% hydrolysis at 210 min. At this point, the sodium enolate of ethyl cyanoacetate, 
formed with excess NaOEt, was added. After 3 h stirring, the reaction mixture was 
acidified and ethyl cyanoacetate was recovered in full.   
 
At this juncture, the aldol approach was abandoned and an approach starting with double 
allylation of ethyl cyanoacetate with allyl bromide was explored. This reaction gave the 
known diallyl ester 228 in quantitative yield (Scheme 2.49).119 
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228
NC CO2Et Br
i
Reagents and yields: i. K2CO3, (Bu4N)2SO4, MeCN, reflux 2.5 h [99%]
CNEtO2C
 
Scheme 2.49 - Double allylation of ethyl cyanoacetate 
 
With access to the diene 228, an allylic oxidation could be envisaged to give rise to the 
1,3-diol motif that was sought. The selectivity of such a reaction was difficult to predict 
and so initially the diene was subjected to a series of allylic oxidation conditions to search 
for the desired reactivity (Table 2.19). 
 
228
CN
OR OR
EtO2CCNEtO2C
See Table
229: R = H
230: R = Bz  
Entry Conditions Product   Outcome 
1 SeO2 (5 mol%), H2O2, t-BuOH, H2O, 90 °C, 1 h 229 No conversion of SM 
2 SeO2, t-BuOOH, CH2Cl2, rt, 48 h 229 No conversion of SM 
3 PhCO3t-Bu, CuI (10 mol%), PhH, 100 °C, 48 h 230 No conversion of SM 
Table 2.19 – Attempted allylic oxidation of diene 228 
 
Treatment of diene 228 with catalytic SeO2 with H2O2 as a stoichiometric oxidant120 
failed to oxidize the diene (entry 1). Terminal alkenes are known to be poorer substrates 
for selenium-mediated oxidations than more electron rich alkenes so it was thought that 
moving to conditions stoichiometric in selenium would prove more successful.121 Once 
again however, despite a long reaction time (48 h), no reaction was observed (entry 2). 
Similar results were obtained in an attempted Kharasch-Sosnovsky reaction with catalytic 
Cu(I) (entry 3)122 where no reactivity was observed despite prolonged heating. 
 
The poor reactivity observed for the allylic oxidation, along with the concerns over the 
eventual stereoselectivty of such a reaction, served to drive a search for alternative 
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synthetic approaches. One possible single step route to the target 1,3-diol motif would be 
the double acylation of ethyl cyanoacetate followed by ketone reduction (Scheme 2.50).  
 
231 232
CN
OH OH
EtO2C
NC CO2Et
i
Reagents and conditions: i. K2CO3, Bu4NI, MeCN, reflux 1 h
Cl
O
CNEtO2C
O O
 
Scheme 2.50 – Attempted double acylation of ethyl cyanoacetate 
 
Inspired by the high yielding double allylation of ethyl cyanoacetate described above, 
subjection to the same conditions but exchanging the electrophile for acryloyl chloride 
failed to acylate the substrate. Instead, extensive polymerisation was observed. In an 
effort to avoid this and to properly assess the potential for acylation of ethyl cyanoacetate, 
it was decide to investigate a double formylation protocol. This would give rise to a 
dialdehyde 231 which could be converted to the desired bis-allylic alcohol by vinylation 
with an appropriate organometallic reagent (Scheme 2.51).  
 
233
NC CO2Et
X
O
CN
OH OH
EtO2CCNEtO2C
H H
OO
H
Acylation Vinylation
232  
Scheme 2.51 – Proposed access to the 1,3-diol via vinylation of a dialdehyde 
 
Such a synthetic route could potentially give rise to the 1,3-diol preferentially as a single 
diastereoisomer. Using the Felkin-Anh model for selectivity of nucleophilic attack at a 
carbonyl,123,124 it was thought that the desired diastereoisomer could be favoured (Scheme 
2.52).  
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Scheme 2.52 – Proposed Felkin-Anh selectivity of double vinylation of dialdehyde 233 
 
For the starting dialdehyde 233 the ethyl ester is designated the large group and the nitrile 
the small group. Should the attack of a nucleophile (in this case vinyl magnesium 
bromide) occur in accordance with Felkin-Anh selectivity, allylic magnesium alkoxide 
234 should preferentially be formed. For the second nucleophilic addition, the ethyl ester 
must once again be designated as the large group if the desired product is to be preferred 
on Felkin-Anh grounds. This selectivity could, in principle, be influenced by changing 
the alkyl group on the ester. For instance, a t-butyl ester is more likely to operate as the 
large group in this step. Importantly, in this second nucleophilic addition, the magnesium 
alkoxide present could also potentially align with the aldehyde carbonyl. This would 
preferentially give the desired 1,3-diol orientation this time by chelation control. 
 
With scope for a selective vinylation, attention was focused upon finding a means to 
formylate the activated methylene compound (Table 2.20). 
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NC CO2Et
CNEtO2C
H H
OO
See Table
233  
Entry Conditions Outcome 
1 Ethyl formate, K2CO3, MeCN, 50 °C 8 h No conversion of ethyl cyanoacetate 
2 HCO2H, oxalyl chloride, DMF (cat.), then 
Et3N, CH2Cl2, rt, 48 h 
No conversion of ethyl cyanoacetate 
Table 2.20 – Attempted double formylation of ethyl cyanoacetate 
 
Under conditions analogous to the successful allylation reaction described above, 
treatment with ethyl formate failed to formylate ethyl cyanoacetate (entry 1). The same 
result was observed when formyl chloride formed in situ from formic acid was used as an 
electrophile (entry 2).  
 
Given the lack of success of attempts based on the double alkylation or double acylation 
of the cyanoacetate nucleophile, attention was diverted back to developing a double aldol 
condensation. Examples of such a process featuring activated methylene compounds such 
as ethyl cyanoacetate are extremely rare.125,126 However, upon searching the literature, an 
intriguing example was found where 1,5-dialdehyde 235 was reacted with t-butyl 
cyanoacetate to give thiopyran 236, apparently as a single diastereoisomer (Scheme 
2.53).126 
 
235 236
S
O
H
O
H
CO2t-BuNC
S
HO OH
NC CO2t-Bu
Reagents and yields: i. Piperidine (0.01 eq.), 1,4-dioxane:H2O (2:1), rt, 16 h [70%]
i
 
Scheme 2.53 – Lopez Aparicio’s formation of thiopyran 236 as a single diastereoisomer 
 
The relative stereochemistry of the product was assigned by Lopez Aparicio based on 1H 
NMR coupling constants and it agrees with the stereochemistry required for the 
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euonyminol synthesis i.e. a syn relationship between the nitrile and alcohol functional 
groups. When considering that a sulfide functional group may serve as a synthetic 
precursor to an alkene via oxidation and subsequent Ramberg-Bäcklund reaction,127 the 
thiopyran 236 became an attractive target. By conversion to a cyclopentene intermediate, 
this sulfone 237 would allow an investigation into a novel method of decalin formation 
by ring-rearrangement/ring-closing metathesis (Scheme 2.54). 
 
237 238
239240
S
HO OH
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Scheme 2.54 – Proposed elaboration of thiopyran 236 to the desired decalin framework 
via a Ramberg-Bäcklund ring contraction 
 
The Ramberg-Bäcklund reaction at its inception involved the conversion of an α-halo 
sulfone to an alkene with the extrusion of sulfur dioxide. There have been a number of 
developments since the discovery of the reaction128 and the alkene is now commonly 
obtained in a single pot from the sulfone often using conditions based on the Meyers 
variant of the Ramberg-Bäcklund reaction129 where carbon tetrachloride is introduced to 
generate an α-chlorosulfone in situ.  
 
Should the Ramberg-Bäcklund reaction be successful on cyclic sulfone 237, a double 
allylation of the ester should give triol 239. This substrate could in principle be converted 
to decalin 240 in a single step by the use of a metathesis catalyst to promote first the ring 
opening of the cyclopentene ring and second, the double cyclohexene ring closure to 
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form the decalin. As indicated previously, to our knowledge only a single example exists 
in the literature of a double ring closing metathesis to form a decalin (Scheme 2.55).118  
 
H
OR
H
OROR
241 - R = PMB
242  - R = H
cis-243 - R = PMB
cis-244 - R = H
trans-243 - R = PMB
trans-244 - R = H
Grubbs I
0.1 M in CH2Cl2
 
Entry Starting Material Product Yield (%) Ratio cis:trans 
1 241 243 80 8:1 
2 242 244 84 1:2.8 
Table 2.21 – Lautens’ decalin formation by ring-closing metathesis86,118 
 
In this study by Lautens, decalin products were obtained in high yield and the cis:trans 
selectivity of the product could be influenced by derivatising the tertiary alcohol. 
Protecting group tuneability has also been observed in related systems which do not 
directly furnish decalins.130 An informative study could be envisaged starting from 
cyclopentene 239 and attempting to progress via metathesis chemistry to the target 
decalin 240 and so a synthesis of the Ramberg-Bäcklund substrate 237 was embarked 
upon. 
 
The published synthesis of thiopyran 236 begins with the double alkylation of sodium 
sulfide with the commercially available bromoacetaldehyde diethyl acetal.131 Hydrolysis 
of the resulting diacetal with aqueous HCl then apparently gives the cyclic hydrate, 1,4-
oxathiane 246 as a white solid.132 We considered that the 1,4-oxathiane 246 was preferred 
practically to the dialdehyde 235 used in the work of Lopez Apparicio (Scheme 2.53, 
above) on account of its manageable physical form and its reduced moisture sensitivity 
relative to the aldehyde 235. Given that the two species are in equilibrium in aqueous 
solution, the hydrate was carried forward into the condensation with t-butylcyanoacetate 
(Scheme 2.56).  
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Scheme 2.56 – Synthesis of thiopyran 236 via 1,4-oxathiane 246 
 
Pleasingly, it was found that the 1,4-oxathiane 246 performed well in the condensation 
with ethyl cyanoacetate and the yield obtained significantly exceeded the literature 
method which used the dehydrate dialdehyde as the electrophile (99% cf. 70%). The 
relative stereochemistry assigned in the literature, in which the nitrile and alcohol 
functionalities are syn to one another, was also confirmed by X-ray crystallography 
(Figure 2.5).   
 
 
Figure 2.5 – Molecular structure of thiopyran 236 from a single crystal X-ray crystal 
structure determination 
 
In order to proceed with the synthetic route, it was intended to protect the hydroxyl 
groups as benzyl ethers prior to performing the Ramberg-Bäcklund reaction. The 
rationale for this was based upon literature precedent; no examples were found of 
Ramberg-Bäcklund reactions featuring a β-hydroxysulfone, whereas a number of 
examples were found employing β-alkoxysulfones as substrates.133-135 Diol 236 was 
therefore subjected to base mediated alkylation conditions (Scheme 2.57). 
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Scheme 2.57 – Attempted benzylation of diol 236 
 
The desired bis-benzyl ether could not be isolated from the reaction and instead rapid 
decomposition of the starting diol was observed with the formation of a complex tar from 
which no single product could be identified. Upon treatment with base, it is possible that 
the molecule could undergo retro-aldol processes. It also is possible that the nucleophilic 
sulfide functional group could be participating in such a decomposition so it was 
converted to the non-nucleophilic sulfone by oxidation (Scheme 2.58).  
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Scheme 2.58 – Oxidation of cyclic sulfide 236 
 
It was found that oxidation with m-CPBA provided the cyclic sulfone 237 in good yield. 
Subjection of this compound to the same benzylation conditions as described above failed 
to furnish the desired bis-benzyl ether (Scheme 2.59). 
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Scheme 2.59 – Attempted benzylation of sulfone 237 
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Once again a complex mixture was obtained from the reaction and this seems to highlight 
a lability of the densely functionalised molecule to strong base. In future, efforts to 
alkylate this substrate should be focused upon milder conditions avoiding the use of 
strong base. Examples are Lewis acid catalysed trichloroacetimidate alkylations67 and 
recently described heat and mix methods.136 In order to gauge the reactivity of the 
unprotected diol 237 in a Ramberg-Bäcklund reaction, a test reaction was performed 
under typical conditions for a Meyers variant of the Ramberg-Bäcklund reaction (Scheme 
2.60).134 
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Scheme 2.60 – Attempted Ramberg-Bäcklund of unprotected diol 237 
 
Unfortunately, none of the desired alkene was observed in the reaction. The starting 
material was again consumed to give a complex mixture of products. The failure of this 
initial reaction may reflect the fact that there are, to our knowledge, no examples of β,β-
dihydroxy sulfones as Ramberg-Bäcklund substrates in the literature. The most desirable 
synthetic approach going forward will be to protect both hydroxyl groups before 
attempting the ring contraction. 
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CHAPTER 3 - Conclusions and Future Work 
 
The primary objective of this work was to develop a method for the installation of the 
southern periphery functionality of euonyminol on a model system. The most promising 
route to achieve this proved to be one based on an Ireland-Claisen rearrangement of a 
lactate ester 176. Future work will require this rearrangement to be applied to the fully-
oxygenated system (Scheme 3.1).   
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Scheme 3.1 – Proposed transfer of lactate Ireland-Claisen rearrangement to fully-
oxygenated decalin system 
 
Results obtained as part of this work highlight the choice of base as being the most 
influential factor in determining the stereoselectivity of the rearrangement. An efficient 
total synthesis of (–)-euonyminol will require a highly selective procedure for the 
formation of the quaternary C11 stereogenic centre and a screen of bases should provide 
the most attractive avenue for optimisation of this procedure. 
 
In further synthetic work on this route, the foundations for the total synthesis have been 
laid using the model system. A pivotal step involves the formation of the THF C-ring by 
the Lewis acid-catalysed intramolecular attack of a tertiary methyl ether upon a 
bridgehead epoxide (Scheme 3.2).  
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Scheme 3.2 – THF ring-closure to install the tricyclic skeleton of euonyminol 
 
Following two further synthetic steps, the final bis-methyl ether 203 was obtained with 
the final step involving the attack of MeMgCl on the α-face of the molecule as 
determined by NOESY experiments (Scheme 2.37, 2.38). In the final euonyminol 
synthesis a method for the deprotection of both methyl ethers will need to be developed 
and suitable timing for the reduction of the bridgehead nitrile to a hydroxymethyl group 
must be established. In order to reduce the overall step count of the synthesis, initial 
efforts should be directed towards performing this reduction concomitantly with the 
methyl ester reduction which forms part of the synthesis of the model. 
 
With the southern periphery functionality in place on the model system, it will also be 
possible to use this molecule as a tool immediately for the exploration of a strategy for 
preparation of macrodilactone-containing natural products of the Celastraceae family. 
Key to this investigation will be the establishment of an order of events for a generic 
macrolactonisation of the polyol derived from the bis-methyl ether 203 with a number of 
naturally occurring diacid ligands13 (Scheme 3.3).  
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Scheme 3.3 – Proposed elaboration of the naturally occurring macrodilactone motif from 
the model polyol 203 
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In parallel work, preliminary investigations have been undertaken towards a new 
synthetic route for the fully-oxygenated system. The new route was designed to include a 
Ramberg-Bäcklund reaction to form a cyclopentene ring which it is envisaged will be 
opened in a metathesis process to give a polyene 251 which will hopefully undergo RCM 
in situ to form the desired trans-decalin ring system (Scheme 3.4).  
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Scheme 3.4 – Proposed route to advanced intermediate 252 featuring a Ramberg-
Bäcklund reaction and RCM 
 
A synthesis of sulfone 237 has been developed but a method for its protection remains to 
be found. Following protection and a Ramberg-Bäcklund ring contraction to form alkene 
249, studies should focus on decalin formation by means of RCM. It is the future 
development of this route combined with the chemistry developed for the southern 
hemisphere which is expected to provide a synthetic route to (–)-euonyminol which is 
competitive on step count to the racemic synthesis of White and co-workers.37  
 
 
 
 
 
Chapter 4 - Experimental 
124 
CHAPTER 4 – Experimental 
 
General Directions 
 
All reactions were performed under anhydrous conditions and an atmosphere of nitrogen 
unless otherwise stated. Yields refer chromatographically homogeneous material. 
Chromatography: All flash chromatography was performed on silica gel (Merck Keiselgel 
60 F254 230-400 mesh) according to the method of W. C. Still.137 Thin layer 
chromatography was performed on Merck aluminium-backed plates pre-coated with silica 
(0.2 mm, 60 F254). Plates were visualised by ultraviolet fluorescence (λmax = 254 and 366 
nm) or charring with either 10% KMnO4 in 1 M H2SO4 or vanillin solution in EtOH. 
Melting points: These were determined on a Khofler hot stage. 
Infra-red spectra: These were recorded as thin films on a Perkin-Elmer Paragon 1000 
Fourier transform spectrometer. Only selected absorbances (νmax) are reported. 
1H NMR spectra: These were recorded at 400 or 500 MHz on Bruker DRX instruments. 
Chemical shifts (δH) are quoted in ppm and are referenced to the residual solvent peak 
(CHCl3 at δ 7.27 ppm). Coupling patterns are assigned as singlet (s), doublet (d), triplet 
(t), quartet (q) or multiples thereof.  
13C NMR: These were recorded at 100 or 125 MHz on Bruker DRX instruments. 
Chemical shifts (δC) are quoted in ppm and are referenced to the residual solvent peak 
(CHCl3 at δ 77.1 ppm). Peaks are assigned as s, d, t and q based on DEPT data. 
Mass spectra: Low resolution mass spectra (m/z) were recorded on either VG platform II 
or VG Autospec spectrometers, molecular ions (M+, MNH4+) and other major peaks 
being quoted with intensities expressed as a percentage of the base peak. High resolution 
mass spectrometry (HRMS) measurements are valid to ±5 ppm. 
Optical rotations: These were recorded on a Perkin-Elmer 241 polarimeter at 589 nm (Na 
D-line) with a path length of 1 dm. Concentrations (c) are quoted in g/100 mL and specific 
rotations, [α]DT, are quoted in units of 10-1degcm2g-1 at the specified temperature, T. 
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1,4,5,8-Tetrahydro-naphthalene, 9941 
 
C10H12
Exact Mass: 132.0939
99  
 
A 3 L round-bottomed flask fitted with a mechanical stirrer, an acetone/cardice cold finger 
and a pressure equalizing dropping funnel was cooled to -78 °C and NH3 (1.5 l) was 
condensed into it via a KOH drying tower. Sodium lumps (100 g, 4.35 mol) were added 
over the course of 1.5 h with vigorous stirring. A solution of naphthalene (100 g, 0.78 
mol) in EtOH (250 mL) and Et2O (300 mL) was added via dropping funnel over 2 h. 
Residual naphthalene was washed from the apparatus with further Et2O (60 mL). The 
reaction was left to stir at -78 °C for 4 h before being left to stand with the cooling bath 
removed. After standing for 15 h, the residual solid was quenched cautiously with ice-
cooled MeOH (300 mL) and then with H2O (2 L). Aqueous mixture was extracted with 
Et2O (400 mL) and subsequently washed with further Et2O (3  200 mL). Combined 
organic collections were dried (MgSO4) and concentrated in vacuo to give an off-white 
solid. The crude isotetralin was purified by recrystallisation from MeOH to give pure 
isotetralin as white plates (78.1 g, 76%) Analytical data was consistent with that 
previously reported: 1H NMR δH (400 MHz, CDCl3) 2.56 (8H, s, CH2), 5.75 (4H, s, 
HC=CH).41 
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11-Oxa-tricyclo[4.4.1.01,6]undeca-3,8-diene, 10041 
 
C10H12O
Exact Mass: 148.0888
O
100  
 
Isotetralin 99 (40.0 g, 303 mmol) and NaOAc (44.7 g, 545 mmol) were dissolved in 
CH2Cl2 and the solution cooled to 0 °C. Peracetic acid (76.3 mL, 32% wt. solution in 
AcOH, 363 mmol) was added by dropping funnel over the course of 1 h. The mixture was 
stirred at room temperature for 1.5 h before the addition of H2O (300 mL). The organic 
phase was separated and the aqueous phase subsequently washed with CH2Cl2 (3  200 
mL). Combined organic extracts were washed with 5% aq. NaOH solution (400 mL) 
before being dried (K2CO3) and concentrated in vacuo to give a white solid. The crude 
material was purified by flash chromatography eluting with EtOAc:petrol (5:95) to give 
epoxide 100 as a white solid (33.1 g, 74%). Analytical data was consistent with that 
previously reported:41 1H NMR δH (400 MHz, CDCl3) 2.31-2.38 (4H, m, CH2), 2.50-
2.63 (4H, m, CH2), 5.51 (4H, m, HC=CH). 
 
8a-Hydroxy-1,5,8,8a-tetrahydro-4H-naphthalene-4a-carbonitrile, 10141 
 
CN
OH
C11H13NO
Exact Mass: 175.0997
101  
 
To an ice-cooled solution of epoxide 100 (24.7 g, 167 mmol) in CH2Cl2 (350 mL) was 
added Et2AlCN (200 mL, 1.0 M in solution in toluene, 200 mmol) via a dropping funnel 
over the course of 30 min. Upon completion of the addition, the cooling bath was 
removed and the reaction was left to stir for 2 h at room temperature. The reaction 
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mixture was diluted with CH2Cl2 (100 mL) and cooled in an ice-water bath. The mixture 
was quenched by the cautious addition of 5% aq. NaOH (200 mL). The organic phase 
was separated and the aqueous phase extracted with CH2Cl2 (3  100 mL). The 
combined organic extracts were dried (MgSO4), and concentrated in vacuo to give an off-
white solid which was recrystallised from EtOAc to give cyanohydrin 101 as white 
needles (24.8 g, 85%). Analytical data was consistent with that previously reported:41 1H 
NMR δH (400 MHz, CDCl3) 2.31-2.38 (4H, m, CH2), 2.50-2.63 (4H, m, CH2), 5.72-5.79 
(4H, m, HC=CH). 
 
9β-Cyano-(2α,3α),(6α,7α)-dioxido-10α-hydroxy-1,2,3,4,5,6,7,8,9,10-  
decahydronaphthalene, 10241 
 
CN
OH
C11H13NO3
Exact Mass: 207.0895
O O
102  
 
To a solution of cyanohydrin 101 (24.8 g, 142 mmol) in CH2Cl2 (150 mL) was added 
VO(acac)2 (3.76 g, 14.2 mmol). The solution was cooled in an ice-water bath and t-
BuOOH (187 mL, 3.03 M solution in toluene, 566 mmol) was added via dropping funnel 
over 30 min. Upon addition, a colour change from green to deep purple was observed. 
The cooling bath was removed and the reaction mixture heated to reflux for 24 h. After 
cooling, 10% aq. Na2SO3 (200 mL) was added and the biphasic mixture stirred vigorously 
for 30 min. The organic phase was then separated and the aqueous phase extracted with 
CH2Cl2 (3  100 mL). The combined organic extracts were dried (MgSO4) and 
concentrated in vacuo to give the crude product as a pale brown solid. This solid was 
washed with cold EtOAc to give bis-epoxide 102 as a white solid (22.4 g, 76%). 
Analytical data was consistent with that previously reported:41 1H NMR δH (400 MHz, 
CDCl3) 2.10 (2H, d, J = 16 Hz, CH2), 2.19 (2H, dd, J = 16.0 and 2.0 Hz, CH2), 2.38-2.48 
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(4H, m, CH2), 3.34-3.40 (4H, m, CHO), 3.47 (1H, s, OH). 
 
9β-Cyano-2β,7β-dimethyl-3α,6α,10α-trihydroxy-1,2,3,4,5,6,7,8,9,10-  
decahydronaphthalene, 10842 
 
CN
OH
C13H21NO3
Exact Mass: 239.1521
OHHO
108  
 
Bis-epoxide 102 (10.36 g, 50 mmol) was dissolved in CH2Cl2 (300 mL) and AlMe3 (2.0 
M solution in hexane, 200 mL, 200 mmol) was added via cannula. The reaction was 
heated to reflux for 16 h and then cooled in an ice-water bath. With constant cooling, 2.0 
M aq. HCl (500 mL) was added cautiously. Following addition, the organic phase was 
separated and the aqueous phase extracted with CHCl3 (4  100 mL). The combined 
organic extracts were dried (MgSO4) and concentrated in vacuo to give triol 108 as a white 
solid (8.25 g, 69%). Analytical data was consistent with that previously reported:42 1H 
NMR δH (400 MHz, MeOD) 1.30 (6H, d, J = 7.6 Hz, CHCH3), 1.64 (2H, d, J = 8.8 Hz, 
CH2), 1.84 (2H, dd, J = 14.8 and 2.8 Hz, CH2), 2.11 (2H, d, J = 3.2 Hz, CH2), 2.14-2.20 
(4H, m, CH2 and CHCH3), 3.33 (2H, dt, J = 3.6 and 1.2 Hz). 
  
9β-Cyano-2β,7β-dimethyl-3α,6α-dimethylsulfonate-10α-hydroxy-  
1,2,3,4,5,6,7,8,9,10-decahydronaphthalene, 10942 
 
CN
OH
C15H25NO7S2
Exact Mass: 395.1072
OMsMsO
109  
 
To a suspension of triol 108 (1.31 g, 5.48 mmol) in CH2Cl2 (30 mL) was added Et3N 
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(2.29 mL, 16.4 mmol). The mixture was cooled in an ice-water bath and MsCl (1.27 mL, 
16.4 mmol) was added drop-wise while ensuring the temperature of the reaction remained 
below 10 °C. The reaction was left to stir at room temperature for 15 h and partitioned 
by the addition of saturated aq. NH4Cl (40 mL) and CHCl3 (30 mL). The organic phase 
was separated and the aqueous phase extracted with CHCl3 (3  40 mL). The combined 
organic extracts were dried (MgSO4) and concentrated in vacuo to give a pale brown 
foaming solid. The crude product was purified by flash chromatography eluting with 
EtOAc:petrol (50:50) to give bis-mesylate 109 as a white solid (2.00 g, 92%). Analytical 
data was consistent with that previously reported:42 1H NMR δH (400 MHz, CDCl3) 
1.37 (6H, d, J = 7.6 Hz, CH3), 1.74 (2H, dd, J = 14.4 and 2.8 Hz, CH2), 2.19 (4H, m, 
CH2 and CHCH3), 2.39 (2H, dd, J = 15.6 and 4.4 Hz, CH2), 2.44-2.51 (2H, m, CH2), 3.07 
(6H, s, SO2CH3), 3.18 (1H, s, OH), 4.89 (2H, dd, J = 7.6 and 4.4 Hz, CHOMs). 
 
9β-Cyano-2β,7β-dimethyl-10α-hydroxy-1,2,7,8,9,10-hexahydronaphthalene, 11042 
 
CN
OH
C13H17NO
Exact Mass: 203.1310
110  
 
A suspension of mesylate 109 (4.40 g, 11.1 mmol) in DBU (12 mL) was heated to 110 °C 
for 12 h. Upon cooling, the mixture was partitioned between 1.0 M aq. citric acid (100 
mL) and CH2Cl2 (100 mL). The organic phase was separated and washed with a further 
portion of citric acid (100 mL). The aqueous phase was extracted with CH2Cl2 (3  50 
mL). The combined organic extracts were dried (Na2SO4) and concentrated in vacuo to 
yield an off-white solid. The crude material was purified on an alumina plug eluting with 
EtOAc:petrol (10:90) to give diene 110 as a white crystalline solid (2.08 g, 92%). 
Analytical data was consistent with that previously reported:42 1H NMR δH (400 MHz, 
CDCl3) 1.38 (6H, d, J = 8.0 Hz, CH3), 1.77 (2H, d, J = 14.0 Hz, CH2), 2.20-2.28 (2H, m, 
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CH2), 2.59 (2H, m, CHCH3), 5.93 (2H, dd, J = 10.0 and 2.8 Hz, OCCH=CH), 5.99 (2H, 
dd, J = 10.0 and 2.0 Hz, OCCH=CH). 
 
(1aS,2R,3aR,5S,7aR,7bS)-7a-Hydroxy-2,5-dimethyl-2,3,4,5,7a,7b-hexahydro-  
1aH-1-oxa-cyclopropa[a]naphthalene-3a-carbonitrile, 11142 
 
CN
OOH
C13H17NO2
Exact Mass: 219.1259
111  
 
According to the modified method of Grainger,44 to a solution of Zr(Oi-Pr)4 (891 mg, 2.30 
mmol), and L-(+)-DIPT (482 µL, 2.30 mmol) in CH2Cl2 (15 mL) at -30 ºC was added 
TBHP (2.84 M in toluene, 809 µL, 5.01 mmol) and stirred for 15 min before addition of 
alcohol 110 (424 mg, 2.09 mmol) as a solution in 7 mL CH2Cl2 dropwise over 10 min. 
The reaction was left to stand at -20 ºC for 42 h.  The reaction was quenched by addition 
of 50% aqueous Na2SO3 solution (20 mL), The organic phase was separated and the 
aqueous phase was extracted with CHCl3 (5  15 mL) with sonication to aid separation.  
The combined organic extracts were dried (Na2SO4) and concentrated in vacuo. The crude 
viscous oil was purified by flash chromatography (silica gel made up with 1mL Et3N/100 
mL silica) eluting with EtOAc:petrol (15:85). Mono-epoxide (–)-111 as a white solid (325 
mg, 71%). Analytical data was consistent with that previously reported.42 1H NMR δH 
(400 MHz, CDCl3) 1.36 (3H, d, J = 7.6 Hz, CH3), 1.43 (1H, d, J = 14.4 Hz, CH2) 1.47 
(3H, d, J = 7.6 Hz, CH3), 1.60 (1H, d, J = 11.2 Hz, CH2), 1.79 (1H, dd, J = 14.8 and 8.8 
Hz, CH2), 2.17 (1H, dd, J = 14.0 and 8.4 Hz, CH2), 2.45 (1H, dt, J = 16.0 and 8.4 Hz, 
CHCH3), 2.54-2.62 (1H, m, CHCH3), 3.08 (1H, s, OH), 3.34 (1H, d, J = 3.6 Hz, CHO), 
3.51 (1H, d, J = 3.6 Hz, CHO), 5.96 (1H, dd, J = 10.0 and 2.0 Hz, OCCH=CH), 6.03 
(1H, dd, J = 10.0 and 2.8 Hz, OCCH=CH). 
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(1aS,2R,3aR,5S,7aR,7bS)-3a-Cyano-1a,2,3,3a,4,5,7a,7b-octahydro-2,5-
dimethylnaphtho[1,2-b]oxiren-7a-yl propionate, 11342 
 
CN
OO
O
C16H21NO3
Exact Mass: 275.1521
113  
 
To a stirred solution of alcohol 111 (135 mg, 0.62 mmol) in THF (5 mL) was added 
dropwise n-BuLi (2.4 M solution in hexanes, 307 µL, 0.74 mmol). After 15 min stirring at 
room temperature, propionyl chloride (83 µL, 0.92 mmol) was added dropwise. The 
reaction was left to stir for 16 h before the addition of saturated aq. NaHCO3 (10 mL). 
The product was extracted with CH2Cl2 (4  20 mL) and the combined organic phases 
were dried (MgSO4) and concentrated in vacuo. Purification by flash chromatography 
(silica gel made up with 1 mL Et3N/100 mL silica) eluting with EtOAc:Petrol (10:90) gave 
the desired ester 113 as a colourless oil (160 mg, 95%). Analytical data was consistent 
with that previously reported:44 1H NMR δH (400 MHz, CDCl3) 1.13 (3H, t, J = 7.6 Hz, 
CH3CH2), 1.35 (3H, d, J = 7.6 Hz, CH3CH), 1.47 (3H, d, J = 8.4 Hz, CH3CH), 1.67 (1H, 
d, J = 14.0 Hz, CH2), 1.94 (1H, dd, J = 14.4 and 8.4 Hz, CHCH3), 2.20-2.35 (3H, m, CH2 
and CHCH3), 2.44-2.59 (3H, m, CH2 and CHCH3), 3.21 (1H, d, J = 3.2 Hz, H-4, CHO), 
3.65 (1H, d, J = 3.2 Hz, H-3, CHO), 5.96 (1H, dd, J = 9.6 Hz and 3.2 Hz, H-6, =CH), 
6.45 (1H, dd, J = 9.6 Hz and 2.4 Hz, H-7, =CH). 
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(3S,3aS,4S,5aS,7R,8S,9bR)-2,3,3a,4,5,5a,6,7,8,9b-Decahydro-8-hydroxy-3,4,7-
trimethyl-2-oxonaphtho[1,2-b]furan-5a-carbonitrile, 11638 
 
116
CN
O
OH
O
C16H21NO3
Exact Mass: 275.1521
 
 
A solution of ester 113 (100 mg, 0.363 mmol) in THF (4 mL) was cooled to -78 ºC and 
TMSCl (102 mL, 0.800 mmol) was added. This was followed by the dropwise addition 
of LHMDS (0.90M solution in hexane, 890 µL, 0.800 mmol). After 30 min stirring at -78 
ºC, the reaction was allowed to reach room temperature then heated to reflux for 15 h. 
After cooling a saturated NH4Cl solution (10 mL) was added and the mixture was left to 
stir for 10 min. The mixture was then further diluted with H2O (5 mL) before being 
extracted with CH2Cl2 (3  10 mL). The combined organic extracts were dried (MgSO4) 
and concentrated in vacuo to give a yellow oil. The oil was redissolved in EtOAc (5 mL) 
and shaken with an aqueous solution of HCl (0.5 M, 5 mL). The organic phase was 
separated, dried (MgSO4) and concentrated in vacuo to give the crude product as a yellow 
oil. Purification by flash chromatography eluting with EtOAc:petrol (40:60) gave the 
lactone 115 as a 3:1 mixture of epimers at C11 (71 mg, 71%). For epimerization of C11 
centre: To a solution of lactone 115 (71 mg, 0.258 mmol) in t-BuOH (2.5 g, 32.8 mmol) 
was added t-BuOK (57 mg, 0.506 mmol).  The reaction mixture was heated to 90 °C for 
1.5 h. After cooling to room temperature, a saturated solution of aq. NHCl4 (5 mL) was 
added and the resulting mixture left to stir for 45 min. HCl (1.0 M aq. solution) was added 
and the resulting mixture extracted with CH2Cl2 (4  20 mL). The combined organic 
extracts were dried (MgSO4) and evaporated in vacuo to give lactone 116 as a colourless 
gum (58 mg, 83%)  Analytical data was consistent with that previously reported:38 1H 
NMR δH (400 MHz, CDCl3) 1.17 (3H, d, J = 6.8 Hz, CH3), 1.22 (3H, d, J = 6.8 Hz, 
CH3), 1.36 (3H, d, J = 7.6 Hz, CH3), 1.64 (1H, m), 1.78 (2H, m), 1.92-2.05 (3H, m), 2.25 
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(1H, q, J = 7.6 Hz, CHCH3), 2.40 (1H, dt, J = 14.8 and 8.0 Hz), 3.94 (1H, m, CHOH), 
5.37 (1H, dt, J = 8.0 and 2.4 Hz, CHOC=O), 6.05 (1H, t, J = 2.4 Hz, C=CH). 
 
(S)-2-(4-Methoxybenzyloxy)propanoyl chloride, 12341 
 
O
Cl
OPMB
C11H13ClO3
Exact Mass: 228.0553
123  
 
According to the method of Thomas,140 acid 173 (800 mg, 3.80 mmol) was dissolved in 
benzene (15 mL). Oxalyl chloride (428 µL, 1.91 mmol) was added followed by DMF (1 
drop) and the reaction mixture was left to stir at room temperature. After 3 h, the reaction 
mixture was concentrated in vacuo, to give the acid chloride 123 as a pale yellow oil (840 
mg) which was used without further purification. Analytical data was consistent with 
that previously reported:45 1H NMR δ (400 MHz, CDCl3) 1.56 (3H, d, J = 6.8 Hz, 
CHCH3), 3.84 (3H, s, Ar-OCH3), 4.28 (1H, q, J = 6.8 Hz, CHCH3), 4.42 (1H, d, J = 11.2 
Hz, OCHHAr), 4.71 (1H, d, J = 11.2 Hz, OCHHAr), 6.93 (2H, d, J = 8.8 Hz, Ar), 7.31 
(2H, d, J = 8.8 Hz, Ar). 
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(2S)-(1aS,2´R,3aR,5S,7aR,7bS)-3a-Cyano-1a,2,3,3a,4,5,7a,7b-octahydro-2,5-
dimethylnaphtho[1,2-b]oxiren-7a-yl 2-(4-methoxybenzyloxy)propanoate, 12441 
 
CN
O
O
O
C24H29NO5
Exact Mass: 411.2046
PMBO
124  
 
To a solution of acid 173 (40 mg, 0.19 mmol) in toluene (1 mL) was added Et3N (34 µL, 
0.25 mmol) and 2,4,6-trichlorobenzoyl chloride (36 µL, 0.23 mmol). The mixture was 
stirred at room temperature for 2 h then a solution of alcohol 111 (83 mg, 0.38 mmol) and 
DMAP (30 mg, 0.25 mmol) in toluene (1 mL) was added. The reaction was heated to 60 
ºC for 2 h then the reaction mixture was concentrated in vacuo. Purification of the residue 
by flash chromatography eluting with EtOAc:Petrol (10:90→20:80→50:50) afforded the 
desired ester 124 as a colourless oil (19 mg, 24%). Analytical data was consistent with 
that previously reported.41 1H NMR δH (400 MHz, CDCl3) 1.34-1.37 (6H, m, CH3CH), 
1.46-1.51 (6H, m, CH3CH and CH2, H-1), 1.68 (1H, d, J = 12.4 Hz, CH2, H-9), 1.93 (1H, 
dd, J = 14.4 and 8.4 Hz, CH2, H-1), 2.20 (1H, dd, J = 9.2 and 5.2 Hz, CH2, H-9), 2.44-
2.54 (2H, m, CHCH3), 3.22 (1H, d, J = 3.2 Hz, CHO, H-4), 3.71 (1H, d, J = 3.2 Hz, 
CHO, H-3), 3.83 (3H, s, OCH3), 3.99 (1H, q, J = 6.8, CHOPMB), 4.36 (1H, d, J = 11.2 
Hz, CH2Ph), 4.64 (1H, d, J = 11.2 Hz CH2Ph), 5.99 (1H, dd, J = 12.8 Hz and 5.6 Hz, H-
6, =CH), 6.45 (1H, dd, J = 10.0 Hz and 2.4 Hz, H-7, =CH). 
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(3S,3aS,4S,5aS,7R,8S,9bR)-5a-Cyano-2,3,3a,4,5,5a,6,7,8,9b-decahydro-3,4,7-
trimethyl-2-oxonaphtho[1,2-b]furan-8-yl benzoate, 12740   
 
CN
C23H25NO4
Exact Mass: 379.1784
O
OBz
O
H
H
127  
 
According to the method of Grainger,40 to a stirred solution of alcohol 116 (20 mg, 0.07 
mmol), benzoic anhydride (25 mg, 0.11 mmol) and Et3N (15 mL, 0.109 mmol) in CH2Cl2 
(2 mL) was added DMAP (4.5 mg, 0.036 mmol). The reaction was left to stir at room 
temperature for 3 h and was then diluted with saturated NaHCO3 solution (3 mL). The 
organic phase was separated and the aqueous phase washed with CH2Cl2 (3  3 mL). 
The combined organic phases were dried (MgSO4) and concentrated in vacuo. Purification 
by flash chromatography eluting with EtOAc/petrol (25:75) gave benzoate ester 127 as a 
colourless oil (27 mg, 98%). Analytical data was consistent with that previously 
reported.40 1H NMR δH (400 MHz, CDCl3) 1.19 (3H, d, J = 6.8 Hz, CH3), 1.22 (3H, d, J 
= 6.8 Hz, CH3), 1.36 (3H, d, J = 7.6 Hz, CH3), 1.77 (1H, m), 2.01-2.16 (5H, m), 2.28 
(1H, q, J = 7.6 Hz, CHCH3), 2.41 (1H, dt, J = 14.8 and 8.4 Hz, CHCHOC=O), 5.33 (1H, 
dt, J = 7.2 and 2.8 Hz, CHOBz), 5.39 (1H, dt, J = 8.4 and 2.4 Hz, CHOC=O), 6.10 (1H, 
t, J = 2.4 Hz, C=CH). 
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(3R,3aR,4S,5aS,7R,8S,9bR)-3-Bromo-5a-cyano-3,4,7-trimethyl-2-oxo-
2,3,3a,4,5,5a,6,7,8,9b-decahydronaphtho[1,2-b]furan-8-yl benzoate, 12840 
 
CN
O
O
OBzBr
C23H24BrNO4
Exact Mass: 457.0889
128  
 
According to the method of Grainger,40 to a solution of diisopropylamine (55 µL, 0.39 
mmol) in THF (3 mL) cooled to -78 ºC was added n-BuLi (2.5 M solution in hexanes, 177 
µL, 2.70 mmol). The reaction mixture was stirred at 0 ºC for 1 h before being cooled to -
78 ºC. A solution of lactone 127 (62 mg, 0.16 mmol) in THF (6 mL) was added dropwise. 
After 15 min, trimethylchlorosilane (54 µL, 0.42 mmol) was added followed by N-
bromosuccinimide (76 mg, 0.42 mmol) a further 15 min later. After 15 min stirring at -78 
ºC, the reaction mixture was allowed to reach room temperature and stirred for 4 h. H2O 
(10 mL) was added to the reaction mixture and the product was extracted into CH2Cl2 (5 
 5 mL). The combined organic phases were dried (MgSO4) and concentrated in vacuo to 
give the crude product as a brown oil. Purification by flash chromatography eluting with 
EtOAc/Petrol (15:85→30:70→100:0) gave the desired bromide 129 as a white solid (19 
mg, 25%). Analytical data was consistent with that previously reported:40 1H NMR  (400 
MHz, CDCl3) δH 1.27 (3H, d, J = 7.2 Hz, CH3), 1.33 (3H, d, J = 6.4 Hz, CH3), 2.00 (3H, 
s, CH3CBr), 2.05-2.33 (7H, m), 5.35 (2H, m, CHOBz and CHOC=O), 6.28 (1H, m, 
CH1=CH0), 7.45 (2H, t, J = 7.6 Hz, Ph), 7.57 (1H, t, J = 7.6 Hz, Ph), 7.98 (1H, d, J = 7.6 
Hz, Ph). 
 
 
 
 
 
Chapter 4 - Experimental 
137 
(3aS,5aS,9S,9aS,9bS)-Octahydro-3,5a,9-trimethylnaphtho[1,2-b]furan-2,8(3H,9bH)-
dione, 13859 
 
O
H
O
H
O
C15H22O3
Exact Mass: 250.1569
138  
 
Pd on CaCO3 (2.2 g, 5% w/w) was added to a solution of  α-(–)-santonin (5 g, 20.3 mmol) 
in EtOAc (350 mL). The reaction vessel was placed under an atmosphere of H2 and 
heated to 50 ºC with vigorous stirring. After 3 h, the reaction mixture was allowed to cool 
to room temperature and then filtered through Celite®. The filtrate was concentrated in 
vacuo to give an oily residue which was dissolved in EtOH (350 mL) and concentrated 
HCl (3 mL) was added. The resulting mixture was heated to 80 ºC for 1 h before the 
solvent was removed in vacuo. Purification by flash chromatography eluting with 
EtOAc/Petrol (30:70) gave a white solid (6.7 g) as a 3:1 mixture of trans:cis decalin 
products. The solid was recrystallised from EtOH to give the trans decalin product 138 
as white needles (2.32 g, 46%). Analytical data was consistent with that previously 
reported:59 1H NMR δ (400 MHz, CDCl3) 1.20 (3H, s, CH3), 1.24 (3H, d, J = 6.8 Hz, 
CH3), 1.27 (3H, d, J = 6.8 Hz, CH3), 1.35 (1H, td, J = 12.4 and 4.0 Hz), 1.56-1.62 (4H, 
dt, m), 1.67-1.77 (3H, m), 1.88 (1H, m), 2.28 (1H, dq, J = 14.0 and 6.8 Hz, CHCH3), 
2.46-2.57 (3H, m), 3.92 (1H, dd, J = 10.0 and 10.0 Hz, CHOC=O). 
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(3S,3aS,5aS,9S,9aS,9bS)-3,5a,9-Trimethyl-octahydro-spiro[[1,3]dioxolane-2,2'-
naphtho][1,2-b]furan-8-one, 13964 
 
H
O
H
O
C17H26O4
Exact Mass: 294.1831
O
O
139  
 
According to the method of Ando,64 ketone 138 (2.31 g, 9.22 mmol), ethylene glycol 
(11.3 mL, 203 mmol) and (1S)-(+)-10-camphorsulfonic acid (107 mg, 0.46 mmol) were 
dissolved in dry benzene (100 mL). The mixture was heated to reflux in a Dean-Stark 
apparatus for 18 h. After cooling, brine (100 mL) was added. The mixture was shaken and 
the organic phase separated. The aqueous phase was further extracted with toluene (4  
30 mL). The combined organic phases were dried (MgSO4) and concentrated in vacuo to 
give a colourless crystalline solid (3.2 g). This crude product was recrystallised from a 
mixture of benzene: Et2O:n-hexane (1:1:1) to give ketal 139 as rhomboidal prisms (1.76 g, 
65%). Analytical data was consistent with that previously reported:64 1H NMR δ (400 
MHz, CDCl3) 1.01 (3H, s, CH3), 1.06 (3H, d, J = 6.8 Hz, CH3), 1.21 (3H, d, J = 6.8 Hz, 
CH3), 1.31 (1H, td, J = 13.6 and 4.0 Hz, C8), 1.38 (1H, dt, J = 12.8 and 4.0 Hz, C8), 
1.50-1.65 (5H, m), 1.68-1.72 (2H, m), 2.02 (1H, dq, J = 11.6 and 6.8 Hz, CHCH3), 2.24 
(1H, dq, J = 12.4 and 6.8 Hz, CHCH3), 3.83 (1H, dd, J = 10.0 and 10.0 Hz, CHOC=O), 
3.95-4.03 (4H, m, CH2O). 
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(3S,3aS,5aS,9R,9aS,9bS)-9-Bromo-3,5a,9-trimethyl-octahydro-spiro[[1,3]dioxolane-
2,2'-naphtho][1,2-b]furan-8-one, 14066 
 
H
O
H
O
C17H25BrO4
Exact Mass: 372.0936
O
O
Br
140  
 
Conditions for large scale reactions (<0.25 mmol): 
Diisopropylamine (92 µL, 0.652 mmol) was dissolved in THF (1 mL) and cooled to -78 
ºC. A solution of n-BuLi (2.5 M in hexanes, 293 µL, 0.733 mmol) was added dropwise. 
After 15 min stirring at -78 ºC, the reaction mixture was allowed to warm to room 
temperature and stirred for 1 h. After cooling again to -78 ºC, a solution of lactone 139 in 
THF (1 mL) was added dropwise. After 15 min, TMSCl (90 µL, 0.71 mmol) was added. 
A further 15 min later, N-bromosuccinimide (125 mg, 0.707 mmol) was added under a 
flow of N2. After 15 min at -78 ºC, the reaction was allowed to reach room temperature 
and stirred for 2 h. The reaction mixture was diluted with Et2O (5 mL) and H2O (3 mL) 
added. The organic phase was separated and the aqueous phase was washed with Et2O (2 
 10 mL). The combined organic phases were dried (MgSO4) and concentrated in vacuo 
to give the crude product as a brown solid. Purification by flash chromatography eluting 
with EtOAc:Petrol (15:85) gave the desired α-bromolactone 140 as an off-white solid (81 
mg, 80%). Analytical was consistent with that previously reported:66 1H NMR δ (400 
MHz, CDCl3) 1.04 (3H, s, CH3), 1.07 (3H, d, J = 6.8 Hz, CH3), 1.39 (2H, m), 1.46-1.55 
(2H, m), 1.61 (1H, m), 1.69-1.79 (5H, m), 1.90 (3H, s, CH3Br), 2.06 (1H, dq, J = 13.2 
and 6.4 Hz, CHCH3), 3.96-4.05 (4H, m, CH2O), 4.16 (1H, dd, J = 10.0 and 10.0 Hz). 
 
Conditions for small scale reactions (>0.25 mmol): 
Under an atmosphere of argon, diisopropylamine (23 µL, 0.16 mmol) was dissolved in 
THF (0.5 mL) and cooled to -78 ºC. A solution of n-BuLi (2.14 M in hexanes, 73 µL, 
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0.18 mmol) was added dropwise. After 15 min stirring at -78 ºC, the mixture was allowed 
to warm to room temperature and stirred for 1 h. After cooling again to -78 ºC, TMSCl 
(22 µL, 0.18 mmol) was added. A solution of lactone 139 (20 mg, 0.070 mmol) in THF 
(0.5 mL) was then added over the course of 40 min by syringe pump. After 15 min 
stirring at -78 ºC, a 0.5 M solution of N-bromosuccinimide in THF (0.5 M, 0.89 mmol, 
177 mL) was added dropwise. The reaction was then allowed to reach room temperature. 
After 1.5 h stirring, saturated aq. NH4Cl (2 mL) was added. The product was extracted 
with CH2Cl2 (3  5 mL), dried (MgSO4) and concentrated in vacuo to give the crude 
product as a brown oil. Purification by flash chromatography eluting with EtOAc:petrol 
(20:80) gave the desired α-bromolactone 140 as an off-white solid (22 mg, 85%). 
Analytical data as above. 
 
(3S,3aS,4S,5aS,7R,8S,9bR)-8-(Benzyloxy)-2,3,3a,4,5,5a,6,7,8,9b-decahydro-3,4,7-
trimethyl-2-oxonaphtho[1,2-b]furan-5a-carbonitrile, 141 
 
CN
OBn
O
O
C23H27NO3
Exact Mass: 365.1991
141  
 
To a solution of alcohol 116 (30 mg, 0.109 mmol) and benzyl 2,2,2-trichloroacetimidate 
(41.3 mg, 0.164 mmol) in a mixture of CH2Cl2 (0.5 mL) and cyclohexane (0.5 mL) was 
added TfOH (5 µL). Immediately a white precipitate was seen to form in the reaction 
mixture. The reaction mixture was left to stir for 15 h at room temperature before the 
addition of CH2Cl2 (5 mL). The reaction mixture was then washed with saturated 
NaHCO3 solution (5 mL). The aqueous phase was then extracted with CH2Cl2 (2  5 
mL) and the combined organic phases were dried (MgSO4) and concentrated in vacuo to 
give the crude product as a yellow oil. Purification by flash chromatography eluting with 
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EtOAc:petrol (20:80) gave the desired benzyl ether as a white solid (41 mg, 100%). IR 
(neat) νmax 2361 (CN), 1777 (C=O), 1692, 1455, 1381, 1267, 1155, 1108 cm-1; 1H NMR: 
δH (400MHz, CDCl3) 1.14 (3H, d, J = 6.8 Hz, CH3), 1.20 (3H, d, J = 7.2 Hz, CH3), 1.34 
(3H, d, J = 7.2 Hz, CH3), 1.71-1.78 (1H, m, CHCH3), 1.87 (1H, m, CHCH3), 1.94-2.00 
(4H, m), 2.23 (1H, q, J = 8.0 Hz, CHC=O), 2.35 (1H, dq, J = 7.6 Hz and 7.6 Hz, 
C(O)CHCH3), 3.65 (1H, dt, J = 6.8 and 2.8 Hz, CHOBn), 4.52 (1H, d, J = 11.6 Hz, 
CHHAr), 4.67 (1H, d, J = 11.6 Hz, CHHAr), 5.35 1H, (dt, J = 8.0 and 2.4 Hz, 
CHOC=O), 6.18 (1H, t, J = 2.4 Hz, C=CH), 7.32-7.40 (5H, m, Ar); 13C NMR: δC (100 
MHz, CDCl3) 15.8 (q)(CH3), 17.5 (q)(CH3), 19.7 (q)(CH3), 30.2 (d)(CH1CH3), 30.7 
(d)(CH1CH3), 32.6 (s)(CCN), 38.0 (d)(CH1), 39.0 (t)(CH2), 42.4 (t)(CH2), 50.0 (d)(CH), 
71.4 (t)(OCH2Ph) 75.5 (d)(CH1OBn), 77.2 (d)(CH1OC=O), 123.6 (s)(CN), 125.2 
(d)(C=CH1), 127.9 (d)(CH1, p-CH2), 128.0 (2d)(CH1, o-CH2), 128.5 (2d)(CH1, m-CH2), 
131.9 (s)(C=CH1), 137.9 (s)(C), 178.6 (s)(C=O); MS (EI+) m/z 365 (5%)(M+), 91 
(100%)(PhCH2+); HRMS (EI+) calcd. for C23H27NO3 (M+) 365.1991, found 365.1988, Δ 
= -0.0003 (0.82 ppm); [α]D22 = -82.6 (c = 1.0, CH2Cl2). 
 
 (3S,3aS,4S,5aS,7R,8S,9bR)-3,4,7-Trimethyl-2-oxo-8-triethylsilanyloxy-
3,3a,4,5,6,7,8,9b-octahydro-2H-naphtho[1,2-b]furan-5a-carbonitrile, 142 
 
CN
OSiEt3
O
O
C22H35NO3Si
Exact Mass: 389.2386
142  
 
A solution of alcohol 116 (100 mg, 0.364 mmol) and imidazole (74 mg, 1.1 mmol) in 
DMF (1.5 mL), was cooled to 0 ºC. TESCl (152 µL, 0.91 mmol) was added after 10 min 
and the reaction mixture was allowed to warm to room temperature. After 2 h stirring, 
H2O (5 mL) was added. The product was extracted into Et2O (4  5 mL) and the 
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combined organic phases washed with saturated NaHCO3 solution (10 mL) and brine (10 
mL) and then dried (Na2SO4) and concentrated in vacuo to give the crude product as a 
colourless oil. Purification by flash chromatography eluting with EtOAc:Petrol (20:80) 
gave the desired product as a white solid (121 mg, 85%). Mp = 79-83 ºC (CHCl3); IR 
(neat) νmax 2957, 1785 (C=O), 1085 cm-1; 1H NMR: δH (400MHz, CDCl3) 0.63 (6H, q, J 
= 8.0 Hz, SiCH2CH3), 0.97 (9H, t, J = 8.0 Hz, SiCH2CH3), 1.10 (3H, d, J = 6.8 Hz, 
CH3), 1.21 (3H, d, J = 7.2 Hz, CH3), 1.33 (3H, d, J = 7.2 Hz, CH3), 1.67 (1H, m, 
CHCH3), 1.79 (1H, m, CHCH3), 1.89-2.02 (4H, m), 2.21 (1H, q, J = 8.0 Hz, CHC=O), 
2.37 (1H, dq, J = 7.2 and 7.2 Hz, C(O)CHCH3), 3.87 (1H, dt, J = 6.8 and 2.8 Hz, 
CHOSiEt3), 5.32 (1H, dt, J = 8.0 Hz and 2.4 Hz, CHOC=O), 5.92 (1H, dd, J = 2.4 and 
2.4 Hz, C=CHCOSiEt3); 13C NMR: δC (100 MHz, CDCl3) 4.9 (t) (SiCH2), 6.8 
(q)(SiCH2CH3) 15.7 (q)(CH3), 17.6 (q)(CH3), 19.9 (q)(CH3), 30.0 (d)(CH1CH3), 32.8 
(s)(CCN), 33.4 (d)(CH1CH3), 37.9 (d)(CH1CH3), 39.2 (t)(CH2), 42.2 (t)(CH2), 50.0 
(d)(CH1), 71.3 (d)(CH1OSi), 75.3 (d)(CH1OC=O), 123.8 (s)(CN), 129.1 (d)(C=CH1), 
130.4 (s)(C=CH1), 178.5 (s)(C=O); MS (CI+) m/z 407 (100%) (MNH4+); HRMS (CI+) 
calcd. for C22H39N2O3Si (MNH4+) 407.2730, found 407.2734, Δ = +0.0004 (0.98 ppm); 
[α]D22 = -68.4 (c = 0.70, CH2Cl2). 
 
(3S,3aS,4S,5aS,7R,8S,9bR)-8-(tert-butyldimethylsilanyloxy)-3,4,7-trimethyl-2-oxo-
3,3a,4,5,6,7,8,9b-octahydro-2H-naphtho[1,2-b]furan-5a-carbonitrile, 14344 
 
CN
OTBS
O
O
C22H35NO3Si
Exact Mass: 389.2386
143  
 
According to the method of Stawinski,68 to a solution of alcohol 116 (15 mg, 0.054 
mmol) in CH2Cl2 (1 mL) was added N-methylimidazole (13 µL, 0.16 mmol) and iodine 
(41 mg, 0.16 mmol) followed by tert-butyldimethylsilyl chloride (9 mg, 0.060 mmol). 
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The reaction was left to stir at room temperature for 18 h. The solvent was evaporated in 
vacuo and the residue redissolved in EtOAc (3 mL). The resulting solution was washed 
with saturated aq. Na2S2O3 solution (2  3 mL) and was then dried (Na2SO4) and 
evaporated in vacuo to give the crude product as a pale brown oil. This material was 
purified by flash chromatography eluting with EtOAc:petrol (33:67) to give TBS ether 
143 as a crystalline white solid (16 mg, 76%). Analytical data was consistent with that 
previously reported: 1H NMR: δH (400MHz, CDCl3) 0.09 (3H, s, SiCH3), 0.10 (3H, s, 
SiCH3), 0.90 (9H, s, SiC(CH3)3), 1.09 (3H, d, J = 6.8 Hz, CH3), 1.19 (3H, d, J = 8.0 Hz, 
CH3), 1.34 (3H, d, J = 7.2 Hz, CH3), 1.66 (1H, m), 1.77 (1H, m), 1.89-2.03 (4H, m), 2.22 
(1H, q, J = 8.0 Hz), 2.36 (1H, dq, J = 7.2 and 7.2 Hz, C(O)CHCH3), 3.87 (1H, dt, J = 6.8 
and 2.8 Hz, CHOSiEt3), 5.31 (1H, dt, J = 8.0 and 2.4 Hz, CHOC=O), 5.91 (1H, dd, J = 
2.4 Hz and 2.4 Hz, C=CHCOSiEt3). 
 
(3S,3aR,4S,5aS,7R,8S,9bR)-3-Bromo-8-(tert-butyldimethylsilanyloxy)-3,4,7-
trimethyl-2-oxo-3,3a,4,5,6,7,8,9b-octahydro-2H-naphtho[1,2-b]furan-5a-
carbonitrile, 143a  
 
CN
O
O
OTBS
Br
C22H34BrNO3Si
Exact Mass: 467.1491
143a  
 
Under an atmosphere of argon, diisopropylamine (48 µL, 0.34 mmol) was dissolved in 
THF (0.5 mL) and cooled to -78 ºC. A solution of n-BuLi (2.50 M in hexanes, 152 µL, 
0.381 mmol) was added dropwise. After 15 min stirring at -78 ºC, the reaction mixture 
was allowed to warm to room temperature where it was stirred for 1 h. After cooling 
again to -78 ºC, TMSCl (47 µL, 0.37 mmol) was added. A solution of lactone 143 (55 mg, 
0.14 mmol) in THF (0.5 mL) was then added over the course of 30 min by syringe pump. 
After 15 min stirring at -78 ºC, a solution of N-bromosuccinimide (0.50 M in THF, 734 
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µL, 0.37 mmol) was added dropwise. The reaction was then allowed to reach room 
temperature. After 3 h stirring, a saturated NH4Cl solution (2 mL) was added. The phases 
were separated and the aqueous layer was extracted with CH2Cl2 (3  5 mL), dried 
(MgSO4) and concentrated in vacuo to give the crude product as a brown oil. Purification 
by flash chromatography eluting with EtOAc:petrol (5:95) gave the desired α-
bromolactone 143a as a white crystalline solid (45 mg, 68%). Mp = 110-111 ºC (CHCl3); 
IR (neat) νmax 2957, 2931, 2230 (CN), 1791 (C=O), 1462, 1257, 1083, 1054 cm-1; 1H 
NMR: δH (400MHz, CDCl3) 0.07 (3H, s, SiCH3), 0.08 (3H, s, SiCH3), 0.87 (9H, s, 
SiC(CH3)3), 1.16 (3H, d, J = 7.2 Hz, CH3), 1.32 (3H, d, J = 6.8 Hz, CH3), 1.82-1.97  (8H, 
m, CH3CBr, CHCH3, 2  CH2), 2.07 (1H, dd, J = 13.6 and 3.6 Hz), 3.16 (1H, t, J  9.2 
Hz, CHCBr), 3.89 (1H, dd, J = 6.4 and 4.0 Hz, CHOSi), 5.34 (1H, dt, J = 8.8 and 2.0 Hz, 
CHOC=O), 5.87 (1H, dd, J = 3.6 and 2.0 Hz, CH1=C); 13C NMR: δC (100 MHz, CDCl3) 
-4.93 (q) (SiCH3), -4.54 (q) (SiCH3), 17.10 (q) (CH3), 17.95 (s) (SiC(CH3)3), 20.51 (q) 
(CH3), 25.70 (q) (SiC(CH3)3), 26.44 (q) (CH3CBr), 26.83 (d) (CHCH3), 31.47 (s) (CCN), 
33.81 (d) (CHCH3), 36.38 (t) (CH2), 42.82 (t) (CH2), 54.57 (s) (CBr), 56.10 (d) 
(CHCBr), 69.38 (d) (CHOTBS), 75.38 (d) (CHOC=O), 123.1 (s) (CN), 127.5 (d) 
(C=CH1), 130.6 (s) (C=CH1), 174.9 (s) (C=O); MS (CI+) m/z 485, 487 (23%) (MNH4+), 
407 (100%) (MNH4+- Br), 293 (45%), 258 (40%); HRMS (CI+) calcd. for 
C22H38BrN2O3Si (MNH4+) 485.1835, found 485.1844, Δ = -0.0009 (1.85 ppm); [α]D22 = 
-1.15 (c = 1.04, CH2Cl2). 
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(3S,3aR,4S,5aS,7R,8S,9bR)-3-Bromo-3,4,7-trimethyl-2-oxo-8-triethylsilanyloxy-
3,3a,4,5,6,7,8,9b-octahydro-2H-naphtho[1,2-b]furan-5a-carbonitrile, 144a 
and 
(3R,3aS,4S,5aS,7R,8S,9bR)-3-Bromo-3,4,7-trimethyl-2-oxo-8-triethylsilanyloxy-
3,3a,4,5,6,7,8,9b-octahydro-2H-naphtho[1,2-b]furan-5a-carbonitrile, 144b 
 
 
C22H34BrNO3Si
Exact Mass: 467.1491
CN
OSiEt3
O
O
Br
CN
OSiEt3
O
O
Br
144a 144b  
 
Under an atmosphere of argon, diisopropylamine (97 µL, 0.69 mmol) was dissolved in 
THF (1.0 mL) and cooled to -78 ºC. A solution of n-BuLi (2.14 M in hexanes, 355 µL, 
0.747 mmol) was added dropwise. After 15 min stirring at -78 ºC, the reaction mixture 
was allowed to warm to room temperature and stirred for 1 h. After cooling again to -78 
ºC, TMSCl (95 µL, 0.75 mmol) was added. A solution of lactone 142 in THF (1.0 mL) 
was then added over the course of 30 min by syringe pump. After 15 min stirring at -78 
ºC, a solution of N-bromosuccinimide (0.5 M in THF, 1.49 mL, 0.75 mmol) was added 
dropwise. The reaction mixture was then allowed to reach room temperature. After 3 h 
stirring, a saturated NH4Cl solution (2 mL) was added and the resulting mixture extracted 
with CH2Cl2 (3  5 mL). The combined organic extracts were dried (MgSO4) and 
concentrated in vacuo to give the crude product as a brown oil. Purification by flash 
chromatography eluting with EtOAc:Petrol (5:95) gave the desired α-bromolactone as a 
mixture of epimers 144a and 144b (121 mg, 90%, 144a:144b = 82:18). 1H NMR (144a): 
δH (400MHz, CDCl3) 0.59 (6H, q, J = 7.6 Hz, SiCH2CH3), 0.94 (9H, t, J = 7.6 Hz, 
SiCH2CH3), 1.15 (3H, d, J = 7.2 Hz, CH3), 1.30 (3H, d, J = 6.4 Hz, CH3), 1.83 (1H, m), 
1.88 (3H, s, BrCCH3), 1.90-1.99 (4H, m), 2.07 (1H, dd, J = 13.6 and 4.0 Hz) 3.14 (1H, 
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dd, J = 8.8 and 8.8 Hz, CHCBr), 3.89 (1H, m, CHOSi), 5.34 (1H, dt, J = 8.8 and 2.0 Hz, 
CHOC=O), 5.87 (1H, dd, J = 3.6 and 2.0 Hz, C=CH); 13C NMR: δC (100 MHz, CDCl3) 
4.8 (t) (SiCH2CH3), 6.8 (q) (SiCH2CH3), 17.1 (q)(CH3), 20.5 (q)(CH3), 26.4 (q)(CH3), 
26.8 (d)(CH1CH3), 31.5 (s)(CCN), 33.8 (d)(CH1CH3), 36.5 (t)(CH2), 42.8 (t)(CH2), 54.7 
(s)(CBr) 56.1 (d)(CH1), 69.3 (d)(CH1OSi), 75.4 (d)(CH1OC=O), 123.1 (s)(CN), 127.6 
(d)(C=CH1), 130.5 (s)(C=CH1), 174.9 (s)(C=O); MS (CI+) m/z 485 (80%) (MNH4+), 
407 (100%) (MNH4+ - 79Br), 333 (60%), 275 (20%); HRMS (CI+) calcd. for 
C22H38N2O3Si79Br (MNH4+) 485.1835, found 485.1839, Δ = +0.0004 (0.82 ppm). 
 
Benzoic acid (3R,3aR,4S,5aS,7R,8S,9bR)-3-bromo-5a-cyano-3,4,7-trimethyl-2-oxo-
2,3,3a,4,5,5a,6,7,8,9b-decahydro-naphtho[1,2-b]furan-8-yl ester, 146  
and 
Benzoic acid (3aS,4S,5aS,7R,8S,9bR)-5a-cyano-4,7-dimethyl-3-methylene-2-oxo-
2,3,3a,4,5,5a,6,7,8,9b-decahydro-naphtho[1,2-b]furan-8-yl ester, 147 
 
CN
O
O
OBz
Br
C23H24BrNO4
Exact Mass: 457.0889
CN
O
O
OBz
C23H23NO4
Exact Mass: 377.1627
146147  
 
To a stirred solution of silyl ether 144 (67 mg, 0.14 mmol) in THF (2 mL) at room 
temperature was added TBAF•3H2O (90 mg, 0.29 mmol) as a single portion. The mixture 
was stirred for 2 h before being diluted with H2O (4 mL). The reaction mixture was 
extracted with CH2Cl2 (4  5 mL) and the combined organic extracts were dried (Na2SO4) 
and concentrated in vacuo to give a pale brown solid (125 mg). Purification by flash 
column chromatography eluting with EtOAc:petrol (50:50) gave a mixture of alcohol 
products as a pale yellow oil (40 mg) which was used directly in the following 
esterification procedure. 
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The mixture of alcohol products previously obtained (25 mg, 0.071 mmol) was dissolved 
in CH2Cl2 (1.5 mL). DMAP (4.5 mg, 0.035 mmol) was added followed by Bz2O (24 mg, 
0.106 mmol). Et3N (15 µL, 0.11 mmol) was then added and the reaction was left to stir 
for 4 h at room temperature. Saturated aq. NaHCO3 (3 mL) was added to the reaction 
mixture and the organic phase was separated. The aqueous phase was washed with 
CH2Cl2 (3  3 mL) and the combined organic extracts were dried (MgSO4) and 
concentrated in vacuo to yield a brown oil. The crude product was purified by flash 
column chromatography eluting with EtOAc:Petrol (10:90 → 30:70) to give 
bromolactone 146 as a colourless film (3.0 mg, 5% from 144). IR (neat) νmax 2232 (CN), 
1789 (C=O lactone), 1715 (C=O ester) 1452, 1266, 1103 cm-1; 1H NMR: δH (400MHz, 
CDCl3) 1.27 (3H, d, J = 6.8 Hz, CH3), 1.34 (3H, d, J = 6.8 Hz, CH3), 1.89 (3H, s, 
CH3CBr), 2.05 (3H, m), 2.12 (2H, d, J = 5.6 Hz), 2.19 (1H, m), 3.20 (1H, dd, J = 5.2 and 
5.2 Hz, CHCBr), 5.33 (1H, m, CHOC=O), 5.44 (1H, m, CHOC(O)Ph), 6.12 (1H, m, 
CH1=CH0), 7.46 (2H, dd, J = 8.0 and 8.0 Hz, Ph), 7.60 (1H, t, J = 7.6 Hz, Ph), 7.96 (2H, 
d, J = 7.2 Hz, Ph); 13C NMR: δC (100 MHz, CDCl3) 17.0 (q) (CH3), 20.6 (q) (CH3), 26.2 
(q) (CH3CBr), 27.0 (d) (CHCH3), 31.6 (d) (CHCH3), 31.7 (s) (CCN), 37.0 (t) (CH2), 43.1 
(t) (CH2), 54.5 (s) (CBr), 55.9 (d) (CHCBr), 71.4 (d) (CHOC(O)Ph), 75.5 (d) 
(CHOC=O), 123.9 (s) (CN), 128.5 (d) (CH1, m-C=O), (d) (CH0=CH1), 129.5 (d) (CH1, 
p-C=O), 129.7 (d) (CH0=CH1), 133.4 (d) (CH1, o-C=O), 134.1 (s) (CH0, i-C=O), 174.4 
(s) (C=O); MS (CI+) m/z 477, 475 (18%) (MNH4+), 397 (100%) (MNH4+- Br), 277 
(40%), 259 (50%); HRMS (CI+) calcd. for C22H28BrN2O4 (MNH4+) 475.1237, found 
475.1232, Δ = -0.0005 (1.05 ppm)  
 
Also obtained was diene 147 as a colourless film (11 mg, 54% from 144); IR (neat) νmax 
2929, 2232 (CN), 1774 (C=O lactone), 1719 (C=O ester), 1452, 1315, 1267, 1140 cm-1; 
1H NMR: δH (400MHz, CDCl3) 1.10 (3H, d, J = 6.4 Hz, CH3), 1.15 (3H, d, J = 5.6 Hz, 
CH3), 1.94-2.19 (6H, m, C1H2, C2H1, C8H1, C9H2), 3.16 (1H, dd, J = 12.0 and 7.2 Hz, 
CHC=C), 5.39 (2H, m, CH-O), 5.74 (1H, d, J = 1.2 Hz, CH2=C), 6.21 (1H, m, 
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CH1=CH0), 6.41 (1H, d, J = 1.2 Hz, CH2=C), 7.48 (2H, t, J = 7.6 Hz, Ph, m-C=O), 7.61 
(1H, t, J = 7.6 Hz, Ph, p-C=O), 8.06 (2H, d, J = 7.6Hz, Ph, o-C=O); 13C NMR: δC (100 
MHz, CDCl3) 17.19 (q) (CH3), 17.48 (q) (CH3), 29.76 (d) (CHCH3), 29.93 (d) (CHCH3), 
33.04 (s) (C-CN), 39.30 (t) (CH2), 43.58 (t) (CH2), 45.48 (d) (CHC=C), 73.63 (d) 
(CHO), 75.84 (d) (CHO), 123.33 (s) (CN), 125.32 (s) (C=C-C=O), 127.02 (d) (CH1, m-
C=O), 128.45 (d) (CH1, p-C=O), 129.7 (t) (CH2=C), 131.63 (s) (CH0=CH1), 133.3 (d) 
(CH1, o-C=O), 135.9 (s) (CH0, i-C=O), 166.2 (s) (C=O ester), 169.12 (s) (C=O lactone); 
MS (CI+) m/z 395 (100%) (MNH4+), 275 (55%), 178 (75%); HRMS (CI+) calcd. for 
C23H27N2O4 (MNH4+) 395.1967, found 395.1971, Δ = +0.0004 (1.01 ppm). 
 
(3S,3aS,5aS,9R,9aS,9bS)-9-Hydroxy-3,5a,9-trimethyloctahydrospiro[[1,3]dioxolane-
2,2'-naphtho][1,2-b]furan-8-one, 150 
 
H
O
O
C17H26O5
Exact Mass: 310.1780
O
OH
HO
150  
 
Diisopropylamine (69 µL, 0.49 mmol) was dissolved in THF (1.0 mL) and cooled to -78 
ºC. A solution of n-BuLi (2.5 M in hexanes, 220 µL, 0.550 mmol) was added dropwise. 
After 15 min stirring at -78 ºC, the mixture was allowed to warm to room temperature 
where it was stirred for 1 h. The reaction mixture was cooled to -78 °C before a solution 
of lactone 139 (60 mg, 0.20 mmol) in THF (1.0 mL) was then added dropwise over the 
course of 15 min and the reaction mixture was left to stir at -78 °C for 15 min. MoOPD 
(123 mg, 0.449 mmol) was then added under a flow of N2. After 1 h stirring at -78 °C the 
cooling bath was removed and the reaction mixture stirred at room temperature for 24 h. 
The reaction mixture was quenched by the addition of 10% aq. Na2SO3 solution (5 mL). 
The product was extracted from the mixture with CH2Cl2 (3 x 5 mL). The combined 
organic phases were dried (MgSO4) and evaporated in vacuo to give the crude product. 
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Purification by flash chromatography eluting with EtOAc:petrol (33:67) gave: lactone 139 
as a white solid (17 mg, 28%), spectroscopic data as above; 
 
Alcohol 150 (39 mg, 62%) as a white solid. Mp = 175-176 ºC; IR (neat) νmax 3443 (br) 
(OH), 2950, 1768 (C=O), 1463, 1267, 1185, 1143, 1100 cm-1; 1H NMR: δH (400MHz, 
CDCl3) 1.01 (H, s, CH3), 1.05 (3H, d, J = 6.4 Hz, CH3), 1.31 (1H, dd, J = 13.2 and 4.4 
Hz), 1.37 (1H, dt, J = 12.8 Hz, 3.6 Hz), 1.43 (3H, s, CH3COH), 1.51-1.70 (7H, m), 1.79 
(1H, qd, J = 13.2 and 3.6 Hz, CHCH3), 2.04 (1H, td, J = 13.2 and 6.8 Hz, CHCOH), 2.24 
(1H, broad, OH), 3.93-4.02 (4H, m, CH2O), 4.29 (1H, dd, J = 10.0 Hz and 10.0 Hz, 
CHOC=O); 13C NMR: δC (100 MHz, CDCl3) 12.1 (s) (CH3), 17.8 (t) (CH2), 18.1 (q) 
(CHCH3), 21.5 (q) (CH3COH), 31.1 (t) (CH2), 36.6 (s) (CCH3), 39.0 (t) (CH2) 39.4 (d) 
(CH1), 40.4 (t) (CH2), 51.2 (d) (CHCH3), 55.9 (d) (CHCOH), 65.1 (t) (CH2-O), 65.2 (t) 
(CH2-O), 72.7 (s) (COH), 82.0 (d) (CHOC=O), 110.7 (s) (C(OR)2), 178.0 (s) (C=O); MS 
(CI+) m/z 328 (100%) (MNH4+), 311 (35%) (MH+); HRMS (CI+) calcd. for C17H27O5 
(MH+) 311.1858, found 311.1864, Δ = +0.0006 (1.92 ppm); [α]D22 = +46.06 (c =1.32, 
CH2Cl2). 
 
(3S,3aS,5aS,9R,9aS,9bS)-9-Trimethylsilyloxy-3,5a,9-
trimethyloctahydrospiro[[1,3]dioxolane-2,2'-naphtho][1,2-b]furan-8-one, 151 
 
H
O
O
C20H34O5Si
Exact Mass: 382.2176
O
OH
Me3SiO
151  
 
Diisopropylamine (69 µL, 0.49 mmol) was dissolved in THF (1.0 mL) and cooled to -78 
ºC. A solution of n-BuLi (2.50 M in hexanes, 220 µL, 0.550 mmol) was added dropwise. 
After 15 min stirring at -78 ºC, the reaction mixture was allowed to warm to room 
temperature where it was stirred for 1 h. After cooling again to -78 ºC, TMSCl (22 µL, 
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0.18 mmol) was added. A solution of lactone 139 (60 mg, 0.204 mmol) in THF (1.0 mL) 
was then added dropwise over the course of 15 min and the reaction mixture was left to 
stir at -78 °C for 15 min. Davis’ oxaziridine72 (0.5 M solution in THF, 1.06 mL, 0.530 
mmol) was then added dropwise. After 1 h stirring at -78 °C the cooling bath was 
removed and the reaction stirred at room temperature for 3.5 h. The reaction was 
quenched by the addition of saturated aq. NH4Cl solution (10 mL). The product was 
extracted from the mixture with CH2Cl2 (4  5 mL). The combined organic phases were 
dried (MgSO4) and evaporated in vacuo to give the crude product. Purification by flash 
chromatography eluting with EtOAc:petrol (20:80  40:60) gave silyl ether 151 (36 mg, 
45%) as a white solid. Mp = 107-109 ºC; IR (neat) νmax 2947, 1781 (C=O), 1454, 1376, 
1350, 1251, 1217, 1130, 1098 cm-1; 1H NMR: δH (400MHz, CDCl3) 0.17 (H, s, 
Si(CH3)3), 1.05 (3H, d, J = 6.8 Hz, CH3), 1.25-1.29 (1H, m), 1.31-1.35 (1H, m), 1.40 
(3H, s, CH3COSi), 1.51-1.59 (4H, m, CH3 and CH2), 1.67-1.72 (3H, m), 2.03 (1H, dt, J = 
11.6 and 6.8 Hz, CHCOTMS), 3.91-4.02 (4H, m, CH2O), 4.17 (1H, dd, J = 11.2 and 9.6 
Hz, CHOC=O); 13C NMR: δC (100 MHz, CDCl3) 0.2 (q) (Si(CH3)3), 12.1 (s) (CH3), 
17.9 (t) (CH2), 18.0 (q) (CHCH3), 21.2 (q) (CH3COH), 31.1 (t) (CH2), 36.5 (s) (CCH3), 
39.0 (t) (CH2) 39.5 (d) (CH1), 40.2 (t) (CH2), 50.8 (d) (CHCH3), 57.9 (d) (CHCOTMS), 
65.1 (t) (CH2-O), 74.7 (s) (COTMS), 81.6 (d) (CHOC=O), 110.7 (s) (C(OR)2), 177.1 (s) 
(C=O); MS (CI+) m/z 400 (100%) (MNH4+), 383 (24%) (MH+), 328 (20%); HRMS 
(CI+) calcd. for C20H35O5Si (MH+) 383.2254, found 383.2245, Δ = -0.0009 (2.34 ppm); 
[α]D22 = +71.50 (c = 0.85, CH2Cl2) 
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(3S,3aR,4S,5aS,7R,8S,9bR)-8-(tert-butyldimethylsilanyloxy)-3-hydroxy-3,4,7-
trimethyl-2-oxo-3,3a,4,5,6,7,8,9b-octahydro-2H-naphtho[1,2-b]furan-5a-
carbonitrile, 152 
 
CN
OTBS
O
O
HO
C22H35NO4Si
Exact Mass: 405.2335
152  
 
Diisopropylamine (118 µL, 0.837 mmol) was dissolved in THF (2 mL) and cooled to -78 
ºC. A solution of n-BuLi (2.5 M in hexanes, 220 µL, 0.550 mmol) was added dropwise. 
After 15 min stirring at -78 ºC, the reaction mixture was allowed to warm to room 
temperature and stirred for 1 h. The reaction mixture was cooled to -78 °C before a 
solution of lactone 143 (34 mg, 0.87 mmol) and lactone 139 (77 mg, 0.26 mmol) in THF 
(2 mL) was then added dropwise over the course of 30 min and the reaction was left to 
stir at -78 °C for 30 min. MoOPD (683 mg, 2.48 mmol) was then added under a flow of 
N2. After 15 min stirring at -78 °C the cooling bath was removed and the reaction mixture 
stirred at room temperature for 4 h. The reaction mixture was quenched by the addition of 
saturated aq. NH4Cl (10 mL) and the resulting suspension was extracted with CH2Cl2 (4 x 
5 mL). The combined organic extracts were dried (MgSO4) and concentrated in vacuo to 
give a brown oil. The crude product was purified by flash chromatography eluting with 
EtOAc:petrol (1:3) to give: lactone 143 as a white solid (4 mg, 12%), spectroscopic data 
as above;  
and hydroxy-lactone 152 as a white solid (22 mg, 63%). 1H NMR: δH (400MHz, CDCl3) 
0.06 (3H, s, SiCH3), 0.08 (3H, s, SiCH3), 0.86 (9H, s, SiC(CH3)3), 1.18 (3H, d, J = 6.8 
Hz, CH3), 1.21 (3H, d, J = 6.8 Hz, CH3), 1.36  (3H, s, CH3COH), 1.83 (m, 1 H, 
CHCH3), 1.90-2.00 (4H, m, CHCH3, C2H2, C9HH), 2.10 (1H, dd, J = 13.2 and 3.2 Hz, 
C9HH), 2.61 (1H, dd, J = 9.6 and 8.4 Hz, CHCOH), 3.86 (1H, m, CHOSi), 5.25 (1H, dt, 
J = 10.0 and 3.2 Hz, CHOC=O), 5.80 (1H, dd, J = 4.0 and 2.4 Hz, CH1=CH0); 13C 
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NMR: δC (100 MHz, CDCl3) -4.96 (q) (SiCH3), -4.6 (q) (SiCH3), 17.0 (q) (CH3), 17.9 (s) 
(SiC(CH3)3), 20.3 (q) (CH3), 23.4 (q) (CH3COH),  25.7 (q) (SiC(CH3)3), 26.4 (d) 
(CHCH3), 31.3 (s) (CCN), 34.2 (d) (CHCH3), 35.9 (t) (CH2), 42.6 (t) (CH2), 52.3 (d) 
(CHCOH), 68.9 (d) (CHOTBS), 73.5 (s) (COH), 74.1 (d) (CHOC=O), 123.3 (s) (CN), 
126.0 (d) (CH0=CH1), 131.0 (s) (CH0=CH1), 179.5 (s) (C=O). 
 
Benzoic acid (3S,3aR,4S,5aS,7R,8S,9bR)-5a-cyano-3-hydroxy-3,4,7-trimethyl-2-oxo-
2,3,3a,4,5,5a,6,7,8,9b-decahydro-naphtho[1,2-b]furan-8-yl ester, 153 
 
CN
OBz
O
O
C23H25NO5
Exact Mass: 395.1733
HO
153  
 
Diisopropylamine (69 µL, 0.489 mmol) was dissolved in THF (1.0 mL) and cooled to -78 
ºC. A solution of n-BuLi (2.5 M in hexanes, 220 µL, 0.550 mmol) was added dropwise. 
After 15 min stirring at -78 ºC, the mixture was allowed to warm to room temperature and 
stirred for 1 h. The reaction mixture was cooled to -78 °C before a solution of lactone 127 
(77 mg, 0.204 mmol) in THF (1.0 mL) was then added dropwise over the course of 30 
min and the reaction was left to stir at -78 °C for 30 min. MoOPD (123 mg, 0.449 mmol) 
was then added under a flow of N2. After 15 min stirring at -78 °C the cooling bath was 
removed and the reaction mixture stirred at room temperature for 4 h. The reaction was 
quenched by the addition of saturated aq. NH4Cl (10 mL) and the resulting suspension 
was extracted with CH2Cl2 (4  5 mL). The combined organic extracts were dried 
(MgSO4) and concentrated in vacuo to give a brown oil. The crude product was purified 
by flash chromatography eluting with EtOAc:petrol (1:3) to give: lactone 127 (17 mg, 
22%) as a white solid, spectroscopic data as above; 
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Hydroxy-lactone 153 (47 mg, 59%) as a white solid. 1H NMR: δH (400MHz, CDCl3) 1.24 
(3H, d, J = 6.8 Hz, CH3), 1.32 (3H, s, CH3COH), 1.33 (3H, d, J = 7.2 Hz, CH3), 1.85 (1H, 
m, CHCH3), 1.99 (1H, dd, J = 14.4 and 4.0 Hz), 2.06-2.14 (3H, m), 2.29 (1H, m, C9HH), 
2.67 (1H, dd, J = 9.6 and 9.6 Hz, CHCOH), 5.31-5.34 (2H, m, CHOC=O), 6.05 (1H, m), 
7.45 (2H, dd, J = 7.6 and 7.6 Hz, Ph, m-C=O), 7.59 (1H, t, J = 7.6 Hz, Ph, p-C=O), 7.94 
(1H, d, J = 7.6 Hz, Ph, o-C=O).  
 
(5a´S,9a´S,9b´R)-3´,5a´-Dimethyl-4´,5´,5a´,6´,7´,9´,9a´,9b´-octahydro-2H-
spiro[[1,3]dioxolane-2,8-naphtho[1,2-b]furan]-2´-one, 156 
 
H
O
O
C17H24O4
Exact Mass: 292.1675
O
O
156  
 
Triphenylphosphine (42 mg, 0.16 mmol) and 4-methoxyphenol (18 mg, 0.15 mmol) were 
dissolved in toluene (400 µL). The resulting solution was heated to 100 °C and to it added 
a solution of ketal 150 (40 mg, 0.13 mmol) and diisopropylazodicarboxylate (32 µL, 0.16 
mmol) in toluene (350 µL) over the course of 2 h via a syringe pump. The reaction 
mixture was heated for 5 h at 100 °C before the solvent was evaporated in vacuo. The 
residue was purified by flash chromatography eluting with EtOAc:petrol (15:85) to give: 
ketal 150 (3.0 mg, 7%) as a white solid, spectroscopic data as above; 
 
Alkene 156 as a white solid (23 mg, 62%). Mp = 184-185 ºC; IR (neat) νmax 2945, 1747 
(C=O), 1685, 1447, 1354, 1301, 1105, 1070 cm-1; 1H NMR: δH (400MHz, CDCl3) 1.10 
(3H, s, CH3), 1.12 (3H, d, J = 6.8 Hz, CH3), 1.32-1.46 (2H, m, CH2), 1.66-1.74 (2H, m, 
CH2), 1.82 (3H, s, H3CC=C), 1.67-1.72 (3H, m), 2.08 (1H, dq, J = 11.2 and 6.8 Hz, 
CHCH3), 2.45 (1H, td, J = 14.4 and 5.2 Hz, CH2C=C), 2.71 (1H, ddd, J = 14.0, 4.4 and 
1.6 Hz, CH2C=C), 3.90-4.00 (4H, m, CH2O), 4.60 (1H, d, J = 11.2 Hz, CHOC=O); 13C 
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NMR: δC (100 MHz, CDCl3) 12.2 (s) (CH3), 16.9 (t) (CH2), 21.9 (q) (CHCH3), 22.7 (q) 
(CH3C=C), 31.0 (t) (CH2), 35.2 (s) (CCH3), 37.8 (t) (CH2) 40.5 (d) (CH1), 40.9 (t) 
(CH2), 53.6 (d) (CHCH3), 65.1 (t) (CH2-O), 65.2 (t) (CH2-O), 82.2 (d) (CHOC=O), 
110.5 (s) (C(OR)2),  156.4 (s) (C=C-C=O), 162.3 (s) (C=C-C=O), 174.5 (s) (C=O); MS 
(CI+) m/z 310 (100%) (MNH4+), 293 (20%) (MH+); HRMS (CI+) calcd. for C17H28NO4 
(MH+) 310.2018, found 310.2025, Δ = +0.0007 (2.26 ppm). 
 
(±)-trans-Decahydro-4a-(phenylthio)naphthalen-8a-yl isobutyrate, 171 
 
C20H28O2S
Exact Mass: 332.1810
SPh
OO
171  
 
To a solution of alcohol 167 (20 mg, 0.076 mmol) and DMAP (1 mg, 0.007 mmol) in 
toluene (0.5 mL) was added n-BuLi (2.26 M solution in hexanes, 40.5 µL, 0.092 mmol). 
This addition was rapidly followed by the addition of isobutyric anhydride (23 µL, 0.12 
mmol). After 1 h stirring, H2O (3 mL) was added to the reaction mixture and the product 
was extracted into Et2O (3  5 mL). The combined organic phases were dried (MgSO4) 
and concentrated in vacuo. The crude product was purified by flash chromatography 
eluting with EtOAc:petrol 5:95 to give the desired ester 171 as a white solid (16 mg, 
64%). Mp = 108-110 °C (CHCl3); IR (neat) νmax 2936, 2859, 1726(C=O), 1448, 1181, 
1160 cm-1; 1H NMR δ (400 MHz, CDCl3) 1.23 (6H, d, J = 7.2 Hz, CH3), 1.41-1.49 (5H, 
m), 1.61-1.73 (5H, m), 1.97 (2H, td, J = 13.6 and 4.4 Hz, CH2), 2.35 (2H, qt, J = 13.6 
and 4.4 Hz, CH2), 2.48 (2H, d, J = 14.0 Hz, CH2), 2.60 (1H, sep, J = 7.2 Hz, C(O)CH), 
7.31-7.40 (3H, m, Ar), 7.52 (2H, d, J = 6.8 Hz, Ar, o-S); 13C NMR δC (125 MHz, 
CDCl3) 19.5 (2q)(CH3), 20.6 (2t)(CH2), 21.3 (2t)(CH2), 28.7 (2t)(CH2), 31.2 (2t)(CH2), 
35.6 (d)(CH1), 59.6 (s)(C-S), 85.7 (s)(C-O), 128.7 (2d)(CH1, m-S), 128.9 (d)(CH1, p-S), 
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137.6 (2d)(CH1, o-S), 175.1 (s)(C=O); MS (EI+) m/z 332 (10 %) (M+); HRMS (EI+) 
calcd. for C20H28O2S (M+) 332.1810, found 332.1814, Δ = +0.0004 (1.20 ppm). 
 
(S)-Methyl 2-(4-methoxybenzyloxy)propanoate, 17265 
 
O
OMe
OPMB
C12H16O4
Exact Mass: 224.1049
172  
 
According to the method of Roush,138 methyl (S)-lactate (1.17 mL, 12.3 mmol) and p-
methoxybenzyl trichloroacetimidate139 (5.15 g, 18.1 mmol) were dissolved in CH2Cl2 (25 
mL) and cyclohexane (25 mL). TfOH (2 µL) was added and the reaction was stirred at 
room temperature. After 3 h, saturated NaHCO3 solution (30 mL) and CH2Cl2 (30 mL) 
were added. The aqueous phase was separated and extracted with CH2Cl2 (2  20 mL). 
The combined organic phases were dried (MgSO4) and concentrated in vacuo to afford a 
yellow solid. The solid was washed with CH2Cl2/Petrol (1:1) and filtered. The filtrate was 
evaporated in vacuo to give a yellow oil which was purified using flash chromatography 
eluting with EtOAc/Petrol (50:50) to give the ester 172 as a colourless oil (2.44 g, 89%). 
Analytical data was consistent with that previously reported:138 1H NMR δ (400 MHz, 
CDCl3) 1.45 (3H, d, J = 6.8 Hz, CHCH3), 3.78 (3H, s, Ar-OCH3), 3.83 (3H, s, CO2CH3), 
4.08 (1H, q, J = 6.8 Hz, CHCH3), 4.42 (1H, d, J = 11.2 Hz, OCHHAr), 4.64 (1H, d, J = 
11.2 Hz, OCHHAr), 6.91 (2H, d, J = 8.8 Hz, Ar), 7.32 (2H, d, J = 8.8 Hz, Ar). 
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(S)-2-(4-Methoxybenzyloxy)propanoic acid, 17365 
 
O
OH
OPMB
C11H14O4
Exact Mass: 210.0892
173  
 
According to the method of Thomas,140 ester 172 (2.24 g, 10.9 mmol) was dissolved in a 
mixture of THF and H2O (3:1) (80 mL) and cooled to 0 ºC. Solid LiOH.H2O (503 mg, 
12.0 mmol) was added and the reaction mixture was allowed to reach room temperature. 
After 3.5 h stirring at room temperature, the reaction mixture was extracted with Et2O (3 
 60 mL). The aqueous phase was acidified with glacial acetic acid and extracted with 
EtOAc (4  60 mL). The combined organic phases were washed with brine (100 mL), 
dried (MgSO4) and concentrated in vacuo to give acid 173 as a pale yellow oil (1.91 g, 
84%) which was used without further purification. Analytical data was consistent with 
that previously reported:140 1H NMR δ (400 MHz, CDCl3) 1.50 (3H, d, J = 6.8 Hz, 
CHCH3), 3.84 (3H, s, Ar-OCH3), 4.12 (1H, q, J = 6.8 Hz, CHCH3), 4.53 (1H, d, J = 11.2 
Hz, OCHHAr), 4.65 (1H, d, J = 11.2 Hz, OCHHAr), 6.92 (2H, d, J = 8.8 Hz, Ar), 7.31 
(2H, d, J = 8.8 Hz, Ar). 
 
(S)-2-(4-Methoxybenzyloxy)propanoic acid anhydride, 174 
 
O
O
OPMB
C22H26O7
Exact Mass: 402.1679
O
OPMB
174  
 
Acid 173 (1.27 g, 6.04 mmol) was dissolved in CH2Cl2 (20 mL). 
Dicyclohexylcarbodiimide (623 mg, 3.02 mmol) was added and the reaction mixture 
immediately became a viscous suspension. Additional CH2Cl2 (15 mL) was added and the 
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reaction left to stir for 6 h. The reaction mixture was then concentrated in vacuo and Et2O 
was added to the residue. The suspension was cooled in an ice bath and filtered through a 
cotton wool plug. The filtrate was concentrated in vacuo to give the acid anhydride 174 as 
a yellow oil (992 mg, 82%) which was used without further purification. IR (neat) νmax 
2935, 2116, 1825 (C=O symmetric), 1753 (C=O asymmetric), 1612, 1513, 1463 cm-1; 1H 
NMR: δH (400MHz, CDCl3) 1.49 (6H, d, J = 6.8 Hz, CHCH3), 3.82 (6H, s, OCH3), 4.15 
(2H, q, J = 6.8 Hz, C=OCH), 4.44 (2H, d, J = 11.2 Hz, CHHAr), 4.68 (2H, d, J = 11.2 
Hz, CHHAr), 6.89 (4H, d, J = 8.4 Hz, Ar, o-OMe), 7.29 (4H, d, J = 8.4 Hz, Ar, m-
OMe); 13C NMR: δC (100 MHz, CDCl3) 18.1 (q)(CH3), 55.3 (q)(O-CH3), 71.8 
(t)(ArCH2), 73.2 (d)(CH1O), 113.9 (2d)(CH1, o-OMe), 129.0 (s) (C, p-OMe), 129.7 
(2d)(CH1, m-OMe), 159.6 (s)(C-OMe), 169.1 (s)(C=O); HRMS (ESI) calcd. for 
C22H26O7Na (MNa+) 425.1576, found 425.1580, Δ = +0.0004 (0.94 ppm). 
 
(2S)-(1aS,2ʹR,3aR,5S,7aR,7bS)-3a-Cyano-1a,2,3,3a,4,5,7a,7b-octahydro-2,5-
dimethylnaphtho[1,2-b]oxiren-7a-yl 2-methoxypropanoate, 176 
 
CN
OOO
MeO
C17H23NO4
Exact Mass: 305.1627
176  
 
To a solution of (–)-S-2-methoxypropionic acid (44 µL, 0.46 mmol) in toluene (1 mL) 
was added Et3N (67 µL, 0.48 mmol) and 2,4,6-trichlorobenzoyl chloride (75 µL, 0.48 
mmol). The reaction mixture was stirred at room temperature for 1.5 h then a solution of 
alcohol 111 (50 mg, 0.23 mmol) and DMAP (31 mg, 0.25 mmol) in toluene (1 mL) was 
added. The reaction mixture was heated to 60 °C for 20 h then concentrated in vacuo. 
Purification of the residue by flash chromatography eluting with EtOAc:Petrol (15:85) 
gave the desired ester 176 as a colourless oil (60 mg, 87%). IR (neat) νmax 2984, 2938, 
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2237 (CN), 1742 (C=O), 1459, 1373, 1266, 1190 cm-1; 1H NMR δH(400 MHz, CDCl3) 
1.35 (3H, d, J = 4 Hz, CH3), 1.37 (3H, d, J = 3.6 Hz, CH3), 1.46-1.50 (4H, m, CH3 and 
CHH, H-1), 1.69 (1H, d, J = 14 Hz, CHH, H-9), 1.95 (1H, dd, J = 14 Hz and 8.4 Hz, 
CHH, H-1), 2.26 (1H, dd, J = 14 Hz and 8.8 Hz, CHH, H-9), 2.46 (1H, dd, J = 8 Hz and 
8 Hz), 2.52-2.59 (1H, m), 3.22 (1H, d, J = 3.2 Hz, CH(O), H-3), 3.40 (3H, s, OCH3), 
3.68 (1H, d, J = 3.2 Hz, CH(O), H-4), 3.84 (1H, q, J = 6.8 Hz, CHOCH3), 5.99 (1H, dd, 
J = 10 Hz and 3.2 Hz, C=CH, H-6), 6.47 (1H, dd, J = 10 Hz and 2.4 Hz, C=CH, H-7); 
13C NMR δC (125 MHz, CDCl3) 18.7 (q)(CH3), 19.7 (q)(CH3), 21.8 (q)(CH3), 26.5 
(d)(CH1CH3), 27.9 (d)(CH1CH3), 31.2 (t)(CH2), 33.4 (t)(CH2), 36.5 (s)(CCN), 56.1 
(q)(OCH3), 57.6 (d)(OCH1), 58.4 (d)(OCH1), 71.4 (s)(COC=O), 76.5 (d)(CH1), 123.1 
(s)(CN), 127.2 (d)(CH1), 139.1 (d)(CH1), 170.8 (s)(C=O); MS (CI+) m/z 323 (100%) 
(MNH4+); HRMS (CI+) calcd. for C17H24NO4 (MH+) 306.1705, found 306.1717, Δ = 
+0.0012 (3.91 ppm); [α]D22 = -12.3 ° (c = 1.26, CH2Cl2). 
 
(3R,3aR,4S,5aS,7R,8S,9bR)-2,3,3a,4,5,5a,6,7,8,9b-Decahydro-8-hydroxy-3-methoxy-
3,4,7-trimethyl-2-oxonaphtho[1,2-b]furan-5a-carbonitrile, 177 
and  
(3S,3aR,4S,5aS,7R,8S,9bR)-2,3,3a,4,5,5a,6,7,8,9b-Decahydro-8-hydroxy-3-methoxy-
3,4,7-trimethyl-2-oxonaphtho[1,2-b]furan-5a-carbonitrile, 178 
 
CN
OH
O
O
C17H23NO4
Exact Mass: 305.1627
C17H23NO4
Exact Mass: 305.1627MeO
CN
OH
O
O
MeO
177 178  
 
Preparation of 1.0 M lithium amide solution: To a solution of (-)-bis[(S)-1-
phenylethyl]amine (120 µL, 0.52 mmol) in THF (180 µL) at -78 ºC was added dropwise 
n-BuLi (2.5 M in hexane 200 µL, 80 mmol). A colour change to purple was observed. 
The mixture was stirred at -78 ºC for 10 min and then allowed to reach room temperature 
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at which point the solution was yellow in appearance.  
Ireland-Claisen Rearrangement: To a solution of ester 176 in THF cooled to -78 ºC was 
added TMSCl. This was followed by the dropwise addition of a 1.0 M solution of the 
chiral lithium amide (see above). The reaction mixture was left to stir for 15 min at -78 ºC 
before being allowed to reach room temperature. The reaction mixture was then heated to 
reflux for 4 h. Upon cooling, a saturated solution of NH4Cl (4 mL) was added. The 
resulting reaction mixture was extracted with CH2Cl2 (4  5 mL) and the combined 
organic phases were dried (MgSO4) and concentrated in vacuo to give the crude product 
as a colourless oil. Purification by flash chromatography eluting with EtOAc:Petrol 
(20:80→40:60→60:40) gave: 
Lactone 177 as a white solid (22 mg, 24%). Mp = 124-125 ºC (EtOAc:hexane); IR (neat) 
νmax 2919, 2232 (CN), 1784 (C=O), cm-1; 1H NMR δ (400 MHz, CDCl3) 1.15 (3H, d, J = 
6.8 Hz, CH3), 1.39 (3H, d, J = 6.4 Hz, CH3), 1.40 (3H, s, CH3), 1.68 (1H, m, CHH, H-1), 
1.86 (1H, dd, J = 13.6 and 4.4 Hz, CHH, H-9), 1.96 (1H, d, J = 2.4 Hz, CHH, H-1), 1.98 
(1H, s, CHCH3), 2.19 (1H, dd, J = 13.6 and 6.0 Hz, CHH, H-9), 2.29 (1H, dd, J = 8.0 
and 3.6 Hz, CHCCH3OCH3, H-7), 2.31-2.37 (1H, m, CHCH3), 3.23 (3H, s, OCH3), 3.92 
(1H, m, CHOH), 5.30 (1H, dt, J = 8.0 and 2.4 Hz, CHOC(O)), 5.90 (1H, t, J = 2.4 Hz, 
C=CH); 13C NMR δC (125 MHz, CDCl3) 17.3 (q)(CH3), 18.0 (q)(CH3), 22.6 (q)(CH3), 
25.5 (d)(CH1CH3), 29.7 (s)(CCN), 33.1 (t)(CH2), 39.2 (t)(CH2), 42.1 (d)(CH1CH3), 51.3 
(q)(OCH3), 53.8 (d)(CH1), 71.0 (d)(CH1OH), 74.8 (d)(CH1OC=O), 76.5 (s)(COCH3), 
123.9 (s)(CN), 126.0 (d)(C=CH1), 133.0 (s)(C=CH1), 174.1 (s)(C=O); MS m/z 323 
(100%) (MNH4+); HRMS (MNH4+) (CI+) calcd. for C17H27N2O4 (MNH4+) 323.1971, 
found 323.1964, Δ = -0.0007 (2.16 ppm); [α]D22 = -12.4, (c = 0.58, CH2Cl2). 
 
Lactone 178 as a colourless gum (22 mg, 24%). IR (neat) νmax 2924, 2283 (CN), 1783 
(C=O), 1382 cm-1; 1H NMR δ (400 MHz, CDCl3) 1.20 (3H, d, J = 6.8 Hz, CH3), 1.22 
(3H, d, J = 6.8 Hz, CH3), 1.37 (3H, s, CH3COCH3), 1.87-2.00 (6H, m), 2.73 (1H, dd, J = 
9.6 and 7.6 Hz, CHCOCH3, H-7), 3.40 (3H, s, OCH3), 3.99 (1H, dt, J = 4.8 and 2.0 Hz, 
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CHOH), 5.30 (1H, dt, J = 9.6 and 2.0 Hz, CHOC(O)), 5.97 (1H, dd, J = 3.2 and 2.0 Hz, 
C=CH); 13C NMR δC (125 MHz, CDCl3) 17.2 (q)(CH3), 20.5 (q)(CH3), 20.7 (q)(CH3), 
26.3 (d)(CH1CH3), 31.9 (s)(CCN), 33.5 (t)(CH2), 37.1 (t)(CH2), 42.6 (d)(CH1CH3), 48.1 
(d)(CH1), 51.7 (q)(OCH3), 69.2 (d)(CH1OH), 73.8 (d)(CH1OC=O), 78.7 (s)(C), 123.2 
(s)(CN), 126.2 (d)(C=CH1), 132.5 (s)(C=CH1), 176.2 (s)(C=O); MS m/z 323 (100%) 
(MNH4+); HRMS (MNH4+) (CI+) calcd. for C17H27N2O4 (MNH4+) 323.1971, found 
323.1973, Δ = +0.0002 (0.62 ppm); [α]D22 = -6.9 (c = 0.30, CH2Cl2). 
 
(R)-2-((1R,2R,3S,4aS,6R,7S)-4a-Cyano-1,7-dimethoxy-3,6-dimethyl-1,2,3,4,4a,5,6,7-
octahydronaphthalen-2-yl)-2-methoxypropionic acid methyl ester, 188 
 
CN
OMe
OMeMeO
Chemical Formula: C20H31NO5
Exact Mass: 365.2202
O
OMe
188  
 
Lactone 177 (133 mg, 0.436 mmol) was dissolved in THF (5 mL) and KOH (244 mg, 4.36 
mmol) was added followed MeI (271 µL, 4.36 mmol). The reaction mixture was heated at 
60 °C for 2 h before being evaporated to dryness in vacuo. The residue was dissolved in 
EtOAc (5 mL), H2O (5 mL) added and the resulting suspension shaken. The organic 
phase was separated and the aqueous phase extracted with EtOAc (3  5 mL). Combined 
organic extracts were dried (Na2SO4) and concentrated in vacuo to give a pale yellow oil 
(167 mg), which was carried forward without further purification.  For an analytical 
sample, lactone 177 (29 mg, 0.095 mmol) was dissolved in THF (2 mL) and KOH (53 mg, 
0.95 mmol) was added followed MeI (59 µL, 0.95 mmol). The reaction mixture was 
heated to reflux for 15 h. Upon cooling, H2O (5 mL) was added and the aqueous mixture 
extracted with CH2Cl2 (3  5 mL). The combined organic extracts were dried (Na2SO4) 
and concentrated in vacuo to give a pale yellow oil. Purification by flash chromatography 
eluting with EtOAc:Petrol (20:80) gave ester 188 as a white solid (15 mg, 43%). Mp = 
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96-97 ºC; IR (neat) νmax 2929, 2227 (CN), 1748 (C=O), 1457, 1178, 1101 cm-1; 1H NMR: 
δH (400MHz, CDCl3) 1.11 (3H, d, J = 6.4 Hz, CH3), 1.43 (3H, s, CH3CCO2Me), 1.45 
(3H, d, J = 7.6 Hz, CH3), 1.73 (1H, d, J = 13.6 Hz), 1.83-1.98 (1H, m, CHCH3), 2.32 
(2H, m, C9), 2.62 (1H, dt, J = 14.4 and 7.2 Hz, CHCOCH3), 3.20, (3H, s, OCH3), 3.39 
(3H, s, OCH3), 3.43 (3H, s, OCH3), 3.60 (1H, dt, J = 6.4 and 2.8 Hz, CHOCH3), 3.72 
(3H, s, OCH3), 4.22 (1H, dt, J = 5.2 and 2.4 Hz, CHOCH3), 5.97 (1H, t, J = 2.4 Hz); 13C 
NMR: δC (100 MHz, CDCl3) 17.5 (q) (CH3), 21.4 (q) (CH3), 22.4 (q) (CH3), 28.6 (d) 
(CHCH3), 30.4 (d) (CHCH3), 34.9 (s) (CCN), 40.4 (t) (CH2), 41.1 (t) (CH2), 51.4 (d) 
(CH1C(OMe)CO2Me), 51.5 (q) (OCH3), 53.0 (q) (OCH3), 54.5 (q) (OCH3), 58.0 (q) 
(OCH3), 77.3 (d) (CHOCH3) 80.4 (d) (CHOCH3), 82.0 (s) (CCO2Me), 122.9 (d) 
(CH0=CH1), 125.7 (s) (CN), 133.5 (s) (C=CH1), 174.8 (s) (C=O); HRMS (CI+) calcd. for 
C20H35N2O5 (MNH4+) 388.2100, found 388.2085, Δ = -0.0015 (3.86 ppm). 
 
(R)-2-((1aR,2S,3R,4aR,6S,7R,8R,8aR)-4a-Cyano-2,8-dimethoxy-3,6-
dimethyloctahydro-1-oxa-cyclopropa[d]naphthalen-7-yl)-2-methoxypropionic acid 
methyl ester, 189 
 
CN
OMe
OMeMeO
Chemical Formula: C20H31NO6
Exact Mass: 381.2151
O
O
OMe
189  
 
Alkene 188 (159 mg, 0.436 mmol) was dissolved in CH2Cl2 (5 mL) and 3-
chloroperbenzoic acid (301 mg, 1.74 mmol) was added. The reaction mixture was stirred 
at room temperature for 34 h before being evaporated to dryness in vacuo. The residue 
was dissolved in EtOAc (5 mL) and saturated aqueous NaHCO3 solution (5 mL). The 
organic phase was separated and subsequently washed with a saturated NaHCO3 solution 
(3  3 mL). The combined organic extracts were dried (Na2SO4) and concentrated in 
vacuo to give a white solid. Purification by flash chromatography eluting with 
EtOAc:petrol (15:85) gave epoxide 189 (136 mg, 82%) as a white solid. Mp = 135-137 
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°C; IR (neat) νmax 2933, 2835, 2234 (CN), 1730 (C=O), 1458, 1253, 1184, 1097 cm-1; 1H 
NMR: δH (400 MHz, C6D6) 0.90 (3H, d, J = 6.4 Hz, CH3), 1.18 (3H, s, CH3), 1.19 (1H, 
m, CHCH3), 1.32 (1H, dt, J = 14.0 and 1.2 Hz), 1.46 (3H, d, J = 8.4 Hz, CH3), 1.47-1.54 
(1H, m, CHCH3), 1.75 (1H, t, J = 13.2 Hz), 2.13 (1H, m), 2.32 (1H, dd, 14.0 and 6.0 Hz, 
C9HH), 2.44 (1H, d, J = 5.6 Hz, CHCOCH3), 2.90 (1H, d, J = 9.6 Hz, CHOCH3), 3.20 
(3H, s, OCH3), 3.30 (3H, s, OCH3), 3.33 (3H, s, OCH3), 3.43 (3H, s, OCH3), 3.95 (1H, 
s, CHOCH3), 4.16 (1H, d, J = 6.0 Hz, CH-O, epoxide); 13C NMR: δC (100 MHz, CDCl3) 
18.4 (q) (CH3), 21.4 (q) (CH3), 22.2 (q) (CH3), 27.8, 29.2, 36.2, 36.8, 37.3, 51.4 (d) 
(CH1C(OMe)CO2Me), 51.5 (q) (OCH3), 53.4 (q) (OCH3), 57.4 (q) (OCH3), 59.5 (q) 
(OCH3), 60.2 (d) (COCH1), 62.6 (s) (COCH1), 74.9 (d) (CHOCH3), 79.7 (d) (CHOCH3), 
81.6 (s) (CCO2Me), 133.7 (s) (CN), 175.3 (s) (C=O); MS (CI+) m/z 399 (100%) MNH4+ 
382 (35%) (MH+); HRMS (CI+) calcd. for C20H32NO6 (MH+) 382.2230, found 
382.2229, Δ = -0.0001 (0.26 ppm). 
 
(1R,2R,3S,4R,6R,8S,9R,10R,12R)-6-Cyano-2-hydroxy-3,12-dimethoxy-4,8,10-
trimethyl-11-oxatricyclo[7.2.1.01,6]dodecane-10-carboxylic acid methyl ester, 195 
and 
(1R,2R,3S,4R,6R,8S,9R,10R,13R)-2-Hydroxy-3,10,13-trimethoxy-4,8,10-trimethyl-
11-oxo-12-oxatricyclo[7.3.1.01,6]tridecane-6-carbonitrile, 196 
 
CN
OMeO
OMe
OH
Chemical Formula: 
C19H29NO6
Exact Mass: 367.1995
OMe
O
CN
OMeO
OMe
OH
O
MeO
Chemical Formula: C19H29NO6
Exact Mass: 367.1995
195 196  
 
Ester 189 (20 mg, 0.052 mmol) was dissolved in CH2Cl2 (2.5 mL) and LiI (28 mg, 0.21 
mmol) was added. The suspension was cooled to -78 °C and a solution of BBr3 (1.0 M in 
CH2Cl2, 210 µl, 0.210 mmol) was added. The reaction mixture was stirred at -78 °C. 
After 1 h, H2O (3 mL) was added and the organic phase separated. The aqueous phase 
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was extracted with CH2Cl2 (3  3 mL). The combined organic extracts were dried 
(MgSO4) and concentrated in vacuo to give a brown oil. Purification by flash 
chromatography eluting with EtOAc:Petrol (20:80→50:50) gave a mixture of products 
lactone 196 and ester 195 (10 mg, 52%) in addition to the individual pure products: 
 
Ester 195 (2.5 mg, 14%) as a white solid: Mp = 131-134 ºC; IR (neat) νmax 3450 (br, OH), 
2235 (CN), 1748 (C=O), 1455, 1131, 1101 cm-1; 1H NMR: δH (400MHz, CDCl3) 1.06 
(3H, d, J = 6.0 Hz, CH3), 1.40 (3H, s, CH3CCO2Me), 1.46 (3H, d, J = 7.6 Hz, CH3), 1.66 
(1H, d, J = 14.8 Hz, C1H ax.), 1.75 (1H, dd, J = 12.8 and 3.6 Hz, C2), 2.01 (1H, t, J = 
12.8 Hz), 2.06-2.15 (1H, m), 2.56 (1H, dt, J = 14.8 and 7.6 Hz, CHC(CH3)OCH3), 2.68-
2.72 (2H, m, C7, C9), 2.86 (1H, s, OH), 3.25, (1H, dd, J = 10.4 and 3.2 Hz, CHOCH3), 
3.40 (3H, s, OCH3), 3.51 (3H, s, OCH3), 3.77 (3H, s, OCH3), 3.83 (1H, d, J = 3.6 Hz), 
4.53 (1H, d, J = 3.2 Hz); 13C NMR: δC (100 MHz, CDCl3) 17.3 (q) (CH3), 20.5 (q) 
(CH3), 22.7 (q) (CH3), 27.1 (d) (CHCH3), 27.6 (d) (CHCH3), 34.4 (t) (CH2), 38.9 (t) 
(CH2), 40.5 (s) (CCN), 43.2 (d) (CH1C-O-CH0), 52.0 (q) (OCH3 ester), 56.0 (q) (OCH3), 
57.3 (q) (OCH3), 67.6 (d) (CH1-OH), 69.2 (s) (CCO2Me), 77.9 (s) (COC(CH3)CO2Me), 
78.1 (d) (CHOCH3), 80.8 (d) (CHOCH3), 124.3 (s) (CN), 174.7 (s) (C=O); MS (CI+) 
m/z 385 (100%) (MNH4+); HRMS (CI+) calcd. for C19H33N2O6 385.2339, found 
385.2343, Δ = +0.0004 (1.03 ppm). 
 
Lactone 196 (1.5 mg, 8%) as a colourless gum: IR (neat) νmax 3496 (br, OH), 2229 (CN), 
1726 (C=O), 1453, 1107 cm-1; 1H NMR: δH (400MHz, CDCl3) 1.29 (3H, d, J = 7.6 Hz, 
CH3), 1.39 (3H, d, J = 7.2 Hz, CH3), 1.45 (3H, s, CH3), 1.73-1.79 (2H, m, CH2), 1.90 
(2H, m, CH2), 2.14 (1H, m, CHCH3), 2.36 (1H, m, CHCH3), 2.90 (1H, d, J = 1.2 Hz, 
CHCOCH3), 3.29 (3H, s, OCH3), 3.33 (1H, m, CHOCH3), 3.54 (3H, s, OCH3), 3.71 (3H, 
s, OCH3), 4.43 (2H, s, CHOCH3 and CHOH); 13C NMR: δC (100 MHz, CDCl3) 18.3 (q) 
(CH3), 18.9 (q) (CH3), 19.7 (q) (CH3), 28.6 (d) (CHCH3), 31.3 (d) (CHCH3), 35.1 (s) 
(CCN), 37.9 (t) (CH2), 40.0 (t) (CH2), 48.6 (d) (CH1C(OMe)Me), 52.2 (q) (OCH3), 55.6 
(q) (OCH3), 57.4 (q) (OCH3), 69.7 (d) (CH1-OH), 83.5 (d) (CHOCH3), 84.0 (d) 
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(CHOCH3), 86.4 (s) (COC=O), 87.4 (s) (C(OMe)C=O), 125.8 (s) (CN); MS (CI+) m/z 
385 (100%) (MNH4+); HRMS (CI+) calcd. for C19H33N2O6 385.2339, found 385.2358, Δ 
= +0.0019 (4.93 ppm). 
 
(1R,2R,3S,4aS,6R,7S)-2-((R)-2-Hydroxy-1-methoxy-1-methyl-ethyl)-1,7-dimethoxy-
3,6-dimethyl-1,3,4,5,6,7-hexahydro-2H-naphthalene-4a-carbonitrile, 198 
 
CN
OMe
OMeMeO
Chemical Formula: C19H31NO4
Exact Mass: 337.2253
HO 198  
 
Ester 188 (18 mg, 0.049 mmol) was dissolved in THF and the solution cooled to -5 °C. 
LiAlH4 (9.0 mg, 0.25 mmol) was added at -5 °C in a single portion. The reaction was 
stirred at -5 °C for 2.5 h before being quenched with H2O (1.5 mL). CH2Cl2 (3 mL) was 
added and the biphasic reaction mixture was stirred vigorously for 10 min. The organic 
phase was separated by the use of a phase separation cartridge (Whatman FT 5.0 µ PTFE, 
15 mm diameter). The aqueous phase was washed with CH2Cl2 (3  3 mL) on the 
separation cartridge with agitation. The combined organic phases were dried (Na2SO4) 
and blown to dryness under N2 to give alcohol 198 as a colourless film (15 mg, 91%) 
which was used without further purification in the next step. 1H NMR: δH (400MHz, 
CDCl3) 1.13 (3H, d, J = 6.8 Hz, CH3), 1.28 (3H, s, H3COCCH3), 1.45 (3H, d, J = 7.6 Hz, 
CH3), 1.72 (1H, d, J = 12.4 Hz, CHCH3), 1.83-1.91 (3H, m, C2H2 and CHCH3), 2.06 
(1H, dd, J = 4.4 and 2.0 Hz, C9 ax.), 2.38-2.48 (2H, m, C7, C9 eq.), 3.11 (3H, s, OCH3), 
3.37 (1H, d, J = 3.6 Hz, CHOH), 3.40 (4H, m, OCH3 and CHOH), 3.47 (3H, s, OCH3), 
3.58 (1H, dt, J = 7.2 and 2.4 Hz, CHOCH3), 4.30 (1H, m, CHOCH3), 5.94 (1H, t, J = 1.6 
Hz, C=CH1). 
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Acetic acid (1R,2R,3S,4R,6R,8S,9R,10R,12R)-6-cyano-2-hydroxy-3,12-dimethoxy-
4,8,10-trimethyl-11-oxatricyclo[7.2.1.01,6]dodec-10-ylmethyl ester, 199 
 
CN
OMe
OMeMeO
Chemical Formula: C21H33NO5
Exact Mass: 379.2359
AcO 199  
 
Alcohol 199 (15 mg, 0.044 mmol) was dissolved in pyridine (1 mL). DMAP (5.5 mg, 
0.044 mmol) was added followed by Ac2O (13 µL, 0.13 mmol). The reaction mixture was 
stirred at room temperature for 45 min and then evaporated to dryness in vacuo. The 
residue was purified by flash chromatography eluting with EtOAc:petrol (1:3) to give 
acetate ester 199 as a colourless film (10 mg, 67 % over two steps from methyl ester 
188). IR (neat) νmax 2934, 2829, 2227 (CN), 1741 (C=O), 1459, 1381, 1241, 1098 cm-1; 
1H NMR: δH (400MHz, CDCl3) 1.16 (3H, d, J = 6.4 Hz, CH3), 1.28 (3H, s, CH3), 1.44 
(3H, d, J = 7.2 Hz, CH3), 1.73-1.90 (4H, m), 2.09 (3H, s, C(O)CH3), 2.13 (1H, t, J = 4.0 
Hz), 2.21 (1H, dd, J = 13.6 and 7.2 Hz, C9HH), 2.42 (1H, m, CHC(CH3)OCH3), 3.17 
(3H, s, OCH3), 3.33 (3H, s, OCH3), 3.42 (3H, s, OCH3), 3.55 (1H, dt, J = 6.4 and 2.0 
Hz, CHOCH3), 4.10 (1H, d, J = 11.6 Hz, CHHOAc), 4.21 (1H, m, CHOCH3), 4.47 (1H, 
d, J = 11.6 Hz, CHHOAc), 5.99 (1H, s, CH0=CH1); 13C NMR: δC (100 MHz, CDCl3) 
18.2 (q) (CH3), 20.1 (q) (CH3), 21.1 (q) (CH3), 22.6 (d) (CHCH3), 27.8 (d) (CHCH3), 
31.3 (t) (CH2), 34.1 (s) (CCN), 40.3 (t) (CH2), 41.1 (d) (CH1C(CH3)OCH3), 49.6 (q) 
(OC(O)CH3), 49.9 (q) (OCH3), 56.5 (q) (OCH3), 57.1 (q) (OCH3), 68.5 (t) (CH2OAc), 
78.6 (d) (CHOCH3), 78.8 (s) (CH0OCH3), 80.0 (d) (CHOCH3), 125.2 (2C, s) (CN and 
CH0=CH1), 134.2 (d) (CH0=CH1), 170.9 (s) (C=O); MS (CI+) m/z 397 (MNH4+) 
(100%), 383 (35%), 348 (MH+ - MeOH) (100%); HRMS (CI+) calcd. for C21H37N2O5 
(MNH4+) 397.2702, found 397.2706, Δ = +0.0004 (1.00 ppm); [α]D22 = 22.5 ° (c = 0.87, 
CH2Cl2). 
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Acetic acid (R)-2-((1R,2R,3S,4aS,6R,7S)-4a-cyano-1,7-dimethoxy-3,6-dimethyl-
1,2,3,4,4a,5,6,7-octahydro-naphthalen-2-yl)-2-methoxy-propyl ester, 200 
 
CN
OMe
OMeMeO
Chemical Formula: C21H33NO6
Exact Mass: 395.2308
O
OAc
200  
 
Alkene 199 (12.2 mg, 0.032 mg) was dissolved in CH2Cl2 (0.5 mL) and m-CPBA (7.2 
mg, 0.042 mmol) was added. The reaction mixture was stirred at room temperature for 1 
h before the addition of further m-CPBA (3.0 mg, 0.018 mmol). The reaction mixture was 
stirred for 2 h before being evaporated to dryness in vacuo. The residue was dissolved in 
the minimum amount of CH2Cl2 and loaded onto a short silica column. Elution with 
EtOAc:petrol (1:3) gave a white solid containing m-CPBA as an impurity. The final 
traces of m-CPBA were removed by dissolving the solid in CH2Cl2 (2 mL) and stirring 
vigorously over Amberlyst A-21 resin (300 mg) for 20 min. The solution was filtered and 
the polymer beads washed with further CH2Cl2 (2  2 mL). The filtrate was evaporated 
in vacuo to give epoxide 200 as a colourless film (11 mg, 87%). IR (neat) νmax 2933, 
2233 (CN), 1740 (C=O), 1460, 1382, 1243, 1096 cm-1; 1H NMR: δH (400MHz, CDCl3) 
0.99 (3H, d, J = 6.0 Hz, CH3), 1.28 (3H, s, CH3), 1.41-1.46 (2H, m), 1.49 (3H, d, J = 7.6 
Hz, CH3), 1.66 (2H, m), 2.10 (3H, s, C(O)CH3), 2.14 (1H, d, J = 5.2 Hz, C2), 2.53 (2H, 
m CHCHCOCH3 and C9), 2.90 (1H, d, J = 5.2 Hz, CHOCH3), 3.21 (3H, s, OCH3), 3.35 
(1H, d, J = 8.8 Hz, CHOCH3), 3.41 (3H, s, OCH3), 3.52 (3H, s, OCH3), 4.07 (1H, d, J = 
5.6 Hz, CH-O, C6), 4.27 (1H, d, J = 10.8 Hz, CHHOAc), 4.49 (1H, d, J = 10.8 Hz, 
CHHOAc); 13C NMR: δC (100 MHz, CDCl3) 18.2 (q) (CH3), 20.5 (q) (CH3), 21.1 (q) 
(CH3), 22.0 (d) (CHCH3), 28.7 (d) (CHCH3), 29.3 (d) (CH1C(CH3)OCH3), 36.2 (t) 
(CH2), 37.1 (s) (CCN), 37.7 (t) (CH2), 49.1 (q) (OC(O)CH3), 49.7 (q) (OCH3), 57.9 
(OCH3), 60.3 (OCH3), 60.4 (d) (CH0-O-CH1), 62.9 (s) (CH0-O-CH1), 69.5 (t) 
(CH2OAc), 76.4 (d) (CHOCH3), 78.8 (s) (CH0OCH3), 81.9 (d) (CHOCH3), 124.6 (s) 
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(CN), 170.7 (s) (C=O); MS (CI+) m/z 413 (MNH4+) (100%), 396 (MH+) (30%), 369 
(40%); HRMS (CI+) calcd. for C21H34NO6 (MH+) 396.2400, found 396.2396, Δ = -
0.0004 (1.01 ppm). 
 
Acetic acid (1R,2R,3S,4R,6R,8S,9R,10R,12R)-6-cyano-2-hydroxy-3,12-dimethoxy-
4,8,10-trimethyl-11-oxatricyclo[7.2.1.01,6]dodec-10-ylmethyl ester, 201 
 
CN
OMeO
OMe
OH
Chemical Formula: C20H31NO6
Exact Mass: 381.2151
OAc 201  
 
To a solution of epoxide 200 (8 mg, 0.023 mmol) in CH2Cl2 (1 mL) was added LiI (15 
mg, 0.11 mmol). The reaction mixture was cooled to -78 °C before the addition of BBr3 
(1.0 M solution in CH2Cl2, 7.0 µl, 0.068 mmol). The reaction mixture was stirred for 3 h 
at -78 °C before the addition of Amberlyst A-21 resin (500 mg). After stirring at room 
temperature for 15 min, the reaction mixture was filtered and the polymer beads washed 
with CH2Cl2 (2  2 mL). The filtrate was evaporated to dryness in vacuo and the residue 
purified on a pad of silica eluting with EtOAc:petrol (1:1) to give alcohol 201 as a 
colourless film (6.0 mg, 76%). 1H NMR: δH (400MHz, CDCl3) 1.27 (3H, d, J = 7.6 Hz, 
CH3), 1.36 (3H, s, CH3), 1.40 (3H, d, J = 7.6 Hz, CH3), 1.75 (1H, dd, J = 14.0 and 6.4 
Hz, C2), 1.88-1.97 (3H, m, 2  CHCH3 and C9), 2.10 (3H, s, C(O)CH3), 2.12 (1H, m, 
C2), 2.32-2.37 (2H, m, C7, C9), 3.39 (3H, s, OCH3), 3.29 (1H, m, CHOCH3), 3.45 (3H, 
s, OCH3), 4.16 (1H, d, J = 10.4 Hz, CH2OAc), 4.24 (1H, d, J = 2.8 Hz, CHOCH3), 4.40 
(1H, d, J = 10.4 Hz, CH2OAc), 4.52 (1H, s, CHOH).  
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Acetic acid (1S,3S,4R,6R,8S,9R,10R,12R)-6-cyano-3,12-dimethoxy-4,8,10-trimethyl-
2-oxo-11-oxatricyclo[7.2.1.01,6]dodec-10-ylmethyl ester, 202 
 
CN
OMeO
OMe
Chemical Formula: C20H29NO6
Exact Mass: 379.1995
OAc
O
202  
 
Alcohol 201 (6.5 mg, 0.017 mol) was dissolved in CH2Cl2 (400 µL) and Dess-Martin 
periodinanane (0.3 M solution in CH2Cl2, 85 µL, 0.026 mmol) was added. The reaction 
mixture was stirred at room temperature for 2 h before being evaporated to dryness in 
vacuo. The residue was then dissolved in a minimum amount of CH2Cl2, loaded onto a 
short silica plug and eluting with EtOAc gave ketone 202 as a white solid (6.0 mg, 88%). 
Mp = 142-144 °C; IR (neat) νmax 2926, 2856, 2225 (CN), 1736 (C=O), 1461, 1380, 1247, 
1042 cm-1; 1H NMR: δH (400MHz, CDCl3) 1.36 (3H, s, CH3), 1.37 (3H, d, J = 7.6 Hz), 
1.43 (3H, d, J = 7.6 Hz, CH3), 1.66 (1H, d, J = 13.6 Hz, C2), 1.82 (1H, d, J = 13.6 Hz, 
C2), 1.91 (1H, m), 2.10 (3H, s, C(O)CH3), 2.15-2.23 (2H, m, C8, C3), 2.35 (2H, m, C7, 
C9), 3.36 (3H, s, OCH3), 3.49 (3H, s, OCH3), 4.21 (1H, d, J = 7.6 Hz, CHOCH3), 4.38 
(1H, d, J = 10.8 Hz, CHHOAc), 4.47 (1H, s, CHOCH3), 4.58 (1H, d, J = 10.8 Hz, 
CHHOAc); 13C NMR: δC (100 MHz, CDCl3) 18.6 (q) (CH3), 19.9 (q) (CH3), 21.1 (q) 
(CH3), 29.7 (d) (CHCH3), 30.4 (d) (CHCH3), 34.1 (t) (CH2), 35.4 (t) (CH2), 38.3 (d) 
(CH1C-O-CH0), 42.7 (s) (CCN), 50.7 (q) (C(O)CH3), 58.1 (q) (OCH3), 58.9 (q) (OCH3), 
69.8 (t) (CH2OAc), 86.0 (d) (CHOCH3), 86.5 (s) (CH0CH2OAc), 87.1 (d) (CHOCH3), 
88.6 (s) (CH0C=O), 124.9 (s) (CN), 170.5 (s) (OC(O)CH3), 203.5 (s) (C(O)COMe); MS 
(CI+) m/z 397 (MNH4+) (100%), 383 (35%), 348 (MH+ - MeOH) (100%); HRMS (CI+) 
calcd. for C21H37N2O5 (MNH4+) 397.2702, found 397.2706, Δ = +0.0004 (1.01 ppm). 
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(1S,2S,3S,4R,6R,8S,9R,10R,12R)-2-Hydroxy-10-hydroxymethyl-3,12-dimethoxy-
2,4,8,10-tetramethyl-11-oxatricyclo[7.2.1.01,6]dodecane-6-carbonitrile, 203 
 
CN
OMeO
OMe
Chemical Formula: C19H31NO5
Exact Mass: 353.2202
OH
OH
203  
 
Ketone 202 (3.0 mg, 0.008 mmol) was dissolved in THF (500 µL). MeMgCl (3.0 M 
solution in THF, 11 µL, 0.032 mmol) was added at room temperature and the reaction 
mixture was left to stir for 4 h. The solvent was then removed by blowing the sample 
with N2. The residue was dissolved in a minimum amount of CH2Cl2 and passed through 
a short silica plug. The eluent collected was evaporated in vacuo to give diol 203 as a 
white solid (2.4 mg, 75%). IR (neat) νmax 3496 (br, OH), 2925, 2856, 2361, 2231 (CN), 
1727, 1461, 1377, 1263, 1111 cm-1; 1H NMR: δH (400MHz, CDCl3) 1.29 (6H, s, CH3), 
1.36 (3H, d, J = 7.6 Hz, CH3), 1.41 (3H, d, J = 8.0 Hz, CH3), 1.87 (3H, m), 1.99 (2H, m), 
2.18 (1H, d, J = 2.8 Hz, C9), 2.36 (1H, m, CHC(CH3)CH2OH), 3.37 (4H, m, CHOCH3 
and CHOCH3), 3.54 (1H, d, J = 10.8 Hz, CHHOH), 3.57 (3H, s, OCH3), 4.04 (1H, d, J = 
10.8 Hz, CHHOH), 4.71 (1H, s, CHOCH3); 13C NMR: δC (125 MHz, CDCl3) 18.6 (q) 
(CH3), 20.2 (q) (CH3), 20.9 (q) (CH3), 22.5 (q) (CH3), 27.2 (d) (CHCH3), 29.2 (d) 
(CHCH3), 30.3 (t) (CH2), 42.1, (t) (CH2), 43.0 (s) (CCN), 45.8 (d) (CH1CCH3), 55.4 (q) 
(OCH3), 60.6 (q) (OCH3), 67.9 (t) (CH2OH), 86.0 (d) (CHOCH3), 87.5 (d) (CHOCH3), 
88.4 (s) (CH0COH), 90.9 (s) (COH), 124.9 (s) (CN); MS (CI+) m/z 397 (MNH4+) 
(100%), 383 (35%), 348 (MH+ - MeOH) (100%); HRMS (CI+) calcd. for C21H37N2O5 
(MNH4+) 397.2702, found 397.2706, Δ = +0.0004 (1.01 ppm). 
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(1aR,2aS,4S,5R,6aR,7aS)-(trimethylsilyloxy)-1a,2,2a,5,6,6a,7,7a-
decahydronaphtho[2,3-b,4,5-b]dioxirene-2a-carbonitrile, 207 
 
CN
OSiMe3
C14H21NO3Si
Exact Mass: 279.1291
OO
207  
 
Cyanohydrin 102  (300 mg, 1.45 mmol) was dissolved in 1-trimethylsilylimidazole (0.8 
mL) and the reaction mixture heated to 100 °C under a reflux condenser for 2 h. After 
cooling to room temperature, MeOH (2.5 mL) was added and the mixture was 
concentrated in vacuo to a volume of ca. 1 mL. The residue was placed onto a flash silica 
plug which was eluted with EtOAc:petrol (40:60). Silyl ether 207 was obtained as a 
colourless oil which crystallised upon standing (390 mg, 97%). Mp = 62-63 ºC; IR (neat) 
νmax 2954, 2242 (CN), 1427, 1249, 1143 cm-1 (C-O); 1H NMR: δH (400MHz, CDCl3) 
0.19 (9H, s, SiCH3), 1.98 (2H, d, J = 15.2 Hz, CH ax.), 2.08 (2H, dd, J = 16.4 and 2.0 Hz, 
CH ax.), 2.21 (2H, m, CH eq.), 2.43 (2H, d, J = 16.4 Hz, CH eq.), 3.23 (4H, m, CHO); 
13C NMR: δC (100 MHz, CDCl3) 2.5 (q) (SiCH3), 32.4 (t) (CH2), 35.6 (t) (CH2), 38.1 (s) 
(CCN), 48.1 (d) (CH-O), 50.9 (d) (CH-O), 123.1 (s) (CCN); MS (CI+) m/z 297 (65%) 
(MNH4+), 280 (50%) (MH+), 90 (100%); HRMS (CI+) calcd. for C14H25N2OSi (MH+) 
280.1369, found 280.1368, Δ = -0.0001 (0.36 ppm). 
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 (1aR,2aR,5R,6aR,7aS)-5-Hydroxy-6a-(trimethylsilyloxy)-1a,2,2a,5,6,6a,7,7a-
octahydronaphtho[2,3-b]oxirene-2a-carbonitrile, 210 
 
CN
OH
OSiMe3
O
C14H21NO3Si
Exact Mass: 279.1291
210  
 
To a solution of TMEDA (6.5 µL, 116 mmol) and DBU (64 µL, 0.43 mmol) in THF (1.0 
mL) was added n-BuLi (2.5 M solution in hexanes, 189 µL, 0.473 mmol) dropwise. After 
10 min, a solution of bis-epoxide 207 (30 mg, 0.11 mmol) in THF (0.5 mL) was added. 
The reaction mixture was then stirred at room temperature for 3.5 before addition of i-
PrOH (250 µL). The mixture was then evaporated to dryness in vacuo, the residue 
dissolved in the minimum amount of CH2Cl2 and loaded onto a short plug of silica and 
eluted with EtOAc to give colourless oil (18 mg) which was purified further by flash 
chromatography eluting with EtOAc:petrol (40:60) to give allylic alcohol 210 as a 
colourless film (3.5 mg, 12%). IR (neat) νmax 3378 (br, OH), 2930, 2360, 2235 (CN), 
1430, 1252, 1162 (C-O), 1093 cm-1 (C-O); 1H NMR: δH (400MHz, CDCl3) 0.19 (9H, s, 
SiCH3), 1.98 (2H, d, J = 15.2 Hz, CH ax.), 2.08 (2H, dd, J = 16.4 and 2.0 Hz, CH ax.), 
2.21 (2H, m, CH eq.), 2.43 (2H, d, J = 16.4 Hz, CH eq.), 3.23 (4H, m, CHO); 13C NMR: 
δC (100 MHz, CDCl3) 2.5 (q) (SiCH3), 32.4 (t) (CH2), 35.6 (t) (CH2), 38.1 (s) (CCN), 
48.1 (d) (CH-O), 50.9 (d) (CH-O), 123.1 (s) (CCN); MS (CI+) m/z 299 (65%) (MNH4+), 
280 (50%) (MH+), 90 (100%); HRMS (CI+) calcd. for C14H25N2OSi (MH+) 280.1369, 
found 280.1368, Δ = -0.0001 (0.36 ppm). 
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8a-Trimethylsilanyloxy-1,5,8,8a-tetrahydro-4H-naphthalene-4a-carbonitrile, 218 
 
CN
OSiMe3
C14H21NOSi
Exact Mass: 247.1392
218  
 
Cyanohydrin 101  (75 mg, 0.43 mmol) was dissolved in 1-trimethylsilylimidazole (0.5 
mL) and the reaction mixture heated to 100 °C under a reflux condenser for 16 h. After 
cooling to room temperature, MeOH (50 µL) was added, the mixture diluted with EtOAc 
(4 mL), washed with H2O (3 x 4 mL) and then dried (MgSO4). Evaporation of the solvent 
in vacuo gave a dark brown residue which was purified by flash chromatography eluting 
with EtOAc:petrol (20:80) to give silyl ether 218 as a white solid (101 mg, 95%). Mp = 
76-78 ºC; IR (neat) νmax 2909, 2236 (CN), 1431, 1250, 841 cm-1; 1H NMR: δH (400MHz, 
CDCl3) 0.11 (9H, s, Si(CH3)3), 2.35 (6H, m, C1 ax., C4, C6, C9 ax.), 2.53 (2H, m, C1 eq., 
C9 eq.), 5.67 (4H, m, HC=CH); 13C NMR: δC (100 MHz, CDCl3) 1.8 (q) (SiCH3), 33.3 
(t) (CH2), 37.2 (t) (CH2), 38.6 (s) (CCN), 70.8 (s) (C-OSiMe3), 123.3 (d) (CH1=CH1), 
123.7 (s) (CCN), 124.1 (d) (CH1=CH1); MS (CI+) m/z 265 (100%) (MNH4+), 52 (40%); 
HRMS (CI+) calcd. for C14H25N2OSi (MNH4+) 265.1740, found 265.1736, Δ = -0.0004 
(1.50 ppm). 
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2-Allyl-2-cyanopent-4-enoic acid ethyl ester, 228119 
 
NC
EtO2C
C11H15NO2
Exact Mass: 193.1103
228  
 
According to the method of Kotora,119 to a stirred suspension of K2CO3 in MeCN was 
added tetrabutylammonium sulfate (50% w/w solution in H2O, 4.0 mL, 8.0 mmol) and 
ethyl cyanoacetate (4.54 mL, 40.0 mmol). Allyl bromide (6.92 mL, 80.0 mmol) was then 
added and the reaction mixture stirred at reflux for 2.5 h. After cooling to room 
temperature, H2O (80 mL) was added and the product was extracted with Et2O (3  80 
mL) and the combined organic extracts were dried (MgSO4) and evaporated in vacuo to 
give a brown oil. The crude product was purified on a silica plug eluting with Et2O to 
give diene 228 as a colourless oil (7.02 g, 99%). Analytical data was consistent with that 
previously reported:119 1H NMR: δH (400MHz, CDCl3) 1.35 (3H, t, J = 7.2 Hz, 
OCH2CH3), 2.56 (2H, dd, J = 14.0 and 7.2 Hz, CH2CH=CH2), 2.67 (2H, dd, J = 14.0 and 
7.2 Hz, CH2CH=CH2), 4.27 (4H, q, J = 7.2 Hz, OCH2CH3), 5.24 (2H, m, CH2CH=CH2), 
5.28 (2H, m, CH2CH=CH2), 5.84 (2H, m, CH2CH=CH2).  
 
(3R,4S,5S)-4-Cyano-3,5-dihydroxytetrahydrothiopyran-4-carboxylic acid tert-butyl 
ester, 236126 
 
S
OHHO
C11H17NO4S
Exact Mass: 259.0878
NC CO2
tBu
236  
 
According to the method of Lopez Aparicio,126 to a solution of oxathiane 246 (1.00 g, 
7.35 mmol) in 1,4-dioxane (10 mL) and H2O (5 mL) was added tert-butyl cyanoacetate 
(1.05 mL, 7.35 mmol) followed by piperidine (7.5 µL, 0.074 mmol). A gradual colour 
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change to dark brown was observed. The reaction mixture was stirred at room 
temperature for 45 min before being concentrated in vacuo to approximately 5 mL in 
volume. To the concentrate was added H2O (5 mL) and brine (5 mL). The aqueous 
mixture was extracted with EtOAc (3  40 mL) and the combined organic extracts were 
dried (Na2SO4) and evaporated in vacuo to yield thiopyran 236 as an off-white solid 
(2.03 g, 100%). Analytical data was consistent with that previously reported.126 1H 
NMR: δH (400MHz, d6-DMSO) 1.46 (9H, s, C(CH3)3), 2.51-2.59 (4H, m, SCH2), 3.93 
(2H, m, CHOH), 6.22 (2H, d, J = 4.8 Hz, CHOH). 
 
1R,2R,6S-tert-Butyl-1-cyano-2,6-dihydroxy-4-sulfonylcyclohexanecarboxylate, 237 
 
S
OHHO
C11H17NO6S
Exact Mass: 291.0777
NC CO2
tBu
O O
237  
 
To a solution of thiopyran 236 (170 mg, 0.61 mmol) in CH2Cl2 (4 mL) and EtOAc (2 
mL) was added m-CPBA (243 mg, 1.41 mmol). The reaction mixture was left to stir at 
room temperature for 1.5 h before being evaporated to dryness in vacuo. The residue was 
dissolved in EtOAc (5 mL) and washed with saturated aq. NaHCO3 (3  5 mL). The 
organic phase was dried (Na2SO4) and evaporated in vacuo to give a white solid (302 
mg). The crude product was purified on a silica pad eluting with EtOAc:petrol (2:3) to 
give sulfone 237 as a white solid (151 mg, 80%). Mp = 151-152 ºC; IR (neat) νmax 3471 
(br, OH), 2927, 1747 (C=O), 1312 (S=O asymm.), 1255, 1158 cm-1 (S=O, symm.); 1H 
NMR: δH (400MHz, MeOD) 1.56 (9H, s, C(CH3)3), 3.36 (4H, m, CH2SO2), 4.37 (2H, dd, 
J = 11.6 and 4.0 Hz, CHOH); 13C NMR: δC (100 MHz, MeOD) 26.7 (q) (C(CH3)3), 53.8 
(t) (CH2SO2), 63.3 (s) (CCN), 67.1 (d) (COH), 84.5 (s) (OC(CH3)3), 112.6 (d) (CN), 
165.0 (s) (C=O); MS (CI+) m/z 309 (75%) (MNH4+), 291 (10%), (M+), 185 (100%); 
HRMS (CI+) calcd. for C11H21N2O6S (MNH4+) 309.1120, found 309.1121, Δ = +0.0001 
(0.32 ppm).  
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2-(2,2-Diethoxyethylsulfanyl)-1,1-diethoxy-ethane, 245131 
 
245
S
OEt
OEt
OEt
EtO
C12H26O4S
Exact Mass: 266.1552
 
 
According to the method of Gonzalez,131 to a solution of sodium sulfide (15 g, 192 mmol) 
in EtOH (100 mL) and H2O (50 mL) was added bromoacetaldehyde diethyl acetal (18 
mL, 120 mmol). The reaction was stirred at 90 °C for 13 h before being concentrated to 
ca. 50 mL in vacuo. The aqueous solution remaining was extracted with Et2O (3  50 
mL). The combined organic phases were dried (Na2SO4) and evaporated in vacuo to yield 
sulfide 245 as a pale brown oil (19.2 g, 60%), which was used without further 
purification. Analytical data was consistent with that previously reported:131 1H NMR: 
δH (400MHz, CDCl3) 1.25 (12H, t, J = 7.2 Hz, OCH2CH3), 2.81 (2H, d, J = 5.6 Hz), 
3.48-3.62 (8H, m, OCH2CH3), 3.67-3.78 (4H, m, SCH2), 4.64 (2H, t, J = 5.6 Hz, 
CHOEt). 
 
(2R,6S)-[1,4]Oxathiane-2,6-diol, 246131 
 
O
S
OHHO
C4H8O3S
Exact Mass: 136.0194
246  
 
Acetal 245 (19.2 g, 71.7 mmol) was suspended in 0.5% aq. HCl solution (65 mL) and the 
stirred vigorously at 50 °C until complete dissolution of 245 was observed (1 h). Once 
cooled, Celite® (3 g) was added and the mixture was filtered. The filtrate was 
concentrated in vacuo (heating at 35 °C) to give 25 g of concentrate. The concentrate was 
extracted with Et2O (3  20 mL). The combined organic extracts were dried (Na2SO4) 
and evaporated in vacuo to give oxathiane 246 as a white solid (3.1 g). The aqueous 
concentrate was then re-extracted with CH2Cl2 (3  10 mL), organics dried (Na2SO4) 
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and evaporated to give a further yield of white solid (1.6 g). The total yield of oxathiane 
246 was 4.7 g, 48%. Analytical data was consistent with that previously reported:132 
Compound equilibrates in d6-DMSO solution to mixture with dehydrated dialdehyde. 1H 
NMR: (400 MHz, d6-DMSO) δH 2.32 (4H, m, SCH2), 4.80 (2H, m, CHOH). 
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Appendix 
X-ray Data 
 
(3S,3aS,5aS,9R,9aS,9bS)-9-Bromo-3,5a,9-trimethyl-octahydro-spiro[[1,3]dioxolane-
2,2'-naphtho][1,2-b]furan-8-one, 140 
 
H
O
H
O
C17H25BrO4
Exact Mass: 372.0936
O
O
Br
140  
 
Identification code AS0704 
Empirical formula C17 H25 Br O4 
Formula weight 373.28 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54184 Å 
Crystal system, space group Monoclinic, P2(1) 
Unit cell dimensions a = 8.00502(5) Å α = 90° 
 b = 10.12595(7) Å β = 110.0133(7)° 
 c = 11.24941(7) Å γ = 90° 
Volume, Z 856.80(3) Å3, 2 
Density (calculated) 1.447 Mg/m3 
Absorption coefficient 3.399 mm-1 
F(000) 388 
Crystal colour / morphology Colourless columnal needles 
Crystal size 0.18 x 0.16 x 0.10 mm3 
θ range for data collection 4.18 to 71.43° 
Index ranges -9<=h<=9, -12<=k<=11, -13<=l<=13 
Reflns collected / unique 24107 / 3237 [R(int) = 0.0215] 
Reflns observed [F>4σ(F)] 3195 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.80523 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3237 / 1 / 200 
Goodness-of-fit on F2 1.066 
Final R indices [F>4σ(F)] R1 = 0.0185, wR2 = 0.0500 
 R1+ = 0.0185, wR2+ = 0.0500 
 R1- = 0.0340, wR2- = 0.0948 
R indices (all data) R1 = 0.0188, wR2 = 0.0500 
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Absolute structure parameter x+ = 0.000(11), x- = 1.007(11) 
Extinction coefficient 0.0032(3) 
Largest diff. peak, hole 0.285, -0.217 eÅ-3 
Mean and maximum shift/error 0.000 and 0.002 
Table 2. Bond lengths [Å] and angles [°] for AS0704. 
 
 
 
 
 
 
 
 
 
 
Bond Lengths: 
C(1)-C(2) 1.539(2) 
C(1)-C(11) 1.539(3) 
C(1)-C(10) 1.543(3) 
C(1)-C(6) 1.573(2) 
C(2)-C(3) 1.534(3) 
C(3)-C(4) 1.516(3) 
C(4)-O(12) 1.428(2) 
C(4)-O(15) 1.436(2) 
C(4)-C(5) 1.536(2) 
C(5)-C(16) 1.538(2) 
C(5)-C(6) 1.544(2) 
C(6)-C(7) 1.518(2) 
C(7)-O(17) 1.4670(19) 
C(7)-C(8) 1.526(2) 
C(8)-C(19) 1.511(2) 
C(8)-C(9) 1.514(2) 
C(9)-C(10) 1.533(3) 
O(12)-C(13) 1.409(3) 
C(13)-C(14) 1.485(3) 
C(14)-O(15) 1.416(2) 
O(17)-C(18) 1.350(2) 
C(18)-O(18) 1.194(2) 
C(18)-C(19) 1.530(2) 
C(19)-C(20) 1.518(3) 
C(19)-Br 1.9938(17) 
 
Bond Angles: 
C(2)-C(1)-C(11) 109.41(16) 
C(2)-C(1)-C(10) 108.43(15) 
C(11)-C(1)-C(10) 108.72(15) 
C(2)-C(1)-C(6) 107.13(13) 
C(11)-C(1)-C(6) 112.94(14) 
C(10)-C(1)-C(6) 110.11(15) 
C(3)-C(2)-C(1) 111.81(16) 
C(4)-C(3)-C(2) 110.70(15) 
O(12)-C(4)-O(15) 105.85(13) 
O(12)-C(4)-C(3) 109.97(15) 
O(15)-C(4)-C(3) 109.38(15) 
O(12)-C(4)-C(5) 108.05(14) 
O(15)-C(4)-C(5) 109.91(14) 
C(3)-C(4)-C(5) 113.40(15) 
C(4)-C(5)-C(16) 109.90(15) 
C(4)-C(5)-C(6) 110.34(14) 
C(16)-C(5)-C(6) 112.40(14) 
C(7)-C(6)-C(5) 115.44(14) 
C(7)-C(6)-C(1) 106.08(12) 
C(5)-C(6)-C(1) 112.51(14) 
O(17)-C(7)-C(6) 115.79(13) 
O(17)-C(7)-C(8) 101.98(13) 
C(6)-C(7)-C(8) 111.39(14) 
C(19)-C(8)-C(9) 123.46(14) 
C(19)-C(8)-C(7) 102.42(14) 
C(9)-C(8)-C(7) 112.71(15) 
C(8)-C(9)-C(10) 107.07(14) 
C(9)-C(10)-C(1) 113.86(15) 
C(13)-O(12)-C(4) 107.44(16) 
O(12)-C(13)-C(14) 104.66(17) 
O(15)-C(14)-C(13) 106.25(18) 
C(14)-O(15)-C(4) 108.36(14) 
C(18)-O(17)-C(7) 109.82(13) 
O(18)-C(18)-O(17) 123.15(16) 
O(18)-C(18)-C(19) 127.09(17) 
O(17)-C(18)-C(19) 109.75(14) 
C(8)-C(19)-C(20) 118.17(16) 
C(8)-C(19)-C(18) 100.62(13) 
C(20)-C(19)-C(18) 114.16(16) 
C(8)-C(19)-Br 111.19(12) 
C(20)-C(19)-Br 108.19(12) 
C(18)-C(19)-Br 103.47(12) 
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(3S,3aR,4S,5aS,7R,8S,9bR)-3-Bromo-8-(tert-butyldimethylsilanyloxy)-3,4,7-trimethyl-2-
oxo-3,3a,4,5,6,7,8,9b-octahydro-2H-naphtho[1,2-b]furan-5a-carbonitrile, 143a 
 
CN
O
O
OTBS
Br
C22H34BrNO3Si
Exact Mass: 467.1491
143a  
 
Identification code AS0801 
Empirical formula C22 H34 Br N O3 Si 
Formula weight 468.50 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur 3, 0.71073 Å 
Crystal system, space group Triclinic, P-1 
Unit cell dimensions a = 8.33764(16) Å α = 87.990(2)° 
 b = 11.1787(3) Å β = 76.8660(19)° 
 c = 14.0235(3) Å γ = 69.337(2)° 
Volume, Z 1189.51(5) Å3, 2 
Density (calculated) 1.308 Mg/m3 
Absorption coefficient 1.799 mm-1 
F(000) 492 
Crystal colour / morphology Colourless blocky needles 
Crystal size 0.24 x 0.21 x 0.06 mm3 
θ range for data collection 3.87 to 32.33° 
Index ranges -12<=h<=10, -16<=k<=16, -19<=l<=20 
Reflns collected / unique 18526 / 7568 [R(int) = 0.0379] 
Reflns observed [F>4σ(F)] 4899 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.88517 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7568 / 0 / 253 
Goodness-of-fit on F2 0.969 
Final R indices [F>4σ(F)] R1 = 0.0330, wR2 = 0.0754 
R indices (all data) R1 = 0.0637, wR2 = 0.0868 
Largest diff. peak, hole 0.588, -0.561 eÅ-3 
Mean and maximum shift/error 0.000 and 0.000 
 
Table 2. Bond lengths [Å] and angles [°] for AS0801. 
Bond Lengths: 
Br-C(23) 1.9997(15) 
C(1)-C(11) 1.493(2) 
C(1)-C(6) 1.516(2) 
C(1)-C(2) 1.540(2) 
C(1)-C(10) 1.551(3) 
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C(2)-C(3) 1.527(2) 
C(3)-C(4) 1.522(2) 
C(3)-C(12) 1.531(3) 
C(4)-O(13) 1.4308(19) 
C(4)-C(5) 1.504(2) 
C(5)-C(6) 1.321(2) 
C(6)-C(7) 1.500(2) 
C(7)-O(21) 1.4543(19) 
C(7)-C(8) 1.555(2) 
C(8)-C(23) 1.539(2) 
C(8)-C(9) 1.545(2) 
C(9)-C(25) 1.527(3) 
C(9)-C(10) 1.540(2) 
C(11)-N(11) 1.136(2) 
O(13)-Si(14) 1.6557(13) 
Si(14)-C(20) 1.866(2) 
Si(14)-C(19) 1.868(2) 
Si(14)-C(15) 1.8751(17) 
C(15)-C(18) 1.531(3) 
C(15)-C(17) 1.535(3) 
C(15)-C(16) 1.537(2) 
O(21)-C(22) 1.342(2) 
C(22)-O(22) 1.2001(19) 
C(22)-C(23) 1.522(2) 
C(23)-C(24) 1.505(3) 
 
Bond Angles: 
C(11)-C(1)-C(6) 107.67(13) 
C(11)-C(1)-C(2) 107.95(14) 
C(6)-C(1)-C(2) 112.10(14) 
C(11)-C(1)-C(10) 109.12(15) 
C(6)-C(1)-C(10) 107.40(14) 
C(2)-C(1)-C(10) 112.46(14) 
C(3)-C(2)-C(1) 111.61(14) 
C(4)-C(3)-C(2) 108.45(14) 
C(4)-C(3)-C(12) 112.11(16) 
C(2)-C(3)-C(12) 110.97(16) 
O(13)-C(4)-C(5) 109.26(14) 
O(13)-C(4)-C(3) 109.91(13) 
 
C(5)-C(4)-C(3) 111.26(14) 
C(6)-C(5)-C(4) 124.04(15) 
C(5)-C(6)-C(7) 125.85(15) 
C(5)-C(6)-C(1) 122.41(15) 
C(7)-C(6)-C(1) 111.58(13) 
O(21)-C(7)-C(6) 109.60(12) 
O(21)-C(7)-C(8) 106.52(13) 
C(6)-C(7)-C(8) 113.16(13) 
C(23)-C(8)-C(9) 119.19(14) 
C(23)-C(8)-C(7) 101.15(12) 
C(9)-C(8)-C(7) 110.12(13) 
C(25)-C(9)-C(10) 107.10(14) 
C(25)-C(9)-C(8) 114.61(15) 
C(10)-C(9)-C(8) 108.04(13) 
C(9)-C(10)-C(1) 115.86(13) 
N(11)-C(11)-C(1) 178.68(18) 
C(4)-O(13)-Si(14) 124.08(11) 
O(13)-Si(14)-C(20) 109.83(8) 
O(13)-Si(14)-C(19) 109.68(9) 
C(20)-Si(14)-C(19) 109.29(11) 
O(13)-Si(14)-C(15) 104.84(7) 
C(20)-Si(14)-C(15) 111.60(9) 
C(19)-Si(14)-C(15) 111.51(9) 
C(18)-C(15)-C(17) 108.66(15) 
C(18)-C(15)-C(16) 109.13(16) 
C(17)-C(15)-C(16) 109.50(15) 
C(18)-C(15)-Si(14) 109.80(12) 
C(17)-C(15)-Si(14) 110.09(13) 
C(16)-C(15)-Si(14) 109.63(12) 
C(22)-O(21)-C(7) 110.62(12) 
O(22)-C(22)-O(21) 121.97(16) 
O(22)-C(22)-C(23) 127.45(16) 
O(21)-C(22)-C(23) 110.58(13) 
C(24)-C(23)-C(22) 112.46(14) 
C(24)-C(23)-C(8) 122.88(15) 
C(22)-C(23)-C(8) 104.08(13) 
C(24)-C(23)-Br 107.78(11) 
C(22)-C(23)-Br 101.24(10) 
C(8)-C(23)-Br        106.17(10)
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(5a´S,9a´S,9b´R)-3´,5a´-dimethyl-4´,5´,5a´,6´,7´,9´,9a´,9b´-octahydro-2H-
spiro[[1,3]dioxolane-2,8-naphtho[1,2-b]furan]-2´-one, 156 
 
H
O
O
C17H24O4
Exact Mass: 292.1675
O
O
156  
 
Identification code AS0804 
Empirical formula C17 H24 O4 
Formula weight 292.36 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54184 Å 
Crystal system, space group Orthorhombic, P2(1)2(1)2(1) 
Unit cell dimensions a = 9.19320(3) Å α = 90° 
 b = 10.52703(5) Å β = 90° 
 c = 15.46574(6) Å γ = 90° 
Volume, Z 1496.73(1) Å3, 4 
Density (calculated) 1.297 Mg/m3 
Absorption coefficient 0.738 mm-1 
F(000) 632 
Crystal colour / morphology Colourless blocks 
Crystal size 0.29 x 0.22 x 0.14 mm3 
θ range for data collection 5.08 to 71.43° 
Index ranges -11<=h<=11, -11<=k<=12, -19<=l<=18 
Reflns collected / unique 41563 / 2893 [R(int) = 0.0251] 
Reflns observed [F>4σ(F)] 2769 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.91699 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2893 / 0 / 192 
Goodness-of-fit on F2 1.064 
Final R indices [F>4σ(F)] R1 = 0.0298, wR2 = 0.0798 
 R1+ = 0.0298, wR2+ = 0.0798 
 R1- = 0.0300, wR2- = 0.0805 
R indices (all data) R1 = 0.0309, wR2 = 0.0804 
Absolute structure parameter x+ = 0.00(16), x- = **** 
Extinction coefficient 0.0051(7) 
Largest diff. peak, hole 0.203, -0.154 eÅ-3 
Mean and maximum shift/error 0.000 and 0.000 
Table 2. Bond lengths [Å] and angles [°] for AS0804. 
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Bond Lengths: 
C(1)-C(2) 1.527(2) 
C(1)-C(10) 1.5353(19) 
C(2)-C(3) 1.522(2) 
C(3)-O(11) 1.4266(16) 
C(3)-O(14) 1.4330(16) 
C(3)-C(4) 1.5324(18) 
C(4)-C(15) 1.5277(19) 
C(4)-C(5) 1.5444(17) 
C(5)-C(6) 1.5338(17) 
C(5)-C(10) 1.5601(17) 
C(6)-O(16) 1.4517(15) 
C(6)-C(7) 1.4969(18) 
C(7)-C(18) 1.333(2) 
C(7)-C(8) 1.4914(19) 
C(8)-C(9) 1.536(2) 
C(9)-C(10) 1.5398(19) 
C(10)-C(20) 1.5385(19) 
O(11)-C(12) 1.4156(19) 
C(12)-C(13) 1.487(2) 
C(13)-O(14) 1.4098(18) 
O(16)-C(17) 1.3644(16) 
C(17)-O(17) 1.2092(18) 
C(17)-C(18) 1.468(2) 
C(18)-C(19) 1.4942(19) 
 
Bond Angles: 
C(2)-C(1)-C( 
10) 112.87(11) 
C(3)-C(2)-C(1) 112.39(12) 
O(11)-C(3)-O(14) 106.04(10) 
O(11)-C(3)-C(2) 109.81(11) 
O(14)-C(3)-C(2) 109.74(11) 
O(11)-C(3)-C(4) 108.82(10) 
O(14)-C(3)-C(4) 109.64(10) 
C(2)-C(3)-C(4) 112.57(11) 
C(15)-C(4)-C(3) 110.98(11) 
C(15)-C(4)-C(5) 114.99(11) 
C(3)-C(4)-C(5) 109.10(10) 
C(6)-C(5)-C(4) 113.81(10) 
C(6)-C(5)-C(10) 109.85(10) 
C(4)-C(5)-C(10) 111.40(10) 
O(16)-C(6)-C(7) 103.65(10) 
O(16)-C(6)-C(5) 111.83(10) 
C(7)-C(6)-C(5) 113.08(11) 
C(18)-C(7)-C(8) 130.34(13) 
C(18)-C(7)-C(6) 110.31(12) 
C(8)-C(7)-C(6) 119.07(12) 
C(7)-C(8)-C(9) 107.26(11) 
C(8)-C(9)-C(10) 113.23(12) 
C(1)-C(10)-C(20) 109.68(12) 
C(1)-C(10)-C(9) 108.69(11) 
C(20)-C(10)-C(9) 108.72(11) 
C(1)-C(10)-C(5) 107.28(11) 
C(20)-C(10)-C(5) 112.92(11) 
C(9)-C(10)-C(5) 109.47(11) 
C(12)-O(11)-C(3) 107.15(11) 
O(11)-C(12)-C(13) 104.94(13) 
O(14)-C(13)-C(12) 105.76(13) 
C(13)-O(14)-C(3) 109.06(11) 
C(17)-O(16)-C(6) 109.13(10) 
O(17)-C(17)-O(16) 121.22(13) 
O(17)-C(17)-C(18) 129.49(13) 
O(16)-C(17)-C(18) 109.27(11) 
C(7)-C(18)-C(17) 107.43(12) 
C(7)-C(18)-C(19) 130.91(13) 
C(17)-C(18)-C(19) 121.65(13) 
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(3R,3aR,4S,5aS,7R,8S,9bR)-2,3,3a,4,5,5a,6,7,8,9b-Decahydro-8-hydroxy-3-methoxy-
3,4,7-trimethyl-2-oxonaphtho[1,2-b]furan-5a-carbonitrile, 177 
 
CN
C17H23NO4
Exact Mass: 305.1627
O
OH
O
H
H
MeO
177  
 
Identification code AS0708 
Empirical formula C17 H23 N O4 . solvent 
 [solvent assigned as C3] 
Formula weight 341.39 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54184 Å 
Crystal system, space group Tetragonal, P4(3) 
Unit cell dimensions a = 16.17334(8) Å α = 90° 
 b = 16.17334(8) Å β = 90° 
 c = 7.32742(7) Å γ = 90° 
Volume, Z 1916.68(12) Å3, 4 
Density (calculated) 1.183 Mg/m3 
Absorption coefficient 0.668 mm-1 
F(000) 728 
Crystal colour / morphology Colourless needles 
Crystal size 0.24 x 0.07 x 0.03 mm3 
θ range for data collection 6.12 to 71.50° 
Index ranges -19<=h<=19, -19<=k<=19, -8<=l<=9 
Reflns collected / unique 27753 / 3390 [R(int) = 0.0497] 
Reflns observed [F>4σ(F)] 2462 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.94336 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3390 / 2 / 232 
Goodness-of-fit on F2 0.923 
Final R indices [F>4σ(F)] R1 = 0.0372, wR2 = 0.0885 
 R1+ = 0.0372, wR2+ = 0.0885 
 R1- = 0.0373, wR2- = 0.0889 
R indices (all data) R1 = 0.0542, wR2 = 0.0956 
Absolute structure parameter x+ = 0.0(2), x- = 1.1(2) 
 Absolute structure indeterminate, 
 assigned by internal reference on 
 C2, C3, C8 and C10 
Extinction coefficient 0.0028(4) 
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Largest diff. peak, hole 0.179, -0.110 eÅ-3 
Mean and maximum shift/error 0.000 and 0.000 
Table 2. Bond lengths [Å] and angles [°] for AS0708.
 
 
Bond Lengths: 
C(1)-C(2) 1.532(2) 
C(1)-C(10) 1.542(3) 
C(2)-C(3) 1.518(3) 
C(2)-C(11) 1.523(3) 
C(3)-O(12) 1.436(2) 
C(3)-C(4) 1.496(3) 
C(4)-C(5) 1.326(3) 
C(5)-C(6) 1.505(3) 
C(5)-C(10) 1.520(3) 
C(6)-O(13) 1.448(2) 
C(6)-C(7) 1.536(3) 
C(7)-C(15) 1.520(3) 
C(7)-C(8) 1.545(3) 
C(8)-C(9) 1.527(3) 
C(8)-C(19) 1.537(3) 
C(9)-C(10) 1.549(3) 
C(10)-C(20) 1.483(3) 
O(13)-C(14) 1.345(3) 
C(14)-O(14) 1.216(3) 
C(14)-C(15) 1.519(4) 
C(15)-O(16) 1.433(3) 
C(15)-C(18) 1.520(3) 
O(16)-C(17) 1.413(3) 
C(20)-N(21) 1.140(3) 
 
Bond Angles: 
C(2)-C(1)-C(10) 113.80(16) 
C(3)-C(2)-C(11) 112.23(15) 
C(3)-C(2)-C(1) 107.18(15) 
C(11)-C(2)-C(1) 110.00(15) 
O(12)-C(3)-C(4) 109.04(15) 
O(12)-C(3)-C(2) 110.00(15) 
C(4)-C(3)-C(2) 111.15(14) 
C(5)-C(4)-C(3) 124.38(18) 
C(4)-C(5)-C(6) 123.93(19) 
C(4)-C(5)-C(10) 122.20(18) 
C(6)-C(5)-C(10) 113.78(16) 
O(13)-C(6)-C(5) 110.71(15) 
O(13)-C(6)-C(7) 104.13(17) 
C(5)-C(6)-C(7) 113.79(18) 
C(15)-C(7)-C(6) 102.44(17) 
C(15)-C(7)-C(8) 117.6(2) 
C(6)-C(7)-C(8) 115.55(18) 
C(9)-C(8)-C(19) 113.1(2) 
C(9)-C(8)-C(7) 113.52(17) 
C(19)-C(8)-C(7) 109.9(2) 
C(8)-C(9)-C(10) 115.87(18) 
C(20)-C(10)-C(5) 108.91(17) 
C(20)-C(10)-C(1) 105.92(16) 
C(5)-C(10)-C(1) 111.88(15) 
C(20)-C(10)-C(9) 110.81(16) 
C(5)-C(10)-C(9) 108.14(17) 
C(1)-C(10)-C(9) 111.19(17) 
C(14)-O(13)-C(6) 109.80(17) 
O(14)-C(14)-O(13) 120.6(3) 
O(14)-C(14)-C(15) 128.4(3) 
O(13)-C(14)-C(15) 111.02(19) 
O(16)-C(15)-C(14) 109.77(17) 
O(16)-C(15)-C(7) 106.18(19) 
C(14)-C(15)-C(7) 101.1(2) 
O(16)-C(15)-C(18) 112.0(2) 
C(14)-C(15)-C(18) 112.4(2) 
C(7)-C(15)-C(18) 114.72(19) 
C(17)-O(16)-C(15) 117.6(2) 
N(21)-C(20)-C(10) 176.9(2) 
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(1R,2R,3S,4R,6R,8S,9R,10R,12R)-6-Cyano-2-hydroxy-3,12-dimethoxy-4,8,10-
trimethyl-11-oxa-tricyclo[7.2.1.01,6]dodecane-10-carboxylic acid methyl ester, 195 
 
CN
OMeO
OMe
OH
Chemical Formula: C19H29NO6
Exact Mass: 367.1995
OMe
O
195  
 
Identification code AS0903 
Empirical formula C19 H29 N O6 
Formula weight 367.43 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54184 Å 
Crystal system, space group Monoclinic, P2(1)/c 
Unit cell dimensions a = 10.6847(2) Å α = 90° 
 b = 12.1746(3) Å β = 95.328(2)° 
 c = 14.6780(3) Å γ = 90° 
Volume, Z 1901.09(7) Å3, 4 
Density (calculated) 1.284 Mg/m3 
Absorption coefficient 0.784 mm-1 
F(000) 792 
Crystal colour / morphology Colourless blocks 
Crystal size 0.26 x 0.17 x 0.14 mm3 
θ range for data collection 4.16 to 72.55° 
Index ranges -12<=h<=13, -15<=k<=15, -18<=l<=15 
Reflns collected / unique 28509 / 3756 [R(int) = 0.0297] 
Reflns observed [F>4σ(F)] 3397 
Absorption correction Analytical 
Max. and min. transmission 0.926 and 0.884 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3756 / 1 / 243 
Goodness-of-fit on F2 1.081 
Final R indices [F>4σ(F)] R1 = 0.0370, wR2 = 0.1000 
R indices (all data) R1 = 0.0407, wR2 = 0.1021 
Extinction coefficient 0.0013(3) 
Largest diff. peak, hole 0.349, -0.185 eÅ-3 
Mean and maximum shift/error 0.000 and 0.000 
 
Table 2. Bond lengths [Å] and angles [°] for AS0903. 
Bond Lengths: 
C(1)-C(2) 1.5336(19) C(1)-C(10) 1.5446(18) 
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C(2)-C(11) 1.532(2) 
C(2)-C(3) 1.5341(18) 
C(3)-O(12) 1.4283(15) 
C(3)-C(4) 1.5364(16) 
C(4)-O(14) 1.4248(14) 
C(4)-C(5) 1.5330(16) 
C(5)-O(15) 1.4529(14) 
C(5)-C(6) 1.5367(17) 
C(5)-C(10) 1.5616(16) 
C(6)-O(21) 1.4197(14) 
C(6)-C(7) 1.5384(16) 
C(7)-C(16) 1.5387(17) 
C(7)-C(8) 1.5444(17) 
C(8)-C(23) 1.5347(19) 
C(8)-C(9) 1.5433(19) 
C(9)-C(10) 1.5537(17) 
C(10)-C(24) 1.4814(18) 
O(12)-C(13) 1.4145(17) 
O(15)-C(16) 1.4356(14) 
C(16)-C(20) 1.5292(17) 
C(16)-C(17) 1.5362(17) 
C(17)-O(17) 1.2105(16) 
C(17)-O(18) 1.3308(15) 
O(18)-C(19) 1.4469(16) 
O(21)-C(22) 1.4272(15) 
C(24)-N(25) 1.1461(18) 
 
Bond Angles: 
C(2)-C(1)-C(10) 115.96(10) 
C(11)-C(2)-C(1) 114.97(12) 
C(11)-C(2)-C(3) 113.02(11) 
C(1)-C(2)-C(3) 110.68(10) 
O(12)-C(3)-C(2) 105.76(10) 
O(12)-C(3)-C(4) 111.86(10) 
C(2)-C(3)-C(4) 114.09(10) 
O(14)-C(4)-C(5) 110.28(9) 
O(14)-C(4)-C(3) 106.31(9) 
C(5)-C(4)-C(3) 113.83(10) 
O(15)-C(5)-C(4) 107.30(9) 
O(15)-C(5)-C(6) 104.79(9) 
C(4)-C(5)-C(6) 114.40(9) 
O(15)-C(5)-C(10) 107.37(9) 
C(4)-C(5)-C(10) 113.47(10) 
C(6)-C(5)-C(10) 108.90(9) 
O(21)-C(6)-C(5) 107.71(9) 
O(21)-C(6)-C(7) 113.09(10) 
C(5)-C(6)-C(7) 99.05(9) 
C(6)-C(7)-C(16) 99.20(9) 
C(6)-C(7)-C(8) 109.83(10) 
C(16)-C(7)-C(8) 113.31(10) 
C(23)-C(8)-C(9) 113.76(11) 
C(23)-C(8)-C(7) 110.94(11) 
C(9)-C(8)-C(7) 112.01(10) 
C(8)-C(9)-C(10) 115.85(10) 
C(24)-C(10)-C(1) 110.08(10) 
C(24)-C(10)-C(9) 107.41(10) 
C(1)-C(10)-C(9) 109.60(10) 
C(24)-C(10)-C(5) 111.72(10) 
C(1)-C(10)-C(5) 109.70(10) 
C(9)-C(10)-C(5) 108.27(10) 
C(13)-O(12)-C(3) 114.74(10) 
C(16)-O(15)-C(5) 109.22(8) 
O(15)-C(16)-C(20) 108.47(10) 
O(15)-C(16)-C(17) 111.86(9) 
C(20)-C(16)-C(17) 105.59(10) 
O(15)-C(16)-C(7) 104.33(9) 
C(20)-C(16)-C(7) 117.52(10) 
C(17)-C(16)-C(7) 109.20(10) 
O(17)-C(17)-O(18) 123.98(11) 
O(17)-C(17)-C(16) 122.76(11) 
O(18)-C(17)-C(16) 112.99(10) 
C(17)-O(18)-C(19) 115.10(10) 
C(6)-O(21)-C(22) 113.86(9) 
N(25)-C(24)-C(10) 174.24(13) 
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(3R,4S,5S)-4-Cyano-3,5-dihydroxy-tetrahydro-thiopyran-4-carboxylic acid tert-
butyl ester, 236 
 
S
OHHO
C11H17NO4S
Exact Mass: 259.0878
NC CO2
tBu
236  
 
 
Identification code AS0908 
Empirical formula C11 H17 N O4 S 
Formula weight 259.32 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54184 Å 
Crystal system, space group Orthorhombic, Pbca 
Unit cell dimensions a = 12.50234(9) Å α = 90° 
 b = 12.10604(9) Å β = 90° 
 c = 17.39771(12) Å γ = 90° 
Volume, Z 2633.21(3) Å3, 8 
Density (calculated) 1.308 Mg/m3 
Absorption coefficient 2.236 mm-1 
F(000) 1104 
Crystal colour / morphology Colourless platy needles 
Crystal size 0.25 x 0.06 x 0.03 mm3 
θ range for data collection 5.08 to 72.51° 
Index ranges -15<=h<=12, -14<=k<=14, -21<=l<=20 
Reflns collected / unique 17153 / 2593 [R(int) = 0.0264] 
Reflns observed [F>4σ(F)] 2300 
Absorption correction Analytical 
Max. and min. transmission 0.938 and 0.717 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2593 / 2 / 162 
Goodness-of-fit on F2 1.062 
Final R indices [F>4σ(F)] R1 = 0.0310, wR2 = 0.0827 
R indices (all data) R1 = 0.0356, wR2 = 0.0846 
Largest diff. peak, hole 0.264, -0.173 eÅ-3 
Mean and maximum shift/error 0.000 and 0.001 
Table 2. Bond lengths [Å] and angles [°] for AS0908. 
 
Bond Lengths: 
S(1)-C(6) 1.8039(13) 
S(1)-C(2) 1.8069(13) 
C(2)-C(3) 1.5169(17) 
C(3)-O(7) 1.4166(15) 
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C(3)-C(4) 1.5487(16) 
C(4)-C(8) 1.4742(16) 
C(4)-C(9) 1.5433(16) 
C(4)-C(5) 1.5573(16) 
C(5)-O(15) 1.4273(14) 
C(5)-C(6) 1.5173(18) 
C(8)-N(8) 1.1449(16) 
C(9)-O(9) 1.2017(15) 
C(9)-O(10) 1.3225(15) 
O(10)-C(11) 1.4979(15) 
C(11)-C(13) 1.509(2) 
C(11)-C(12) 1.516(2) 
C(11)-C(14) 1.518(2) 
 
Bond Angles: 
C(6)-S(1)-C(2) 98.50(6) 
C(3)-C(2)-S(1) 112.29(8) 
O(7)-C(3)-C(2) 111.25(10) 
O(7)-C(3)-C(4) 105.29(9) 
C(2)-C(3)-C(4) 112.76(10) 
C(8)-C(4)-C(9) 112.11(10) 
C(8)-C(4)-C(3) 108.87(9) 
C(9)-C(4)-C(3) 107.96(9) 
C(8)-C(4)-C(5) 110.08(9) 
C(9)-C(4)-C(5) 106.61(9) 
C(3)-C(4)-C(5) 111.21(9) 
O(15)-C(5)-C(6) 109.50(10) 
O(15)-C(5)-C(4) 108.31(9) 
C(6)-C(5)-C(4) 112.44(9) 
C(5)-C(6)-S(1) 111.61(9) 
N(8)-C(8)-C(4) 175.69(13) 
O(9)-C(9)-O(10) 127.23(11) 
O(9)-C(9)-C(4) 119.87(11) 
O(10)-C(9)-C(4) 112.86(9) 
C(9)-O(10)-C(11) 119.95(9) 
O(10)-C(11)-C(13) 102.94(10) 
O(10)-C(11)-C(12) 109.85(11) 
C(13)-C(11)-C(12) 110.57(12) 
O(10)-C(11)-C(14) 108.69(11) 
C(13)-C(11)-C(14) 110.86(13) 
C(12)-C(11)-C(14) 113.40(13) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
